H2N2V1, Istex, Corpus, bibRecord, 000F50

Glycopeptide dendrimers, Part III—a review: Use of glycopeptide dendrimers in immunotherapy and diagnosis of cancer and viral diseases

Identifieur interne : 000F50 ( Istex/Corpus ); précédent : 000F49; suivant : 000F51

Glycopeptide dendrimers, Part III—a review: Use of glycopeptide dendrimers in immunotherapy and diagnosis of cancer and viral diseases

Auteurs : Petr Niederhafner ; Milan Reiniš ; Jaroslav Šebestík ; Jan Ježek

Source :

Journal of Peptide Science [ 1075-2617 ] ; 2008-05.

RBID : ISTEX:0E9802423ACEDED654B076627B0AF400FBC38155

English descriptors

Teeft :
- Acad, Adjuvant, Amino, Amino acid, Analog, Angew, Anticancer, Anticancer vaccine, Anticancer vaccines, Antigen, Antigenic, Antitumor, Antitumor vaccines, Antiviral, Antiviral agents, Assay, Binding patterns, Binding sites, Biol, Biological activities, Biological activity, Bioorg, Biotechnol, Breast cancer, Breast cancer patients, Cancer cells, Cancer immunol, Cancer vaccines, Carbohydrate, Carbohydrate antigen, Carbohydrate antigens, Cell surface, Ceramide, Chem, Chemical synthesis, Chemical technology, Chemokine coreceptors, Cholic, Clin, Clinical trials, Conformation, Conformational analysis, Conjugate, Conjugate vaccine, Cooh, Copyright, Curr, Cyclic, Cyclic glycopeptides, Cyclic peptides, Czech, Czech republic, Danishefsky, Dendrimer, Dendrimeric, Dendrimers, Dendritic, Dendritic polymers, Drug deliv, Drug delivery, Drug discov, Drug discovery, Elisa, Engl, Enzymatic synthesis, Epithelial, Epitope, European peptide society, Free drug, Galactose, Galactose residue, Galcer, Galnac, Glcnac2, Glycans, Glycobiology, Glycoconjugates, Glycodendrimers, Glycopeptide, Glycopeptide dendrimers, Glycopeptide synthesis, Glycopeptides, Glycoprotein, Glycosylated, Glycosylation, Helper peptides, Hexavalent, High degree, High titers, Hong kong, Hooc, Human glycophorin, Human jurkat cells, Human tumor cells, Humoral, Immune, Immune response, Immune system, Immunization, Immunogenic, Immunogenicity, Immunol, Immunological, Immunological evaluation, Immunotherapy, Important role, Infectious diseases, Inhibitor, John wiley sons, Kunz, Leclerc, Lectin, Ligand, Ligation, Lipophilicity, Livingston, Mag, Man9, Marcel dekker, Metastatic breast cancer patients, Mice vaccinated, Moiety, Molecular dynamics, Molecular genetics, Molecular modeling, Monovalent, Monovalent vaccines, More immunogenic, Mppi, Muc1, Mucin, Mucin glycoprotein architecture, Multiantigenic, Multivalent, Natl, Neuraminidase inhibitors, Niederhafner, Oligosaccharide, Opin, Organic chemistry, Padre, Pal3, Pamam, Pamam dendrimer, Pamam dendrimers, Pentavalent, Pentavalent vaccine, Pept, Peptide, Peptide backbone, Peptide sequence, Polymer, Polyvalent, Potent inhibitor, Prague, Proc, Prostate, Prostate cancer, Ragupathi, Recent developments, Recent progress, Receptor, Results show, Saccharide, Saccharides biology, Serine, Sialotrisaccharide units, Side chains, Slea, Subtype strains, Suitable carrier, Sulfate, Synthesis, Synthetic, Synthetic anticancer vaccines, Synthetic carbohydrate, Synthetic glycopeptides, Synthetic peptide, Synthetic vaccine, Synthetic vaccines, Tacas, Therapeutic vaccinations, Titer, Total synthesis, Transgenic mice, Triantennary, Tumor antigens, Tumor cells, Tumor challenge, Unconjugated pentavalent vaccine, Undecasaccharide, Unimolecular, Unimolecular pentavalent, Vaccinated, Vaccination, Vaccine, Viral, Wang, Weinheim, Wiley.

Abstract

Glycopeptide dendrimers containing different types of tumor associated‐carbohydrate antigens (TN, TF, sialyl‐TN, sialyl‐TF, sialyl‐Lex, sialyl‐Lea etc.) were used in diagnosis and therapy of different sorts of cancer. These dendrimeric structures with incorporated T‐cell epitopes and adjuvants can be used as antitumor vaccines. Best results were obtained with multiantigenic vaccines, containing, e.g. five or six different TAAs. The topic of TAAs and their dendrimeric forms at molecular level are reviewed, including structure, syntheses, and biological activities. Use of glycopeptide dendrimers as antiviral vaccines against HIV and influenza is also described. Their syntheses, physico‐chemical properties, and biological activities are given with many examples. Copyright © 2008 European Peptide Society and John Wiley & Sons, Ltd.

Url:

https://api.istex.fr/ark:/67375/WNG-G8S292DG-9/fulltext.pdf

DOI: 10.1002/psc.1011

Links to Exploration step

ISTEX:0E9802423ACEDED654B076627B0AF400FBC38155

Le document en format XML

<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Glycopeptide dendrimers, Part III—a review: Use of glycopeptide dendrimers in immunotherapy and diagnosis of cancer and viral diseases</title>
<author><name sortKey="Niederhafner, Petr" sort="Niederhafner, Petr" uniqKey="Niederhafner P" first="Petr" last="Niederhafner">Petr Niederhafner</name>
<affiliation><mods:affiliation>Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, Flemingovo nám. 2, 166 10 Prague 6, Czech Republic</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Reinis, Milan" sort="Reinis, Milan" uniqKey="Reinis M" first="Milan" last="Reiniš">Milan Reiniš</name>
<affiliation><mods:affiliation>Institute of Molecular Genetics, Academy of Sciences of the Czech Republic, Vídeňská 1083, 142 20 Prague 4, Czech Republic</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Sebestik, Jaroslav" sort="Sebestik, Jaroslav" uniqKey="Sebestik J" first="Jaroslav" last="Šebestík">Jaroslav Šebestík</name>
<affiliation><mods:affiliation>Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, Flemingovo nám. 2, 166 10 Prague 6, Czech Republic</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Jezek, Jan" sort="Jezek, Jan" uniqKey="Jezek J" first="Jan" last="Ježek">Jan Ježek</name>
<affiliation><mods:affiliation>Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, Flemingovo nám. 2, 166 10 Prague 6, Czech Republic</mods:affiliation>
</affiliation>
<affiliation><mods:affiliation>E-mail: jezek@uochb.cas.cz</mods:affiliation>
</affiliation>
<affiliation><mods:affiliation>Correspondence address: Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, Flemingovo nám. 2, 166 10 Prague 6 ‐ Dejvice, Czech Republic</mods:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:0E9802423ACEDED654B076627B0AF400FBC38155</idno>
<date when="2008" year="2008">2008</date>
<idno type="doi">10.1002/psc.1011</idno>
<idno type="url">https://api.istex.fr/ark:/67375/WNG-G8S292DG-9/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000F50</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000F50</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main">Glycopeptide dendrimers, Part III—a review: Use of glycopeptide dendrimers in immunotherapy and diagnosis of cancer and viral diseases</title>
<author><name sortKey="Niederhafner, Petr" sort="Niederhafner, Petr" uniqKey="Niederhafner P" first="Petr" last="Niederhafner">Petr Niederhafner</name>
<affiliation><mods:affiliation>Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, Flemingovo nám. 2, 166 10 Prague 6, Czech Republic</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Reinis, Milan" sort="Reinis, Milan" uniqKey="Reinis M" first="Milan" last="Reiniš">Milan Reiniš</name>
<affiliation><mods:affiliation>Institute of Molecular Genetics, Academy of Sciences of the Czech Republic, Vídeňská 1083, 142 20 Prague 4, Czech Republic</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Sebestik, Jaroslav" sort="Sebestik, Jaroslav" uniqKey="Sebestik J" first="Jaroslav" last="Šebestík">Jaroslav Šebestík</name>
<affiliation><mods:affiliation>Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, Flemingovo nám. 2, 166 10 Prague 6, Czech Republic</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Jezek, Jan" sort="Jezek, Jan" uniqKey="Jezek J" first="Jan" last="Ježek">Jan Ježek</name>
<affiliation><mods:affiliation>Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, Flemingovo nám. 2, 166 10 Prague 6, Czech Republic</mods:affiliation>
</affiliation>
<affiliation><mods:affiliation>E-mail: jezek@uochb.cas.cz</mods:affiliation>
</affiliation>
<affiliation><mods:affiliation>Correspondence address: Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, Flemingovo nám. 2, 166 10 Prague 6 ‐ Dejvice, Czech Republic</mods:affiliation>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j" type="main">Journal of Peptide Science</title>
<title level="j" type="alt">JOURNAL OF PEPTIDE SCIENCE</title>
<idno type="ISSN">1075-2617</idno>
<idno type="eISSN">1099-1387</idno>
<imprint><biblScope unit="vol">14</biblScope>
<biblScope unit="issue">5</biblScope>
<biblScope unit="page" from="556">556</biblScope>
<biblScope unit="page" to="587">587</biblScope>
<biblScope unit="page-count">32</biblScope>
<publisher>John Wiley & Sons, Ltd.</publisher>
<pubPlace>Chichester, UK</pubPlace>
<date type="published" when="2008-05">2008-05</date>
</imprint>
<idno type="ISSN">1075-2617</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">1075-2617</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="Teeft" xml:lang="en"><term>Acad</term>
<term>Adjuvant</term>
<term>Amino</term>
<term>Amino acid</term>
<term>Analog</term>
<term>Angew</term>
<term>Anticancer</term>
<term>Anticancer vaccine</term>
<term>Anticancer vaccines</term>
<term>Antigen</term>
<term>Antigenic</term>
<term>Antitumor</term>
<term>Antitumor vaccines</term>
<term>Antiviral</term>
<term>Antiviral agents</term>
<term>Assay</term>
<term>Binding patterns</term>
<term>Binding sites</term>
<term>Biol</term>
<term>Biological activities</term>
<term>Biological activity</term>
<term>Bioorg</term>
<term>Biotechnol</term>
<term>Breast cancer</term>
<term>Breast cancer patients</term>
<term>Cancer cells</term>
<term>Cancer immunol</term>
<term>Cancer vaccines</term>
<term>Carbohydrate</term>
<term>Carbohydrate antigen</term>
<term>Carbohydrate antigens</term>
<term>Cell surface</term>
<term>Ceramide</term>
<term>Chem</term>
<term>Chemical synthesis</term>
<term>Chemical technology</term>
<term>Chemokine coreceptors</term>
<term>Cholic</term>
<term>Clin</term>
<term>Clinical trials</term>
<term>Conformation</term>
<term>Conformational analysis</term>
<term>Conjugate</term>
<term>Conjugate vaccine</term>
<term>Cooh</term>
<term>Copyright</term>
<term>Curr</term>
<term>Cyclic</term>
<term>Cyclic glycopeptides</term>
<term>Cyclic peptides</term>
<term>Czech</term>
<term>Czech republic</term>
<term>Danishefsky</term>
<term>Dendrimer</term>
<term>Dendrimeric</term>
<term>Dendrimers</term>
<term>Dendritic</term>
<term>Dendritic polymers</term>
<term>Drug deliv</term>
<term>Drug delivery</term>
<term>Drug discov</term>
<term>Drug discovery</term>
<term>Elisa</term>
<term>Engl</term>
<term>Enzymatic synthesis</term>
<term>Epithelial</term>
<term>Epitope</term>
<term>European peptide society</term>
<term>Free drug</term>
<term>Galactose</term>
<term>Galactose residue</term>
<term>Galcer</term>
<term>Galnac</term>
<term>Glcnac2</term>
<term>Glycans</term>
<term>Glycobiology</term>
<term>Glycoconjugates</term>
<term>Glycodendrimers</term>
<term>Glycopeptide</term>
<term>Glycopeptide dendrimers</term>
<term>Glycopeptide synthesis</term>
<term>Glycopeptides</term>
<term>Glycoprotein</term>
<term>Glycosylated</term>
<term>Glycosylation</term>
<term>Helper peptides</term>
<term>Hexavalent</term>
<term>High degree</term>
<term>High titers</term>
<term>Hong kong</term>
<term>Hooc</term>
<term>Human glycophorin</term>
<term>Human jurkat cells</term>
<term>Human tumor cells</term>
<term>Humoral</term>
<term>Immune</term>
<term>Immune response</term>
<term>Immune system</term>
<term>Immunization</term>
<term>Immunogenic</term>
<term>Immunogenicity</term>
<term>Immunol</term>
<term>Immunological</term>
<term>Immunological evaluation</term>
<term>Immunotherapy</term>
<term>Important role</term>
<term>Infectious diseases</term>
<term>Inhibitor</term>
<term>John wiley sons</term>
<term>Kunz</term>
<term>Leclerc</term>
<term>Lectin</term>
<term>Ligand</term>
<term>Ligation</term>
<term>Lipophilicity</term>
<term>Livingston</term>
<term>Mag</term>
<term>Man9</term>
<term>Marcel dekker</term>
<term>Metastatic breast cancer patients</term>
<term>Mice vaccinated</term>
<term>Moiety</term>
<term>Molecular dynamics</term>
<term>Molecular genetics</term>
<term>Molecular modeling</term>
<term>Monovalent</term>
<term>Monovalent vaccines</term>
<term>More immunogenic</term>
<term>Mppi</term>
<term>Muc1</term>
<term>Mucin</term>
<term>Mucin glycoprotein architecture</term>
<term>Multiantigenic</term>
<term>Multivalent</term>
<term>Natl</term>
<term>Neuraminidase inhibitors</term>
<term>Niederhafner</term>
<term>Oligosaccharide</term>
<term>Opin</term>
<term>Organic chemistry</term>
<term>Padre</term>
<term>Pal3</term>
<term>Pamam</term>
<term>Pamam dendrimer</term>
<term>Pamam dendrimers</term>
<term>Pentavalent</term>
<term>Pentavalent vaccine</term>
<term>Pept</term>
<term>Peptide</term>
<term>Peptide backbone</term>
<term>Peptide sequence</term>
<term>Polymer</term>
<term>Polyvalent</term>
<term>Potent inhibitor</term>
<term>Prague</term>
<term>Proc</term>
<term>Prostate</term>
<term>Prostate cancer</term>
<term>Ragupathi</term>
<term>Recent developments</term>
<term>Recent progress</term>
<term>Receptor</term>
<term>Results show</term>
<term>Saccharide</term>
<term>Saccharides biology</term>
<term>Serine</term>
<term>Sialotrisaccharide units</term>
<term>Side chains</term>
<term>Slea</term>
<term>Subtype strains</term>
<term>Suitable carrier</term>
<term>Sulfate</term>
<term>Synthesis</term>
<term>Synthetic</term>
<term>Synthetic anticancer vaccines</term>
<term>Synthetic carbohydrate</term>
<term>Synthetic glycopeptides</term>
<term>Synthetic peptide</term>
<term>Synthetic vaccine</term>
<term>Synthetic vaccines</term>
<term>Tacas</term>
<term>Therapeutic vaccinations</term>
<term>Titer</term>
<term>Total synthesis</term>
<term>Transgenic mice</term>
<term>Triantennary</term>
<term>Tumor antigens</term>
<term>Tumor cells</term>
<term>Tumor challenge</term>
<term>Unconjugated pentavalent vaccine</term>
<term>Undecasaccharide</term>
<term>Unimolecular</term>
<term>Unimolecular pentavalent</term>
<term>Vaccinated</term>
<term>Vaccination</term>
<term>Vaccine</term>
<term>Viral</term>
<term>Wang</term>
<term>Weinheim</term>
<term>Wiley</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Glycopeptide dendrimers containing different types of tumor associated‐carbohydrate antigens (TN, TF, sialyl‐TN, sialyl‐TF, sialyl‐Lex, sialyl‐Lea etc.) were used in diagnosis and therapy of different sorts of cancer. These dendrimeric structures with incorporated T‐cell epitopes and adjuvants can be used as antitumor vaccines. Best results were obtained with multiantigenic vaccines, containing, e.g. five or six different TAAs. The topic of TAAs and their dendrimeric forms at molecular level are reviewed, including structure, syntheses, and biological activities. Use of glycopeptide dendrimers as antiviral vaccines against HIV and influenza is also described. Their syntheses, physico‐chemical properties, and biological activities are given with many examples. Copyright © 2008 European Peptide Society and John Wiley & Sons, Ltd.</div>
</front>
</TEI>
<istex><corpusName>wiley</corpusName>
<keywords><teeft><json:string>dendrimers</json:string>
<json:string>glycopeptide</json:string>
<json:string>vaccine</json:string>
<json:string>glycopeptides</json:string>
<json:string>chem</json:string>
<json:string>peptide</json:string>
<json:string>epitope</json:string>
<json:string>pept</json:string>
<json:string>adjuvant</json:string>
<json:string>danishefsky</json:string>
<json:string>carbohydrate</json:string>
<json:string>anticancer</json:string>
<json:string>john wiley sons</json:string>
<json:string>european peptide society</json:string>
<json:string>copyright</json:string>
<json:string>tacas</json:string>
<json:string>glycopeptide dendrimers</json:string>
<json:string>glycosylation</json:string>
<json:string>antitumor</json:string>
<json:string>mucin</json:string>
<json:string>glycoconjugates</json:string>
<json:string>glycoprotein</json:string>
<json:string>dendrimer</json:string>
<json:string>niederhafner</json:string>
<json:string>pamam</json:string>
<json:string>glycodendrimers</json:string>
<json:string>ragupathi</json:string>
<json:string>cooh</json:string>
<json:string>immunogenicity</json:string>
<json:string>unimolecular</json:string>
<json:string>elisa</json:string>
<json:string>oligosaccharide</json:string>
<json:string>saccharide</json:string>
<json:string>tumor cells</json:string>
<json:string>viral</json:string>
<json:string>muc1</json:string>
<json:string>epithelial</json:string>
<json:string>immune</json:string>
<json:string>pentavalent</json:string>
<json:string>curr</json:string>
<json:string>man9</json:string>
<json:string>glcnac2</json:string>
<json:string>receptor</json:string>
<json:string>cyclic</json:string>
<json:string>biol</json:string>
<json:string>pal3</json:string>
<json:string>pamam dendrimers</json:string>
<json:string>glycobiology</json:string>
<json:string>immunological</json:string>
<json:string>kunz</json:string>
<json:string>czech</json:string>
<json:string>opin</json:string>
<json:string>glycosylated</json:string>
<json:string>weinheim</json:string>
<json:string>analog</json:string>
<json:string>antiviral</json:string>
<json:string>multiantigenic</json:string>
<json:string>livingston</json:string>
<json:string>mag</json:string>
<json:string>bioorg</json:string>
<json:string>carbohydrate antigens</json:string>
<json:string>dendritic</json:string>
<json:string>glycans</json:string>
<json:string>galnac</json:string>
<json:string>leclerc</json:string>
<json:string>lipophilicity</json:string>
<json:string>wang</json:string>
<json:string>moiety</json:string>
<json:string>proc</json:string>
<json:string>immunotherapy</json:string>
<json:string>dendrimeric</json:string>
<json:string>synthetic vaccines</json:string>
<json:string>monovalent</json:string>
<json:string>engl</json:string>
<json:string>natl</json:string>
<json:string>immunogenic</json:string>
<json:string>czech republic</json:string>
<json:string>lectin</json:string>
<json:string>biotechnol</json:string>
<json:string>antigenic</json:string>
<json:string>undecasaccharide</json:string>
<json:string>angew</json:string>
<json:string>immunol</json:string>
<json:string>humoral</json:string>
<json:string>synthetic glycopeptides</json:string>
<json:string>acad</json:string>
<json:string>total synthesis</json:string>
<json:string>anticancer vaccines</json:string>
<json:string>assay</json:string>
<json:string>antigen</json:string>
<json:string>vaccinated</json:string>
<json:string>serine</json:string>
<json:string>human tumor cells</json:string>
<json:string>galcer</json:string>
<json:string>galactose</json:string>
<json:string>slea</json:string>
<json:string>padre</json:string>
<json:string>ligation</json:string>
<json:string>hooc</json:string>
<json:string>mppi</json:string>
<json:string>triantennary</json:string>
<json:string>ceramide</json:string>
<json:string>immune response</json:string>
<json:string>cholic</json:string>
<json:string>biological activities</json:string>
<json:string>polyvalent</json:string>
<json:string>hexavalent</json:string>
<json:string>clin</json:string>
<json:string>sulfate</json:string>
<json:string>immunization</json:string>
<json:string>multivalent</json:string>
<json:string>ligand</json:string>
<json:string>prostate cancer</json:string>
<json:string>monovalent vaccines</json:string>
<json:string>organic chemistry</json:string>
<json:string>breast cancer patients</json:string>
<json:string>antitumor vaccines</json:string>
<json:string>mice vaccinated</json:string>
<json:string>cyclic peptides</json:string>
<json:string>polymer</json:string>
<json:string>amino</json:string>
<json:string>tumor antigens</json:string>
<json:string>cancer vaccines</json:string>
<json:string>synthetic vaccine</json:string>
<json:string>cell surface</json:string>
<json:string>saccharides biology</json:string>
<json:string>helper peptides</json:string>
<json:string>drug discovery</json:string>
<json:string>cancer cells</json:string>
<json:string>synthetic carbohydrate</json:string>
<json:string>cancer immunol</json:string>
<json:string>synthetic anticancer vaccines</json:string>
<json:string>tumor challenge</json:string>
<json:string>enzymatic synthesis</json:string>
<json:string>breast cancer</json:string>
<json:string>immune system</json:string>
<json:string>suitable carrier</json:string>
<json:string>unconjugated pentavalent vaccine</json:string>
<json:string>conjugate vaccine</json:string>
<json:string>cyclic glycopeptides</json:string>
<json:string>human glycophorin</json:string>
<json:string>chemical technology</json:string>
<json:string>molecular modeling</json:string>
<json:string>chemical synthesis</json:string>
<json:string>drug discov</json:string>
<json:string>inhibitor</json:string>
<json:string>prostate</json:string>
<json:string>conformation</json:string>
<json:string>synthetic</json:string>
<json:string>vaccination</json:string>
<json:string>transgenic mice</json:string>
<json:string>anticancer vaccine</json:string>
<json:string>pamam dendrimer</json:string>
<json:string>peptide backbone</json:string>
<json:string>sialotrisaccharide units</json:string>
<json:string>free drug</json:string>
<json:string>molecular dynamics</json:string>
<json:string>more immunogenic</json:string>
<json:string>clinical trials</json:string>
<json:string>carbohydrate antigen</json:string>
<json:string>metastatic breast cancer patients</json:string>
<json:string>unimolecular pentavalent</json:string>
<json:string>mucin glycoprotein architecture</json:string>
<json:string>pentavalent vaccine</json:string>
<json:string>high degree</json:string>
<json:string>potent inhibitor</json:string>
<json:string>galactose residue</json:string>
<json:string>binding patterns</json:string>
<json:string>human jurkat cells</json:string>
<json:string>chemokine coreceptors</json:string>
<json:string>side chains</json:string>
<json:string>drug delivery</json:string>
<json:string>neuraminidase inhibitors</json:string>
<json:string>results show</json:string>
<json:string>high titers</json:string>
<json:string>immunological evaluation</json:string>
<json:string>marcel dekker</json:string>
<json:string>hong kong</json:string>
<json:string>recent developments</json:string>
<json:string>glycopeptide synthesis</json:string>
<json:string>peptide sequence</json:string>
<json:string>binding sites</json:string>
<json:string>amino acid</json:string>
<json:string>molecular genetics</json:string>
<json:string>important role</json:string>
<json:string>conformational analysis</json:string>
<json:string>infectious diseases</json:string>
<json:string>biological activity</json:string>
<json:string>synthetic peptide</json:string>
<json:string>antiviral agents</json:string>
<json:string>recent progress</json:string>
<json:string>drug deliv</json:string>
<json:string>dendritic polymers</json:string>
<json:string>subtype strains</json:string>
<json:string>therapeutic vaccinations</json:string>
<json:string>synthesis</json:string>
<json:string>titer</json:string>
<json:string>wiley</json:string>
<json:string>prague</json:string>
<json:string>conjugate</json:string>
</teeft>
</keywords>
<author><json:item><name>Petr Niederhafner</name>
<affiliations><json:string>Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, Flemingovo nám. 2, 166 10 Prague 6, Czech Republic</json:string>
</affiliations>
</json:item>
<json:item><name>Milan Reiniš</name>
<affiliations><json:string>Institute of Molecular Genetics, Academy of Sciences of the Czech Republic, Vídeňská 1083, 142 20 Prague 4, Czech Republic</json:string>
</affiliations>
</json:item>
<json:item><name>Jaroslav Šebestík</name>
<affiliations><json:string>Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, Flemingovo nám. 2, 166 10 Prague 6, Czech Republic</json:string>
</affiliations>
</json:item>
<json:item><name>Jan Ježek</name>
<affiliations><json:string>Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, Flemingovo nám. 2, 166 10 Prague 6, Czech Republic</json:string>
<json:string>E-mail: jezek@uochb.cas.cz</json:string>
<json:string>Correspondence address: Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, Flemingovo nám. 2, 166 10 Prague 6 ‐ Dejvice, Czech Republic</json:string>
</affiliations>
</json:item>
</author>
<subject><json:item><lang><json:string>eng</json:string>
</lang>
<value>anticancer vaccines</value>
</json:item>
<json:item><lang><json:string>eng</json:string>
</lang>
<value>antiviral vaccines</value>
</json:item>
<json:item><lang><json:string>eng</json:string>
</lang>
<value>dendrimers</value>
</json:item>
<json:item><lang><json:string>eng</json:string>
</lang>
<value>glycobiology</value>
</json:item>
<json:item><lang><json:string>eng</json:string>
</lang>
<value>glycocluster</value>
</json:item>
<json:item><lang><json:string>eng</json:string>
</lang>
<value>glycoconjugates</value>
</json:item>
<json:item><lang><json:string>eng</json:string>
</lang>
<value>glycodendrimers</value>
</json:item>
<json:item><lang><json:string>eng</json:string>
</lang>
<value>glycopeptides</value>
</json:item>
<json:item><lang><json:string>eng</json:string>
</lang>
<value>glycotope</value>
</json:item>
<json:item><lang><json:string>eng</json:string>
</lang>
<value>ligation chemistry</value>
</json:item>
<json:item><lang><json:string>eng</json:string>
</lang>
<value>multiple antigen glycopeptides (MAGs)</value>
</json:item>
<json:item><lang><json:string>eng</json:string>
</lang>
<value>review</value>
</json:item>
<json:item><lang><json:string>eng</json:string>
</lang>
<value>synthetic vaccine</value>
</json:item>
<json:item><lang><json:string>eng</json:string>
</lang>
<value>tumor associated antigen</value>
</json:item>
</subject>
<articleId><json:string>PSC1011</json:string>
</articleId>
<arkIstex>ark:/67375/WNG-G8S292DG-9</arkIstex>
<language><json:string>eng</json:string>
</language>
<originalGenre><json:string>reviewArticle</json:string>
</originalGenre>
<abstract>Glycopeptide dendrimers containing different types of tumor associated‐carbohydrate antigens (TN, TF, sialyl‐TN, sialyl‐TF, sialyl‐Lex, sialyl‐Lea etc.) were used in diagnosis and therapy of different sorts of cancer. These dendrimeric structures with incorporated T‐cell epitopes and adjuvants can be used as antitumor vaccines. Best results were obtained with multiantigenic vaccines, containing, e.g. five or six different TAAs. The topic of TAAs and their dendrimeric forms at molecular level are reviewed, including structure, syntheses, and biological activities. Use of glycopeptide dendrimers as antiviral vaccines against HIV and influenza is also described. Their syntheses, physico‐chemical properties, and biological activities are given with many examples. Copyright © 2008 European Peptide Society and John Wiley & Sons, Ltd.</abstract>
<qualityIndicators><score>8.356</score>
<pdfWordCount>18725</pdfWordCount>
<pdfCharCount>127268</pdfCharCount>
<pdfVersion>1.3</pdfVersion>
<pdfPageCount>32</pdfPageCount>
<pdfPageSize>595 x 791 pts</pdfPageSize>
<pdfWordsPerPage>585</pdfWordsPerPage>
<pdfText>true</pdfText>
<refBibsNative>true</refBibsNative>
<abstractWordCount>113</abstractWordCount>
<abstractCharCount>839</abstractCharCount>
<keywordCount>14</keywordCount>
</qualityIndicators>
<title>Glycopeptide dendrimers, Part III—a review: Use of glycopeptide dendrimers in immunotherapy and diagnosis of cancer and viral diseases</title>
<pmid><json:string>18275089</json:string>
</pmid>
<genre><json:string>review-article</json:string>
</genre>
<host><title>Journal of Peptide Science</title>
<language><json:string>unknown</json:string>
</language>
<doi><json:string>10.1002/(ISSN)1099-1387</json:string>
</doi>
<issn><json:string>1075-2617</json:string>
</issn>
<eissn><json:string>1099-1387</json:string>
</eissn>
<publisherId><json:string>PSC</json:string>
</publisherId>
<volume>14</volume>
<issue>5</issue>
<pages><first>556</first>
<last>587</last>
<total>32</total>
</pages>
<genre><json:string>journal</json:string>
</genre>
<subject><json:item><value>Review</value>
</json:item>
<json:item><value>Reviews</value>
</json:item>
</subject>
</host>
<namedEntities><unitex><date><json:string>1974</json:string>
<json:string>2000</json:string>
<json:string>1981</json:string>
<json:string>2005</json:string>
<json:string>1993</json:string>
<json:string>2006</json:string>
<json:string>2002</json:string>
<json:string>2007</json:string>
<json:string>1961</json:string>
<json:string>1988</json:string>
<json:string>1966</json:string>
<json:string>2008</json:string>
<json:string>1951</json:string>
<json:string>1978</json:string>
<json:string>2004</json:string>
<json:string>1985</json:string>
</date>
<geogName></geogName>
<orgName><json:string>Grant Agency</json:string>
<json:string>Czech Republic, Grant Agency of the Czech Academy of Sciences KAN</json:string>
<json:string>Charles University</json:string>
<json:string>Czech Republic, Flemingovo</json:string>
<json:string>Institute of Organic Chemistry and z</json:string>
<json:string>Institute of Chemical Technology, Prague</json:string>
<json:string>Ministry of Agriculture</json:string>
<json:string>Institute of Molecular Genetics, Prague, Laboratory of Tumor Immunology</json:string>
<json:string>Institute of Molecular Genetics, Academy of Sciences of the Czech Republic</json:string>
<json:string>Torrey Pines Institute for Molecular Studies, San Diego</json:string>
<json:string>Biomira, Inc., Edmonton, Canada</json:string>
<json:string>US FDA</json:string>
<json:string>Shemyakin Institute of Bioorganic Chemistry, Moscow</json:string>
<json:string>Sons, Ltd.</json:string>
<json:string>Institute of Organic Chemistry and Biochemistry</json:string>
<json:string>Rockefeller University</json:string>
<json:string>Laboratory of Immunogenetics</json:string>
<json:string>Research Project Z</json:string>
<json:string>Sons, Ltd</json:string>
<json:string>Institute of Molecular Genetics, Academy of Sciences of the Czech Republic, Prague</json:string>
<json:string>Institute for Biochemistry and Biophysics</json:string>
<json:string>Department of Molecular Spectroscopy, Institute of Organic Chemistry and Biochemistry</json:string>
<json:string>HIV Research Laboratory</json:string>
<json:string>National Reference Laboratory on AIDS, Institute of Public Health, Prague</json:string>
<json:string>Friedrich Schiller University</json:string>
</orgName>
<orgName_funder></orgName_funder>
<orgName_provider></orgName_provider>
<persName><json:string>Barbara Weiser</json:string>
<json:string>IgM</json:string>
<json:string>John Wiley</json:string>
<json:string>Jan Hlava</json:string>
<json:string>R.B. Merri</json:string>
<json:string>M. Zaoral</json:string>
<json:string>Peptide Society</json:string>
<json:string>R.A. Houghten</json:string>
<json:string>Any J. Pept</json:string>
<json:string>Fabio Malavasi</json:string>
<json:string>Petr Bour</json:string>
<json:string>Matya</json:string>
<json:string>The</json:string>
<json:string>Jan Je</json:string>
<json:string>Ivan Stibor</json:string>
<json:string>J. Pept</json:string>
<json:string>Sciences</json:string>
<json:string>T.M. Andronova</json:string>
<json:string>Jan Hlavacek</json:string>
<json:string>H. Signi</json:string>
<json:string>Harold Burger</json:string>
<json:string>Martina Nussbaumer-Zikmundova</json:string>
<json:string>Petr Niederhafner</json:string>
<json:string>Ley Ab</json:string>
<json:string>V.T. Ivanov</json:string>
<json:string>Milan Reini</json:string>
</persName>
<placeName><json:string>Mlada Boleslav</json:string>
<json:string>Germany</json:string>
<json:string>Jena</json:string>
<json:string>Prague</json:string>
<json:string>Czech Republic</json:string>
<json:string>Ostrava</json:string>
<json:string>Puri</json:string>
<json:string>York</json:string>
<json:string>Italy</json:string>
</placeName>
<ref_url></ref_url>
<ref_bibl><json:string>[72]</json:string>
<json:string>[113]</json:string>
<json:string>[132]</json:string>
<json:string>[32,33]</json:string>
<json:string>Danishefsky et al. [119]</json:string>
<json:string>[89]</json:string>
<json:string>[129]</json:string>
<json:string>[121]</json:string>
<json:string>[140]</json:string>
<json:string>[22,33]</json:string>
<json:string>[29]</json:string>
<json:string>[16,59,121,122,126]</json:string>
<json:string>[110]</json:string>
<json:string>[93]</json:string>
<json:string>[194]</json:string>
<json:string>[16,60,61,106]</json:string>
<json:string>[107]</json:string>
<json:string>[126]</json:string>
<json:string>[97,98]</json:string>
<json:string>Hakomori et al. [186]</json:string>
<json:string>[172]</json:string>
<json:string>[191]</json:string>
<json:string>[81]</json:string>
<json:string>[104]</json:string>
<json:string>[123]</json:string>
<json:string>[188]</json:string>
<json:string>[142]</json:string>
<json:string>Nakada et al. [103]</json:string>
<json:string>[80,81]</json:string>
<json:string>[11,32]</json:string>
<json:string>[76]</json:string>
<json:string>[112]</json:string>
<json:string>[177]</json:string>
<json:string>[196]</json:string>
<json:string>[53,80,94]</json:string>
<json:string>[128]</json:string>
<json:string>[10,16]</json:string>
<json:string>[101,182]</json:string>
<json:string>[120]</json:string>
<json:string>[185]</json:string>
<json:string>[183,184]</json:string>
<json:string>Danishefsky et al. [178]</json:string>
<json:string>[117]</json:string>
<json:string>[97]</json:string>
<json:string>[174]</json:string>
<json:string>[73,75,90]</json:string>
<json:string>[125]</json:string>
<json:string>[130,131]</json:string>
<json:string>[61,122]</json:string>
<json:string>[105,119,161]</json:string>
<json:string>[11,18,22,32,101]</json:string>
<json:string>[51,15]</json:string>
<json:string>[179]</json:string>
<json:string>[133]</json:string>
<json:string>[59,69]</json:string>
<json:string>Livingston et al. [170]</json:string>
<json:string>[15,93,117,118]</json:string>
<json:string>[187]</json:string>
<json:string>[141]</json:string>
<json:string>[15,80]</json:string>
<json:string>[69]</json:string>
<json:string>Nishimura et al. [133]</json:string>
<json:string>[157]</json:string>
<json:string>[111]</json:string>
<json:string>[176]</json:string>
<json:string>[21,84,85]</json:string>
<json:string>[195]</json:string>
<json:string>June 2003</json:string>
<json:string>[11,22,32,101]</json:string>
<json:string>[108]</json:string>
<json:string>[127]</json:string>
<json:string>[175,176]</json:string>
<json:string>[51,85,100]</json:string>
<json:string>[95]</json:string>
<json:string>[101,180,181]</json:string>
<json:string>[116]</json:string>
<json:string>[2]</json:string>
<json:string>[57]</json:string>
<json:string>[173]</json:string>
<json:string>[25,75,77,84]</json:string>
<json:string>Danishefsky et al. [125]</json:string>
<json:string>Dumy et al. [114]</json:string>
<json:string>[105]</json:string>
<json:string>[124]</json:string>
<json:string>[28,29,53,54]</json:string>
<json:string>Danishefsky et al. [160]</json:string>
</ref_bibl>
<bibl></bibl>
</unitex>
</namedEntities>
<ark><json:string>ark:/67375/WNG-G8S292DG-9</json:string>
</ark>
<categories><wos><json:string>1 - science</json:string>
<json:string>2 - chemistry, analytical</json:string>
<json:string>2 - biochemistry & molecular biology</json:string>
</wos>
<scienceMetrix><json:string>1 - health sciences</json:string>
<json:string>2 - biomedical research</json:string>
<json:string>3 - biophysics</json:string>
</scienceMetrix>
<scopus><json:string>1 - Physical Sciences</json:string>
<json:string>2 - Chemistry</json:string>
<json:string>3 - Organic Chemistry</json:string>
<json:string>1 - Life Sciences</json:string>
<json:string>2 - Pharmacology, Toxicology and Pharmaceutics</json:string>
<json:string>3 - Drug Discovery</json:string>
<json:string>1 - Life Sciences</json:string>
<json:string>2 - Pharmacology, Toxicology and Pharmaceutics</json:string>
<json:string>3 - Pharmacology</json:string>
<json:string>1 - Life Sciences</json:string>
<json:string>2 - Biochemistry, Genetics and Molecular Biology</json:string>
<json:string>3 - Molecular Biology</json:string>
<json:string>1 - Life Sciences</json:string>
<json:string>2 - Biochemistry, Genetics and Molecular Biology</json:string>
<json:string>3 - Molecular Medicine</json:string>
<json:string>1 - Health Sciences</json:string>
<json:string>2 - Medicine</json:string>
<json:string>3 - General Medicine</json:string>
<json:string>1 - Life Sciences</json:string>
<json:string>2 - Biochemistry, Genetics and Molecular Biology</json:string>
<json:string>3 - Biochemistry</json:string>
<json:string>1 - Life Sciences</json:string>
<json:string>2 - Biochemistry, Genetics and Molecular Biology</json:string>
<json:string>3 - Structural Biology</json:string>
</scopus>
<inist><json:string>1 - sciences appliquees, technologies et medecines</json:string>
<json:string>2 - sciences biologiques et medicales</json:string>
<json:string>3 - sciences medicales</json:string>
</inist>
</categories>
<publicationDate>2008</publicationDate>
<copyrightDate>2008</copyrightDate>
<doi><json:string>10.1002/psc.1011</json:string>
</doi>
<id>0E9802423ACEDED654B076627B0AF400FBC38155</id>
<score>1</score>
<fulltext><json:item><extension>pdf</extension>
<original>true</original>
<mimetype>application/pdf</mimetype>
<uri>https://api.istex.fr/ark:/67375/WNG-G8S292DG-9/fulltext.pdf</uri>
</json:item>
<json:item><extension>zip</extension>
<original>false</original>
<mimetype>application/zip</mimetype>
<uri>https://api.istex.fr/ark:/67375/WNG-G8S292DG-9/bundle.zip</uri>
</json:item>
<istex:fulltextTEI uri="https://api.istex.fr/ark:/67375/WNG-G8S292DG-9/fulltext.tei"><teiHeader><fileDesc><titleStmt><title level="a" type="main">Glycopeptide dendrimers, Part III—a review: Use of glycopeptide dendrimers in immunotherapy and diagnosis of cancer and viral diseases</title>
<title level="a" type="short" xml:lang="en">GLYCOPEPTIDE DENDRIMERS</title>
</titleStmt>
<publicationStmt><authority>ISTEX</authority>
<publisher>John Wiley & Sons, Ltd.</publisher>
<pubPlace>Chichester, UK</pubPlace>
<availability><licence>Copyright © 2008 European Peptide Society and John Wiley & Sons, Ltd.</licence>
</availability>
<date type="published" when="2008-05"></date>
</publicationStmt>
<notesStmt><note type="content-type" subtype="review-article" source="reviewArticle" scheme="https://content-type.data.istex.fr/ark:/67375/XTP-L5L7X3NF-P">review-article</note>
<note type="publication-type" subtype="journal" scheme="https://publication-type.data.istex.fr/ark:/67375/JMC-0GLKJH51-B">journal</note>
</notesStmt>
<sourceDesc><biblStruct type="review-article"><analytic><title level="a" type="main">Glycopeptide dendrimers, Part III—a review: Use of glycopeptide dendrimers in immunotherapy and diagnosis of cancer and viral diseases</title>
<title level="a" type="short" xml:lang="en">GLYCOPEPTIDE DENDRIMERS</title>
<author xml:id="author-0000"><persName><forename type="first">Petr</forename>
<surname>Niederhafner</surname>
</persName>
<affiliation><orgName type="institution">Institute of Organic Chemistry and Biochemistry</orgName>
<orgName type="institution">Academy of Sciences of the Czech Republic</orgName>
<address><addrLine>Flemingovo nám. 2</addrLine>
<addrLine>166 10 Prague 6, Czech Republic</addrLine>
<country key="CZ" xml:lang="en">CZECH REPUBLIC</country>
</address>
</affiliation>
</author>
<author xml:id="author-0001"><persName><forename type="first">Milan</forename>
<surname>Reiniš</surname>
</persName>
<affiliation><orgName type="institution">Institute of Molecular Genetics</orgName>
<orgName type="institution">Academy of Sciences of the Czech Republic</orgName>
<address><addrLine>Vídeňská 1083</addrLine>
<addrLine>142 20 Prague 4, Czech Republic</addrLine>
<country key="CZ" xml:lang="en">CZECH REPUBLIC</country>
</address>
</affiliation>
</author>
<author xml:id="author-0002"><persName><forename type="first">Jaroslav</forename>
<surname>Šebestík</surname>
</persName>
<affiliation><orgName type="institution">Institute of Organic Chemistry and Biochemistry</orgName>
<orgName type="institution">Academy of Sciences of the Czech Republic</orgName>
<address><addrLine>Flemingovo nám. 2</addrLine>
<addrLine>166 10 Prague 6, Czech Republic</addrLine>
<country key="CZ" xml:lang="en">CZECH REPUBLIC</country>
</address>
</affiliation>
</author>
<author xml:id="author-0003" role="corresp"><persName><forename type="first">Jan</forename>
<surname>Ježek</surname>
</persName>
<email>jezek@uochb.cas.cz</email>
<affiliation><orgName type="institution">Institute of Organic Chemistry and Biochemistry</orgName>
<orgName type="institution">Academy of Sciences of the Czech Republic</orgName>
<address><addrLine>Flemingovo nám. 2</addrLine>
<addrLine>166 10 Prague 6, Czech Republic</addrLine>
<country key="CZ" xml:lang="en">CZECH REPUBLIC</country>
</address>
</affiliation>
</author>
<idno type="istex">0E9802423ACEDED654B076627B0AF400FBC38155</idno>
<idno type="ark">ark:/67375/WNG-G8S292DG-9</idno>
<idno type="DOI">10.1002/psc.1011</idno>
<idno type="unit">PSC1011</idno>
<idno type="toTypesetVersion">file:PSC.PSC1011.pdf</idno>
</analytic>
<monogr><title level="j" type="main">Journal of Peptide Science</title>
<title level="j" type="alt">JOURNAL OF PEPTIDE SCIENCE</title>
<idno type="pISSN">1075-2617</idno>
<idno type="eISSN">1099-1387</idno>
<idno type="book-DOI">10.1002/(ISSN)1099-1387</idno>
<idno type="book-part-DOI">10.1002/psc.v14:5</idno>
<idno type="product">PSC</idno>
<imprint><biblScope unit="vol">14</biblScope>
<biblScope unit="issue">5</biblScope>
<biblScope unit="page" from="556">556</biblScope>
<biblScope unit="page" to="587">587</biblScope>
<biblScope unit="page-count">32</biblScope>
<publisher>John Wiley & Sons, Ltd.</publisher>
<pubPlace>Chichester, UK</pubPlace>
<date type="published" when="2008-05"></date>
</imprint>
</monogr>
</biblStruct>
</sourceDesc>
</fileDesc>
<encodingDesc><schemaRef type="ODD" url="https://xml-schema.delivery.istex.fr/tei-istex.odd"></schemaRef>
<appInfo><application ident="pub2tei" version="1.0.10" when="2019-12-20"><label>pub2TEI-ISTEX</label>
<desc>A set of style sheets for converting XML documents encoded in various scientific publisher formats into a common TEI format.
                        <ref target="http://www.tei-c.org/">We use TEI</ref>
</desc>
</application>
</appInfo>
</encodingDesc>
<profileDesc><abstract xml:lang="en" style="main"><head>Abstract</head>
<p>Glycopeptide dendrimers containing different types of tumor associated‐carbohydrate antigens (T<hi rend="subscript">N</hi>
, TF, sialyl‐T<hi rend="subscript">N</hi>
, sialyl‐TF, sialyl‐Le<hi rend="superscript">x</hi>
, sialyl‐Le<hi rend="superscript">a</hi>
 etc.) were used in diagnosis and therapy of different sorts of cancer. These dendrimeric structures with incorporated T‐cell epitopes and adjuvants can be used as antitumor vaccines. Best results were obtained with multiantigenic vaccines, containing, e.g. five or six different TAAs. The topic of TAAs and their dendrimeric forms at molecular level are reviewed, including structure, syntheses, and biological activities. Use of glycopeptide dendrimers as antiviral vaccines against HIV and influenza is also described. Their syntheses, physico‐chemical properties, and biological activities are given with many examples. Copyright © 2008 European Peptide Society and John Wiley & Sons, Ltd.</p>
</abstract>
<textClass><keywords xml:lang="en"><term xml:id="kwd1">anticancer vaccines</term>
<term xml:id="kwd2">antiviral vaccines</term>
<term xml:id="kwd3">dendrimers</term>
<term xml:id="kwd4">glycobiology</term>
<term xml:id="kwd5">glycocluster</term>
<term xml:id="kwd6">glycoconjugates</term>
<term xml:id="kwd7">glycodendrimers</term>
<term xml:id="kwd8">glycopeptides</term>
<term xml:id="kwd9">glycotope</term>
<term xml:id="kwd10">ligation chemistry</term>
<term xml:id="kwd11">multiple antigen glycopeptides (MAGs)</term>
<term xml:id="kwd12">review</term>
<term xml:id="kwd13">synthetic vaccine</term>
<term xml:id="kwd14">tumor associated antigen</term>
</keywords>
<keywords rend="articleCategory"><term>Review</term>
</keywords>
<keywords rend="tocHeading1"><term>Reviews</term>
</keywords>
</textClass>
<langUsage><language ident="en"></language>
</langUsage>
</profileDesc>
<revisionDesc><change when="2019-12-20" who="#istex" xml:id="pub2tei">formatting</change>
</revisionDesc>
</teiHeader>
</istex:fulltextTEI>
<json:item><extension>txt</extension>
<original>false</original>
<mimetype>text/plain</mimetype>
<uri>https://api.istex.fr/ark:/67375/WNG-G8S292DG-9/fulltext.txt</uri>
</json:item>
</fulltext>
<metadata><istex:metadataXml wicri:clean="Wiley, elements deleted: body"><istex:xmlDeclaration>version="1.0" encoding="UTF-8" standalone="yes"</istex:xmlDeclaration>
<istex:document><component version="2.0" type="serialArticle" xml:lang="en"><header><publicationMeta level="product"><publisherInfo><publisherName>John Wiley & Sons, Ltd.</publisherName>
<publisherLoc>Chichester, UK</publisherLoc>
</publisherInfo>
<doi registered="yes">10.1002/(ISSN)1099-1387</doi>
<issn type="print">1075-2617</issn>
<issn type="electronic">1099-1387</issn>
<idGroup><id type="product" value="PSC"></id>
</idGroup>
<titleGroup><title type="main" xml:lang="en" sort="JOURNAL OF PEPTIDE SCIENCE">Journal of Peptide Science</title>
<title type="subtitle">An Official Publication of the European Peptide Society</title>
<title type="short">J. Peptide Sci.</title>
</titleGroup>
</publicationMeta>
<publicationMeta level="part" position="50"><doi origin="wiley" registered="yes">10.1002/psc.v14:5</doi>
<numberingGroup><numbering type="journalVolume" number="14">14</numbering>
<numbering type="journalIssue">5</numbering>
</numberingGroup>
<coverDate startDate="2008-05">May 2008</coverDate>
</publicationMeta>
<publicationMeta level="unit" type="reviewArticle" position="20" status="forIssue"><doi origin="wiley" registered="yes">10.1002/psc.1011</doi>
<idGroup><id type="unit" value="PSC1011"></id>
</idGroup>
<countGroup><count type="pageTotal" number="32"></count>
</countGroup>
<titleGroup><title type="articleCategory">Review</title>
<title type="tocHeading1">Reviews</title>
</titleGroup>
<copyright ownership="joint">Copyright © 2008 European Peptide Society and John Wiley & Sons, Ltd.</copyright>
<eventGroup><event type="manuscriptReceived" date="2007-11-28"></event>
<event type="manuscriptAccepted" date="2007-11-28"></event>
<event type="publishedOnlineEarlyUnpaginated" date="2008-02-15"></event>
<event type="firstOnline" date="2008-02-15"></event>
<event type="publishedOnlineFinalForm" date="2008-04-17"></event>
<event type="xmlConverted" agent="Converter:JWSART34_TO_WML3G version:2.3.2 mode:FullText source:HeaderRef result:HeaderRef" date="2010-03-10"></event>
<event type="xmlConverted" agent="Converter:WILEY_ML3G_TO_WILEY_ML3GV2 version:3.8.8" date="2014-02-07"></event>
<event type="xmlConverted" agent="Converter:WML3G_To_WML3G version:4.1.7 mode:FullText,remove_FC" date="2014-10-30"></event>
</eventGroup>
<numberingGroup><numbering type="pageFirst">556</numbering>
<numbering type="pageLast">587</numbering>
</numberingGroup>
<correspondenceTo>Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, Flemingovo nám. 2, 166 10 Prague 6 ‐ Dejvice, Czech Republic</correspondenceTo>
<linkGroup><link type="toTypesetVersion" href="file:PSC.PSC1011.pdf"></link>
</linkGroup>
</publicationMeta>
<contentMeta><countGroup><count type="figureTotal" number="14"></count>
<count type="tableTotal" number="3"></count>
<count type="referenceTotal" number="203"></count>
</countGroup>
<titleGroup><title type="main" xml:lang="en">Glycopeptide dendrimers, Part III—a review: Use of glycopeptide dendrimers in immunotherapy and diagnosis of cancer and viral diseases</title>
<title type="short" xml:lang="en">GLYCOPEPTIDE DENDRIMERS</title>
</titleGroup>
<creators><creator xml:id="au1" creatorRole="author" affiliationRef="#af1"><personName><givenNames>Petr</givenNames>
<familyName>Niederhafner</familyName>
</personName>
</creator>
<creator xml:id="au2" creatorRole="author" affiliationRef="#af2"><personName><givenNames>Milan</givenNames>
<familyName>Reiniš</familyName>
</personName>
</creator>
<creator xml:id="au3" creatorRole="author" affiliationRef="#af1"><personName><givenNames>Jaroslav</givenNames>
<familyName>Šebestík</familyName>
</personName>
</creator>
<creator xml:id="au4" creatorRole="author" affiliationRef="#af1" corresponding="yes"><personName><givenNames>Jan</givenNames>
<familyName>Ježek</familyName>
</personName>
<contactDetails><email>jezek@uochb.cas.cz</email>
</contactDetails>
</creator>
</creators>
<affiliationGroup><affiliation xml:id="af1" countryCode="CZ" type="organization"><unparsedAffiliation>Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, Flemingovo nám. 2, 166 10 Prague 6, Czech Republic</unparsedAffiliation>
</affiliation>
<affiliation xml:id="af2" countryCode="CZ" type="organization"><unparsedAffiliation>Institute of Molecular Genetics, Academy of Sciences of the Czech Republic, Vídeňská 1083, 142 20 Prague 4, Czech Republic</unparsedAffiliation>
</affiliation>
</affiliationGroup>
<keywordGroup xml:lang="en" type="author"><keyword xml:id="kwd1">anticancer vaccines</keyword>
<keyword xml:id="kwd2">antiviral vaccines</keyword>
<keyword xml:id="kwd3">dendrimers</keyword>
<keyword xml:id="kwd4">glycobiology</keyword>
<keyword xml:id="kwd5">glycocluster</keyword>
<keyword xml:id="kwd6">glycoconjugates</keyword>
<keyword xml:id="kwd7">glycodendrimers</keyword>
<keyword xml:id="kwd8">glycopeptides</keyword>
<keyword xml:id="kwd9">glycotope</keyword>
<keyword xml:id="kwd10">ligation chemistry</keyword>
<keyword xml:id="kwd11">multiple antigen glycopeptides (MAGs)</keyword>
<keyword xml:id="kwd12">review</keyword>
<keyword xml:id="kwd13">synthetic vaccine</keyword>
<keyword xml:id="kwd14">tumor associated antigen</keyword>
</keywordGroup>
<fundingInfo><fundingAgency>Ministry of Agriculture</fundingAgency>
<fundingNumber>QF3115/2003</fundingNumber>
</fundingInfo>
<fundingInfo><fundingAgency>Grant Agency of the Czech Republic</fundingAgency>
<fundingNumber>203/03/1362</fundingNumber>
<fundingNumber>203/07/1517</fundingNumber>
</fundingInfo>
<fundingInfo><fundingAgency>Grant Agency of the Czech Academy of Sciences</fundingAgency>
<fundingNumber>KAN200520703</fundingNumber>
</fundingInfo>
<fundingInfo><fundingAgency>AS CR</fundingAgency>
<fundingNumber>Z40550506</fundingNumber>
<fundingNumber>AVOZ50520514</fundingNumber>
</fundingInfo>
<abstractGroup><abstract type="main" xml:lang="en"><title type="main">Abstract</title>
<p>Glycopeptide dendrimers containing different types of tumor associated‐carbohydrate antigens (T<sub>N</sub>
, TF, sialyl‐T<sub>N</sub>
, sialyl‐TF, sialyl‐Le<sup>x</sup>
, sialyl‐Le<sup>a</sup>
 etc.) were used in diagnosis and therapy of different sorts of cancer. These dendrimeric structures with incorporated T‐cell epitopes and adjuvants can be used as antitumor vaccines. Best results were obtained with multiantigenic vaccines, containing, e.g. five or six different TAAs. The topic of TAAs and their dendrimeric forms at molecular level are reviewed, including structure, syntheses, and biological activities. Use of glycopeptide dendrimers as antiviral vaccines against HIV and influenza is also described. Their syntheses, physico‐chemical properties, and biological activities are given with many examples. Copyright © 2008 European Peptide Society and John Wiley & Sons, Ltd.</p>
</abstract>
</abstractGroup>
</contentMeta>
</header>
</component>
</istex:document>
</istex:metadataXml>
<mods version="3.6"><titleInfo lang="en"><title>Glycopeptide dendrimers, Part III—a review: Use of glycopeptide dendrimers in immunotherapy and diagnosis of cancer and viral diseases</title>
</titleInfo>
<titleInfo type="abbreviated" lang="en"><title>GLYCOPEPTIDE DENDRIMERS</title>
</titleInfo>
<titleInfo type="alternative" contentType="CDATA" lang="en"><title>Glycopeptide dendrimers, Part III—a review: Use of glycopeptide dendrimers in immunotherapy and diagnosis of cancer and viral diseases</title>
</titleInfo>
<name type="personal"><namePart type="given">Petr</namePart>
<namePart type="family">Niederhafner</namePart>
<affiliation>Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, Flemingovo nám. 2, 166 10 Prague 6, Czech Republic</affiliation>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">Milan</namePart>
<namePart type="family">Reiniš</namePart>
<affiliation>Institute of Molecular Genetics, Academy of Sciences of the Czech Republic, Vídeňská 1083, 142 20 Prague 4, Czech Republic</affiliation>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">Jaroslav</namePart>
<namePart type="family">Šebestík</namePart>
<affiliation>Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, Flemingovo nám. 2, 166 10 Prague 6, Czech Republic</affiliation>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">Jan</namePart>
<namePart type="family">Ježek</namePart>
<affiliation>Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, Flemingovo nám. 2, 166 10 Prague 6, Czech Republic</affiliation>
<affiliation>E-mail: jezek@uochb.cas.cz</affiliation>
<affiliation>Correspondence address: Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, Flemingovo nám. 2, 166 10 Prague 6 ‐ Dejvice, Czech Republic</affiliation>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<typeOfResource>text</typeOfResource>
<genre type="review-article" displayLabel="reviewArticle" authority="ISTEX" authorityURI="https://content-type.data.istex.fr" valueURI="https://content-type.data.istex.fr/ark:/67375/XTP-L5L7X3NF-P">review-article</genre>
<originInfo><publisher>John Wiley & Sons, Ltd.</publisher>
<place><placeTerm type="text">Chichester, UK</placeTerm>
</place>
<dateIssued encoding="w3cdtf">2008-05</dateIssued>
<dateCaptured encoding="w3cdtf">2007-11-28</dateCaptured>
<dateValid encoding="w3cdtf">2007-11-28</dateValid>
<copyrightDate encoding="w3cdtf">2008</copyrightDate>
</originInfo>
<language><languageTerm type="code" authority="rfc3066">en</languageTerm>
<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
</language>
<physicalDescription><extent unit="figures">14</extent>
<extent unit="tables">3</extent>
<extent unit="references">203</extent>
</physicalDescription>
<abstract lang="en">Glycopeptide dendrimers containing different types of tumor associated‐carbohydrate antigens (TN, TF, sialyl‐TN, sialyl‐TF, sialyl‐Lex, sialyl‐Lea etc.) were used in diagnosis and therapy of different sorts of cancer. These dendrimeric structures with incorporated T‐cell epitopes and adjuvants can be used as antitumor vaccines. Best results were obtained with multiantigenic vaccines, containing, e.g. five or six different TAAs. The topic of TAAs and their dendrimeric forms at molecular level are reviewed, including structure, syntheses, and biological activities. Use of glycopeptide dendrimers as antiviral vaccines against HIV and influenza is also described. Their syntheses, physico‐chemical properties, and biological activities are given with many examples. Copyright © 2008 European Peptide Society and John Wiley & Sons, Ltd.</abstract>
<note type="funding">Ministry of Agriculture - No. QF3115/2003; </note>
<note type="funding">Grant Agency of the Czech Republic - No. 203/03/1362; No. 203/07/1517; </note>
<note type="funding">Grant Agency of the Czech Academy of Sciences - No. KAN200520703; </note>
<note type="funding">AS CR - No. Z40550506; No. AVOZ50520514; </note>
<subject lang="en"><genre>keywords</genre>
<topic>anticancer vaccines</topic>
<topic>antiviral vaccines</topic>
<topic>dendrimers</topic>
<topic>glycobiology</topic>
<topic>glycocluster</topic>
<topic>glycoconjugates</topic>
<topic>glycodendrimers</topic>
<topic>glycopeptides</topic>
<topic>glycotope</topic>
<topic>ligation chemistry</topic>
<topic>multiple antigen glycopeptides (MAGs)</topic>
<topic>review</topic>
<topic>synthetic vaccine</topic>
<topic>tumor associated antigen</topic>
</subject>
<relatedItem type="host"><titleInfo><title>Journal of Peptide Science</title>
<subTitle>An Official Publication of the European Peptide Society</subTitle>
</titleInfo>
<titleInfo type="abbreviated"><title>J. Peptide Sci.</title>
</titleInfo>
<genre type="journal" authority="ISTEX" authorityURI="https://publication-type.data.istex.fr" valueURI="https://publication-type.data.istex.fr/ark:/67375/JMC-0GLKJH51-B">journal</genre>
<subject><genre>article-category</genre>
<topic>Review</topic>
<topic>Reviews</topic>
</subject>
<identifier type="ISSN">1075-2617</identifier>
<identifier type="eISSN">1099-1387</identifier>
<identifier type="DOI">10.1002/(ISSN)1099-1387</identifier>
<identifier type="PublisherID">PSC</identifier>
<part><date>2008</date>
<detail type="volume"><caption>vol.</caption>
<number>14</number>
</detail>
<detail type="issue"><caption>no.</caption>
<number>5</number>
</detail>
<extent unit="pages"><start>556</start>
<end>587</end>
<total>32</total>
</extent>
</part>
</relatedItem>
<relatedItem type="references" displayLabel="cit1"><titleInfo><title>Glycopeptide dendrimers. Part I [A Review]</title>
</titleInfo>
<name type="personal"><namePart type="given">P</namePart>
<namePart type="family">Niederhafner</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">J</namePart>
<namePart type="family">Šebestík</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">J</namePart>
<namePart type="family">Ježek</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Niederhafner P, Šebestík J, Ježek J. Glycopeptide dendrimers. Part I [A Review]. J. Pept. Sci. 2008; 14: 2–43.</note>
<part><date>2008</date>
<detail type="volume"><caption>vol.</caption>
<number>14</number>
</detail>
<extent unit="pages"><start>2</start>
<end>43</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>J. Pept. Sci</title>
</titleInfo>
<part><date>2008</date>
<detail type="volume"><caption>vol.</caption>
<number>14</number>
</detail>
<extent unit="pages"><start>2</start>
<end>43</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit2"><titleInfo><title>Glycopeptide dendrimers. Part II [A Review]</title>
</titleInfo>
<name type="personal"><namePart type="given">P</namePart>
<namePart type="family">Niederhafner</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">J</namePart>
<namePart type="family">Šebestík</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">J</namePart>
<namePart type="family">Ježek</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Niederhafner P, Šebestík J, Ježek J. Glycopeptide dendrimers. Part II [A Review]. J. Pept. Sci. 2008; 14: 44–65.</note>
<part><date>2008</date>
<detail type="volume"><caption>vol.</caption>
<number>14</number>
</detail>
<extent unit="pages"><start>44</start>
<end>65</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>J. Pept. Sci</title>
</titleInfo>
<part><date>2008</date>
<detail type="volume"><caption>vol.</caption>
<number>14</number>
</detail>
<extent unit="pages"><start>44</start>
<end>65</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit3"><titleInfo><title>Peptide dendrimers</title>
</titleInfo>
<name type="personal"><namePart type="given">P</namePart>
<namePart type="family">Niederhafner</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">J</namePart>
<namePart type="family">Šebestík</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">J</namePart>
<namePart type="family">Ježek</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Niederhafner P, Šebestík J, Ježek J. Peptide dendrimers [A Review]. J. Pept. Sci. 2005; 11: 757–788.</note>
<part><date>2005</date>
<detail type="volume"><caption>vol.</caption>
<number>11</number>
</detail>
<extent unit="pages"><start>757</start>
<end>788</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>J. Pept. Sci.</title>
</titleInfo>
<part><date>2005</date>
<detail type="volume"><caption>vol.</caption>
<number>11</number>
</detail>
<extent unit="pages"><start>757</start>
<end>788</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit4"><titleInfo><title>Synthetic methods of glycopeptide assembly, and biological analysis of glycopeptide products</title>
</titleInfo>
<name type="personal"><namePart type="given">M</namePart>
<namePart type="family">Meldal</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">PM</namePart>
<namePart type="family">St Hilaire</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Meldal M, St Hilaire PM. Synthetic methods of glycopeptide assembly, and biological analysis of glycopeptide products [A Review]. Curr. Opin. Chem. Biol. 1997; 1: 552–563.</note>
<part><date>1997</date>
<detail type="volume"><caption>vol.</caption>
<number>1</number>
</detail>
<extent unit="pages"><start>552</start>
<end>563</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Curr. Opin. Chem. Biol.</title>
</titleInfo>
<part><date>1997</date>
<detail type="volume"><caption>vol.</caption>
<number>1</number>
</detail>
<extent unit="pages"><start>552</start>
<end>563</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit5"><titleInfo><title>Glycopeptides and glycoproteins: their past, present and future</title>
</titleInfo>
<name type="personal"><namePart type="given">ChD</namePart>
<namePart type="family">Warren</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">HG</namePart>
<namePart type="family">Garg</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>book-chapter</genre>
<relatedItem type="host"><titleInfo><title>Glycopeptides and Related Compounds. Synthesis, Analysis and Applications</title>
</titleInfo>
<originInfo><publisher>Marcel Dekker, Inc</publisher>
<place><placeTerm type="text">New York, Basel, Hong Kong</placeTerm>
</place>
</originInfo>
<part><date>1997</date>
<extent unit="pages"><start>1</start>
<end>22</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit6"><titleInfo><title>Recent developments in glycoconjugates</title>
</titleInfo>
<name type="personal"><namePart type="given">BG</namePart>
<namePart type="family">Davis</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Davis BG. Recent developments in glycoconjugates [A Review]. J. Chem. Soc., Perkin Trans. 1 1999; 3215–3237.</note>
<part><date>1999</date>
<extent unit="pages"><start>3215</start>
<end>3237</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>J. Chem. Soc., Perkin Trans. 1</title>
</titleInfo>
<part><date>1999</date>
<extent unit="pages"><start>3215</start>
<end>3237</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit7"><titleInfo><title>Glycopeptide synthesis and the effects of glycosylation on protein structure and activity</title>
</titleInfo>
<name type="personal"><namePart type="given">O</namePart>
<namePart type="family">Seitz</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Seitz O. Glycopeptide synthesis and the effects of glycosylation on protein structure and activity [A Review]. Chembiochem 2000; 1: 214–246.</note>
<part><date>2000</date>
<detail type="volume"><caption>vol.</caption>
<number>1</number>
</detail>
<extent unit="pages"><start>214</start>
<end>246</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Chembiochem</title>
</titleInfo>
<part><date>2000</date>
<detail type="volume"><caption>vol.</caption>
<number>1</number>
</detail>
<extent unit="pages"><start>214</start>
<end>246</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit8"><titleInfo><title>Chemical glycobiology</title>
</titleInfo>
<name type="personal"><namePart type="given">CR</namePart>
<namePart type="family">Bertozzi</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">LL</namePart>
<namePart type="family">Kiessling</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Bertozzi CR, Kiessling LL. Chemical glycobiology [A Review]. Science 2001; 291: 2357–2364.</note>
<part><date>2001</date>
<detail type="volume"><caption>vol.</caption>
<number>291</number>
</detail>
<extent unit="pages"><start>2357</start>
<end>2364</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Science</title>
</titleInfo>
<part><date>2001</date>
<detail type="volume"><caption>vol.</caption>
<number>291</number>
</detail>
<extent unit="pages"><start>2357</start>
<end>2364</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit9"><titleInfo><title>Chemical and biological strategies for ingeneering cell surface glycosylation</title>
</titleInfo>
<name type="personal"><namePart type="given">E</namePart>
<namePart type="family">Saxon</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">CR</namePart>
<namePart type="family">Bertozzi</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Saxon E, Bertozzi CR. Chemical and biological strategies for ingeneering cell surface glycosylation [A Review]. Annu. Rev. Cell Dev. Biol. 2001; 17: 1–23.</note>
<part><date>2001</date>
<detail type="volume"><caption>vol.</caption>
<number>17</number>
</detail>
<extent unit="pages"><start>1</start>
<end>23</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Annu. Rev. Cell Dev. Biol.</title>
</titleInfo>
<part><date>2001</date>
<detail type="volume"><caption>vol.</caption>
<number>17</number>
</detail>
<extent unit="pages"><start>1</start>
<end>23</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit10"><titleInfo><title>Biological applications of dendrimers</title>
</titleInfo>
<name type="personal"><namePart type="given">MJ</namePart>
<namePart type="family">Cloninger</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Cloninger MJ. Biological applications of dendrimers [A Review]. Curr. Opin. Chem. Biol. 2002; 6: 742–748.</note>
<part><date>2002</date>
<detail type="volume"><caption>vol.</caption>
<number>6</number>
</detail>
<extent unit="pages"><start>742</start>
<end>748</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Curr. Opin. Chem. Biol.</title>
</titleInfo>
<part><date>2002</date>
<detail type="volume"><caption>vol.</caption>
<number>6</number>
</detail>
<extent unit="pages"><start>742</start>
<end>748</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit11"><titleInfo><title>Synthesis of tumor‐associated glycopeptide antigens</title>
</titleInfo>
<name type="personal"><namePart type="given">C</namePart>
<namePart type="family">Brocke</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">H</namePart>
<namePart type="family">Kunz</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Brocke C, Kunz H. Synthesis of tumor‐associated glycopeptide antigens [A Review]. Bioorg. Med. Chem. 2002; 10: 3085–3112.</note>
<part><date>2002</date>
<detail type="volume"><caption>vol.</caption>
<number>10</number>
</detail>
<extent unit="pages"><start>3085</start>
<end>3112</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Bioorg. Med. Chem.</title>
</titleInfo>
<part><date>2002</date>
<detail type="volume"><caption>vol.</caption>
<number>10</number>
</detail>
<extent unit="pages"><start>3085</start>
<end>3112</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit12"><titleInfo><title>Artificial multivalent sugar ligands to understand and manipulate carbohydrate‐protein interactions</title>
</titleInfo>
<name type="personal"><namePart type="given">TK</namePart>
<namePart type="family">Lindhorst</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Lindhorst TK. Artificial multivalent sugar ligands to understand and manipulate carbohydrate‐protein interactions [A Review]. Top. Curr. Chem. 2002; 218: 201–235.</note>
<part><date>2002</date>
<detail type="volume"><caption>vol.</caption>
<number>218</number>
</detail>
<extent unit="pages"><start>201</start>
<end>235</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Top. Curr. Chem.</title>
</titleInfo>
<part><date>2002</date>
<detail type="volume"><caption>vol.</caption>
<number>218</number>
</detail>
<extent unit="pages"><start>201</start>
<end>235</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit13"><titleInfo><title>Design, functional evaluation and biomedical applications of carbohydrate dendrimers (glycodendrimers)</title>
</titleInfo>
<name type="personal"><namePart type="given">K</namePart>
<namePart type="family">Bezouška</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Bezouška K. Design, functional evaluation and biomedical applications of carbohydrate dendrimers (glycodendrimers) [A Review]. Rev. Mol. Biotechnol. 2002; 90: 269–290.</note>
<part><date>2002</date>
<detail type="volume"><caption>vol.</caption>
<number>90</number>
</detail>
<extent unit="pages"><start>269</start>
<end>290</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Rev. Mol. Biotechnol.</title>
</titleInfo>
<part><date>2002</date>
<detail type="volume"><caption>vol.</caption>
<number>90</number>
</detail>
<extent unit="pages"><start>269</start>
<end>290</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit14"><titleInfo><title>Synthetic glycopeptides for the development of tumour‐selective vaccines</title>
</titleInfo>
<name type="personal"><namePart type="given">H</namePart>
<namePart type="family">Kunz</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Kunz H. Synthetic glycopeptides for the development of tumour‐selective vaccines [A Review]. J. Pept. Sci. 2003; 9: 563–573.</note>
<part><date>2003</date>
<detail type="volume"><caption>vol.</caption>
<number>9</number>
</detail>
<extent unit="pages"><start>563</start>
<end>573</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>J. Pept. Sci.</title>
</titleInfo>
<part><date>2003</date>
<detail type="volume"><caption>vol.</caption>
<number>9</number>
</detail>
<extent unit="pages"><start>563</start>
<end>573</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit15"><titleInfo><title>Synthetic carbohydrate‐based vaccines</title>
</titleInfo>
<name type="personal"><namePart type="given">SJ</namePart>
<namePart type="family">Keding</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">SJ</namePart>
<namePart type="family">Danishefsky</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>book-chapter</genre>
<relatedItem type="host"><titleInfo><title>Carbohydrate‐Based Drug Discovery</title>
</titleInfo>
<originInfo><publisher>Wiley‐VCH GmbH & Co KGaA</publisher>
<place><placeTerm type="text">Weinheim</placeTerm>
</place>
</originInfo>
<part><date>2003</date>
<detail type="volume"><caption>vol.</caption>
<number>1</number>
</detail>
<extent unit="pages"><start>381</start>
<end>406</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit16"><titleInfo><title>Exploring and exploiting the therapeutic potential of glycoconjugates</title>
</titleInfo>
<name type="personal"><namePart type="given">KJ</namePart>
<namePart type="family">Doores</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">DP</namePart>
<namePart type="family">Gamblin</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">BG</namePart>
<namePart type="family">Davis</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Doores KJ, Gamblin DP, Davis BG. Exploring and exploiting the therapeutic potential of glycoconjugates [A Review]. Chem. Eur. J. 2006; 12: 656–665.</note>
<part><date>2006</date>
<detail type="volume"><caption>vol.</caption>
<number>12</number>
</detail>
<extent unit="pages"><start>656</start>
<end>665</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Chem. Eur. J.</title>
</titleInfo>
<part><date>2006</date>
<detail type="volume"><caption>vol.</caption>
<number>12</number>
</detail>
<extent unit="pages"><start>656</start>
<end>665</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit17"><titleInfo><title>Synthetic multivalent carbohydrate ligands as effectors or inhibitors of biological processes</title>
</titleInfo>
<name type="personal"><namePart type="given">LL</namePart>
<namePart type="family">Kiessling</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">JK</namePart>
<namePart type="family">Pontrello</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">MC</namePart>
<namePart type="family">Schuster</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>book-chapter</genre>
<relatedItem type="host"><titleInfo><title>Carbohydrate‐Based Drug Discovery</title>
</titleInfo>
<originInfo><publisher>Wiley‐VCH GmbH & Co KGaA</publisher>
<place><placeTerm type="text">Weinheim</placeTerm>
</place>
</originInfo>
<part><date>2003</date>
<detail type="volume"><caption>vol.</caption>
<number>2</number>
</detail>
<extent unit="pages"><start>575</start>
<end>608</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit18"><titleInfo><title>A decade of glycodendrimer chemistry</title>
</titleInfo>
<name type="personal"><namePart type="given">R</namePart>
<namePart type="family">Roy</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Roy R. A decade of glycodendrimer chemistry [A Review]. Trends Glycosci. Glycotechnol. 2003; 15: 291–310.</note>
<part><date>2003</date>
<detail type="volume"><caption>vol.</caption>
<number>15</number>
</detail>
<extent unit="pages"><start>291</start>
<end>310</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Trends Glycosci. Glycotechnol.</title>
</titleInfo>
<part><date>2003</date>
<detail type="volume"><caption>vol.</caption>
<number>15</number>
</detail>
<extent unit="pages"><start>291</start>
<end>310</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit19"><titleInfo><title>Recent developments in the synthesis and discovery of oligosaccharides and glycoconjugates for the treatment of disease</title>
</titleInfo>
<name type="personal"><namePart type="given">D</namePart>
<namePart type="family">Macmillan</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">AM</namePart>
<namePart type="family">Daines</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Macmillan D, Daines AM. Recent developments in the synthesis and discovery of oligosaccharides and glycoconjugates for the treatment of disease [A Review]. Curr. Med. Chem. 2003; 10: 2733–2773.</note>
<part><date>2003</date>
<detail type="volume"><caption>vol.</caption>
<number>10</number>
</detail>
<extent unit="pages"><start>2733</start>
<end>2773</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Curr. Med. Chem.</title>
</titleInfo>
<part><date>2003</date>
<detail type="volume"><caption>vol.</caption>
<number>10</number>
</detail>
<extent unit="pages"><start>2733</start>
<end>2773</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit20"><titleInfo><title>Carbohydrate diversity: synthesis of glycoconjugates and complex carbohydrates</title>
</titleInfo>
<name type="personal"><namePart type="given">A</namePart>
<namePart type="family">Holemann</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">PH</namePart>
<namePart type="family">Seeberger</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Holemann A, Seeberger PH. Carbohydrate diversity: synthesis of glycoconjugates and complex carbohydrates [A Review]. Curr. Opin. Biotechnol. 2004; 15: 615–622.</note>
<part><date>2004</date>
<detail type="volume"><caption>vol.</caption>
<number>15</number>
</detail>
<extent unit="pages"><start>615</start>
<end>622</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Curr. Opin. Biotechnol.</title>
</titleInfo>
<part><date>2004</date>
<detail type="volume"><caption>vol.</caption>
<number>15</number>
</detail>
<extent unit="pages"><start>615</start>
<end>622</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit21"><titleInfo><title>Synthetic carbohydrate‐based antitumor vaccines: challenges and opportunities</title>
</titleInfo>
<name type="personal"><namePart type="given">O</namePart>
<namePart type="family">Ouerfelli</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">JD</namePart>
<namePart type="family">Warren</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">RM</namePart>
<namePart type="family">Wilson</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">SJ</namePart>
<namePart type="family">Danishefsky</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Ouerfelli O, Warren JD, Wilson RM, Danishefsky SJ. Synthetic carbohydrate‐based antitumor vaccines: challenges and opportunities [A Review]. Expert Rev. Vaccines 2005; 4: 677–685.</note>
<part><date>2005</date>
<detail type="volume"><caption>vol.</caption>
<number>4</number>
</detail>
<extent unit="pages"><start>677</start>
<end>685</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Expert Rev. Vaccines</title>
</titleInfo>
<part><date>2005</date>
<detail type="volume"><caption>vol.</caption>
<number>4</number>
</detail>
<extent unit="pages"><start>677</start>
<end>685</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit22"><titleInfo><title>Synthesis of tumor‐associated glycopeptide antigens for the development of tumor‐selective vaccines</title>
</titleInfo>
<name type="personal"><namePart type="given">S</namePart>
<namePart type="family">Dziadek</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">H</namePart>
<namePart type="family">Kunz</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Dziadek S, Kunz H. Synthesis of tumor‐associated glycopeptide antigens for the development of tumor‐selective vaccines [A Review]. Chem. Rec. 2004; 3: 308–321.</note>
<part><date>2004</date>
<detail type="volume"><caption>vol.</caption>
<number>3</number>
</detail>
<extent unit="pages"><start>308</start>
<end>321</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Chem. Rec.</title>
</titleInfo>
<part><date>2004</date>
<detail type="volume"><caption>vol.</caption>
<number>3</number>
</detail>
<extent unit="pages"><start>308</start>
<end>321</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit23"><titleInfo><title>Design and synthesis of glycodendrimers</title>
</titleInfo>
<name type="personal"><namePart type="given">WB</namePart>
<namePart type="family">Turnbull</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">JF</namePart>
<namePart type="family">Stoddart</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Turnbull WB, Stoddart JF. Design and synthesis of glycodendrimers [A Review]. Rev. Mol. Biotechnol. 2002; 90: 231–255.</note>
<part><date>2002</date>
<detail type="volume"><caption>vol.</caption>
<number>90</number>
</detail>
<extent unit="pages"><start>231</start>
<end>255</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Rev. Mol. Biotechnol.</title>
</titleInfo>
<part><date>2002</date>
<detail type="volume"><caption>vol.</caption>
<number>90</number>
</detail>
<extent unit="pages"><start>231</start>
<end>255</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit24"><titleInfo><title>Synthesis and application of carbohydrate‐containing polymers</title>
</titleInfo>
<name type="personal"><namePart type="given">W</namePart>
<namePart type="family">Wang</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">JS</namePart>
<namePart type="family">Dordick</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">RJ</namePart>
<namePart type="family">Linhardt</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Wang W, Dordick JS, Linhardt RJ. Synthesis and application of carbohydrate‐containing polymers [A Review]. Chem. Mater. 2002; 14: 3232–3244.</note>
<part><date>2002</date>
<detail type="volume"><caption>vol.</caption>
<number>14</number>
</detail>
<extent unit="pages"><start>3232</start>
<end>3244</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Chem. Mater.</title>
</titleInfo>
<part><date>2002</date>
<detail type="volume"><caption>vol.</caption>
<number>14</number>
</detail>
<extent unit="pages"><start>3232</start>
<end>3244</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit25"><titleInfo><title>From the laboratory to the clinic: a retrospective on fully synthetic carbohydrate‐based anticancer vaccines</title>
</titleInfo>
<name type="personal"><namePart type="given">SJ</namePart>
<namePart type="family">Danishefsky</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">JR</namePart>
<namePart type="family">Allen</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Danishefsky SJ, Allen JR. From the laboratory to the clinic: a retrospective on fully synthetic carbohydrate‐based anticancer vaccines [A Review]. Angew. Chem. Int. Ed. Engl. 2000; 39: 836–863.</note>
<part><date>2000</date>
<detail type="volume"><caption>vol.</caption>
<number>39</number>
</detail>
<extent unit="pages"><start>836</start>
<end>863</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Angew. Chem. Int. Ed. Engl.</title>
</titleInfo>
<part><date>2000</date>
<detail type="volume"><caption>vol.</caption>
<number>39</number>
</detail>
<extent unit="pages"><start>836</start>
<end>863</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit26"><titleInfo><title>Intervention with bacterial adhesion by multivalent carbohydrates</title>
</titleInfo>
<name type="personal"><namePart type="given">RJ</namePart>
<namePart type="family">Pieters</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Pieters RJ. Intervention with bacterial adhesion by multivalent carbohydrates [A Review]. Med. Res. Rev. 2007; 27: 796–816.</note>
<part><date>2007</date>
<detail type="volume"><caption>vol.</caption>
<number>27</number>
</detail>
<extent unit="pages"><start>796</start>
<end>816</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Med. Res. Rev.</title>
</titleInfo>
<part><date>2007</date>
<detail type="volume"><caption>vol.</caption>
<number>27</number>
</detail>
<extent unit="pages"><start>796</start>
<end>816</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit27"><titleInfo><title>Glycopeptides as versatile tools for glycobiology</title>
</titleInfo>
<name type="personal"><namePart type="given">T</namePart>
<namePart type="family">Buskas</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">S</namePart>
<namePart type="family">Ingale</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">GJ</namePart>
<namePart type="family">Boons</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Buskas T, Ingale S, Boons GJ. Glycopeptides as versatile tools for glycobiology [A Review]. Glycobiology 2006; 16: 113R–136R.</note>
<part><date>2006</date>
<detail type="volume"><caption>vol.</caption>
<number>16</number>
</detail>
<extent unit="pages"><start>113R</start>
<end>136R</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Glycobiology</title>
</titleInfo>
<part><date>2006</date>
<detail type="volume"><caption>vol.</caption>
<number>16</number>
</detail>
<extent unit="pages"><start>113R</start>
<end>136R</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit28"><titleInfo><title>Cancer vaccines targeting carbohydrate antigens</title>
</titleInfo>
<name type="personal"><namePart type="given">PO</namePart>
<namePart type="family">Livingston</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">G</namePart>
<namePart type="family">Ragupathi</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Livingston PO, Ragupathi G. Cancer vaccines targeting carbohydrate antigens [Commentary]. Hum. Vaccin. 2006; 2: 137–143.</note>
<part><date>2006</date>
<detail type="volume"><caption>vol.</caption>
<number>2</number>
</detail>
<extent unit="pages"><start>137</start>
<end>143</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Hum. Vaccin.</title>
</titleInfo>
<part><date>2006</date>
<detail type="volume"><caption>vol.</caption>
<number>2</number>
</detail>
<extent unit="pages"><start>137</start>
<end>143</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit29"><titleInfo><title>Antibody inducing polyvalent cancer vaccines</title>
</titleInfo>
<name type="personal"><namePart type="given">G</namePart>
<namePart type="family">Ragupathi</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">J</namePart>
<namePart type="family">Gathuru</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">P</namePart>
<namePart type="family">Livingston</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Ragupathi G, Gathuru J, Livingston P. Antibody inducing polyvalent cancer vaccines [A Review]. Cancer Treat. Res. 2005; 123: 157–180.</note>
<part><date>2005</date>
<detail type="volume"><caption>vol.</caption>
<number>123</number>
</detail>
<extent unit="pages"><start>157</start>
<end>180</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Cancer Treat. Res.</title>
</titleInfo>
<part><date>2005</date>
<detail type="volume"><caption>vol.</caption>
<number>123</number>
</detail>
<extent unit="pages"><start>157</start>
<end>180</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit30"><titleInfo><title>Peptide dendrimers as artificial enzymes, receptors, and drug‐delivery agents</title>
</titleInfo>
<name type="personal"><namePart type="given">T</namePart>
<namePart type="family">Darbre</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">JL</namePart>
<namePart type="family">Reymond</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Darbre T, Reymond JL. Peptide dendrimers as artificial enzymes, receptors, and drug‐delivery agents [A Review]. Acc. Chem. Res. 2006; 39: 925–934.</note>
<part><date>2006</date>
<detail type="volume"><caption>vol.</caption>
<number>39</number>
</detail>
<extent unit="pages"><start>925</start>
<end>934</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Acc. Chem. Res.</title>
</titleInfo>
<part><date>2006</date>
<detail type="volume"><caption>vol.</caption>
<number>39</number>
</detail>
<extent unit="pages"><start>925</start>
<end>934</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit31"><titleInfo><title>Recent progress in the solid‐phase synthesis of glycopeptide</title>
</titleInfo>
<name type="personal"><namePart type="given">H</namePart>
<namePart type="family">Hojo</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">Y</namePart>
<namePart type="family">Nakahara</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Hojo H, Nakahara Y. Recent progress in the solid‐phase synthesis of glycopeptide [A Review]. Curr. Protein Pept. Sci. 2000; 1: 23–48.</note>
<part><date>2000</date>
<detail type="volume"><caption>vol.</caption>
<number>1</number>
</detail>
<extent unit="pages"><start>23</start>
<end>48</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Curr. Protein Pept. Sci.</title>
</titleInfo>
<part><date>2000</date>
<detail type="volume"><caption>vol.</caption>
<number>1</number>
</detail>
<extent unit="pages"><start>23</start>
<end>48</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit32"><titleInfo><title>Synthesis of glycopeptides containing carbohydrate and peptide recognition motifs</title>
</titleInfo>
<name type="personal"><namePart type="given">H</namePart>
<namePart type="family">Herzner</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">T</namePart>
<namePart type="family">Reipen</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">M</namePart>
<namePart type="family">Schultz</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">H</namePart>
<namePart type="family">Kunz</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Herzner H, Reipen T, Schultz M, Kunz H. Synthesis of glycopeptides containing carbohydrate and peptide recognition motifs [A Review]. Chem. Rev. 2000; 100: 4495–4537.</note>
<part><date>2000</date>
<detail type="volume"><caption>vol.</caption>
<number>100</number>
</detail>
<extent unit="pages"><start>4495</start>
<end>4537</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Chem. Rev.</title>
</titleInfo>
<part><date>2000</date>
<detail type="volume"><caption>vol.</caption>
<number>100</number>
</detail>
<extent unit="pages"><start>4495</start>
<end>4537</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit33"><titleInfo><title>Synthetic vaccines consisting of tumor‐associated MUC1 glycopeptide antigens and bovine serum albumin</title>
</titleInfo>
<name type="personal"><namePart type="given">S</namePart>
<namePart type="family">Dziadek</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">D</namePart>
<namePart type="family">Kowalczyk</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">H</namePart>
<namePart type="family">Kunz</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Dziadek S, Kowalczyk D, Kunz H. Synthetic vaccines consisting of tumor‐associated MUC1 glycopeptide antigens and bovine serum albumin. Angew. Chem. Int. Ed. Engl. 2005; 44: 7624–7630.</note>
<part><date>2005</date>
<detail type="volume"><caption>vol.</caption>
<number>44</number>
</detail>
<extent unit="pages"><start>7624</start>
<end>7630</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Angew. Chem. Int. Ed. Engl.</title>
</titleInfo>
<part><date>2005</date>
<detail type="volume"><caption>vol.</caption>
<number>44</number>
</detail>
<extent unit="pages"><start>7624</start>
<end>7630</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit34"><titleInfo><title>Recent advances in the synthesis of glycopeptides</title>
</titleInfo>
<name type="personal"><namePart type="given">H</namePart>
<namePart type="family">Kunz</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">M</namePart>
<namePart type="family">Schultz</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>book-chapter</genre>
<relatedItem type="host"><titleInfo><title>Glycopeptides and Related Compounds. Synthesis, Analysis and Applications</title>
</titleInfo>
<originInfo><publisher>Marcel Dekker, Inc</publisher>
<place><placeTerm type="text">New York, Basel, Hong Kong</placeTerm>
</place>
</originInfo>
<part><date>1997</date>
<extent unit="pages"><start>23</start>
<end>78</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit35"><titleInfo><title>Syntheses of oligosaccharides and glycopeptides on insoluble and soluble supports</title>
</titleInfo>
<name type="personal"><namePart type="given">SJ</namePart>
<namePart type="family">Danishefsky</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">JY</namePart>
<namePart type="family">Roberge</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>book-chapter</genre>
<relatedItem type="host"><titleInfo><title>Glycopeptides and Related Compounds. Synthesis, Analysis and Applications</title>
</titleInfo>
<originInfo><publisher>Marcel Dekker, Inc</publisher>
<place><placeTerm type="text">New York, Basel, Hong Kong</placeTerm>
</place>
</originInfo>
<part><date>1997</date>
<extent unit="pages"><start>245</start>
<end>294</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit36"><titleInfo><title>Synthetic glycopeptides with tumor‐associated antigen and cell adhesion ligand structure</title>
</titleInfo>
<name type="personal"><namePart type="given">H</namePart>
<namePart type="family">Kunz</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">B</namePart>
<namePart type="family">Liebe</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">O</namePart>
<namePart type="family">Seitz</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">J</namePart>
<namePart type="family">Habermann</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">K</namePart>
<namePart type="family">Peilstocker</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">U</namePart>
<namePart type="family">Sprengard</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Kunz H, Liebe B, Seitz O, Habermann J, Peilstocker K, Sprengard U. Synthetic glycopeptides with tumor‐associated antigen and cell adhesion ligand structure [A Review]. Collect. Symp. Ser. 1999; 1: 134–146.</note>
<part><date>1999</date>
<detail type="volume"><caption>vol.</caption>
<number>1</number>
</detail>
<extent unit="pages"><start>134</start>
<end>146</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Collect. Symp. Ser.</title>
</titleInfo>
<part><date>1999</date>
<detail type="volume"><caption>vol.</caption>
<number>1</number>
</detail>
<extent unit="pages"><start>134</start>
<end>146</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit37"><titleInfo><title>Synthetic glycopeptides and glycoproteins</title>
</titleInfo>
<name type="personal"><namePart type="given">H</namePart>
<namePart type="family">Kunz</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Kunz H. Synthetic glycopeptides and glycoproteins [A Review]. Collect. Symp. Ser. 1999; 1: 67–78.</note>
<part><date>1999</date>
<detail type="volume"><caption>vol.</caption>
<number>1</number>
</detail>
<extent unit="pages"><start>67</start>
<end>78</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Collect. Symp. Ser.</title>
</titleInfo>
<part><date>1999</date>
<detail type="volume"><caption>vol.</caption>
<number>1</number>
</detail>
<extent unit="pages"><start>67</start>
<end>78</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit38"><titleInfo><title>Glycopeptide synthesis in solution and on the solid phase</title>
</titleInfo>
<name type="personal"><namePart type="given">H</namePart>
<namePart type="family">Kunz</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">M</namePart>
<namePart type="family">Schultz</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>book-chapter</genre>
<relatedItem type="host"><titleInfo><title>Carbohydrates in Chemistry and Biology</title>
</titleInfo>
<originInfo><publisher>WILEY‐VCH</publisher>
<place><placeTerm type="text">Weinheim, New York</placeTerm>
</place>
</originInfo>
<part><date>2000</date>
<extent unit="pages"><start>267</start>
<end>304</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit39"><titleInfo><title>Molecular design and syntheses of glycopolymers</title>
</titleInfo>
<name type="personal"><namePart type="given">M</namePart>
<namePart type="family">Okada</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Okada M. Molecular design and syntheses of glycopolymers [A Review]. Prog. Polym. Sci. 2001; 26: 67–104.</note>
<part><date>2001</date>
<detail type="volume"><caption>vol.</caption>
<number>26</number>
</detail>
<extent unit="pages"><start>67</start>
<end>104</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Prog. Polym. Sci.</title>
</titleInfo>
<part><date>2001</date>
<detail type="volume"><caption>vol.</caption>
<number>26</number>
</detail>
<extent unit="pages"><start>67</start>
<end>104</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit40"><titleInfo><title>Heterogeneously functionalized dendrimers</title>
</titleInfo>
<name type="personal"><namePart type="given">JR</namePart>
<namePart type="family">Morgan</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">MJ</namePart>
<namePart type="family">Cloninger</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Morgan JR, Cloninger MJ. Heterogeneously functionalized dendrimers [A Review]. Curr. Opin. Drug Discov. Devel. 2002; 5: 966–973.</note>
<part><date>2002</date>
<detail type="volume"><caption>vol.</caption>
<number>5</number>
</detail>
<extent unit="pages"><start>966</start>
<end>973</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Curr. Opin. Drug Discov. Devel.</title>
</titleInfo>
<part><date>2002</date>
<detail type="volume"><caption>vol.</caption>
<number>5</number>
</detail>
<extent unit="pages"><start>966</start>
<end>973</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit41"><titleInfo><title>Glycopeptides and glycoproteins: synthetic chemistry and biology</title>
</titleInfo>
<name type="personal"><namePart type="given">O</namePart>
<namePart type="family">Seitz</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>book-chapter</genre>
<relatedItem type="host"><titleInfo><title>Carbohydrate‐Based Drug Discovery</title>
</titleInfo>
<originInfo><publisher>Wiley‐VCH GmbH & Co KGaA</publisher>
<place><placeTerm type="text">Weinheim</placeTerm>
</place>
</originInfo>
<part><date>2003</date>
<detail type="volume"><caption>vol.</caption>
<number>1</number>
</detail>
<extent unit="pages"><start>169</start>
<end>214</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit42"><titleInfo><title>Solid‐phase synthesis of mucin glycopeptides</title>
</titleInfo>
<name type="personal"><namePart type="given">M</namePart>
<namePart type="family">Liu</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">D</namePart>
<namePart type="family">Live</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">G</namePart>
<namePart type="family">Barany</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Liu M, Live D, Barany G. Solid‐phase synthesis of mucin glycopeptides [A Review]. Chim. Oggi (Chemistry Today) 2004; 22: 30–34.</note>
<part><date>2004</date>
<detail type="volume"><caption>vol.</caption>
<number>22</number>
</detail>
<extent unit="pages"><start>30</start>
<end>34</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Chim. Oggi (Chemistry Today)</title>
</titleInfo>
<part><date>2004</date>
<detail type="volume"><caption>vol.</caption>
<number>22</number>
</detail>
<extent unit="pages"><start>30</start>
<end>34</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit43"><titleInfo><title>Glycopeptide and glycoprotein synthesis involving unprotected carbohydrate building blocks</title>
</titleInfo>
<name type="personal"><namePart type="given">Z</namePart>
<namePart type="family">Guo</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">N</namePart>
<namePart type="family">Shao</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Guo Z, Shao N. Glycopeptide and glycoprotein synthesis involving unprotected carbohydrate building blocks [A Review]. Med. Res. Rev. 2005; 25: 655–678.</note>
<part><date>2005</date>
<detail type="volume"><caption>vol.</caption>
<number>25</number>
</detail>
<extent unit="pages"><start>655</start>
<end>678</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Med. Res. Rev.</title>
</titleInfo>
<part><date>2005</date>
<detail type="volume"><caption>vol.</caption>
<number>25</number>
</detail>
<extent unit="pages"><start>655</start>
<end>678</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit44"><titleInfo><title>A fully synthetic vaccine consisting of a tumor‐associated glycopeptide antigen and a T‐cell epitope for the induction of a highly specific humoral immune response</title>
</titleInfo>
<name type="personal"><namePart type="given">S</namePart>
<namePart type="family">Dziadek</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">A</namePart>
<namePart type="family">Hobel</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">E</namePart>
<namePart type="family">Schmitt</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">H</namePart>
<namePart type="family">Kunz</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Dziadek S, Hobel A, Schmitt E, Kunz H. A fully synthetic vaccine consisting of a tumor‐associated glycopeptide antigen and a T‐cell epitope for the induction of a highly specific humoral immune response. Angew. Chem. Int. Ed. Engl. 2005; 44: 7630–7635.</note>
<part><date>2005</date>
<detail type="volume"><caption>vol.</caption>
<number>44</number>
</detail>
<extent unit="pages"><start>7630</start>
<end>7635</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Angew. Chem. Int. Ed. Engl.</title>
</titleInfo>
<part><date>2005</date>
<detail type="volume"><caption>vol.</caption>
<number>44</number>
</detail>
<extent unit="pages"><start>7630</start>
<end>7635</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit45"><titleInfo><title>Functional dendrimers, hyperbranched and star polymers</title>
</titleInfo>
<name type="personal"><namePart type="given">K</namePart>
<namePart type="family">Inoue</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Inoue K. Functional dendrimers, hyperbranched and star polymers [A Review]. Prog. Polym. Sci. 2000; 25: 453–571.</note>
<part><date>2000</date>
<detail type="volume"><caption>vol.</caption>
<number>25</number>
</detail>
<extent unit="pages"><start>453</start>
<end>571</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Prog. Polym. Sci.</title>
</titleInfo>
<part><date>2000</date>
<detail type="volume"><caption>vol.</caption>
<number>25</number>
</detail>
<extent unit="pages"><start>453</start>
<end>571</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit46"><titleInfo><title>Glycodendrimers</title>
</titleInfo>
<name type="personal"><namePart type="given">N</namePart>
<namePart type="family">Rockendorf</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">TK</namePart>
<namePart type="family">Lindhorst</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Rockendorf N, Lindhorst TK. Glycodendrimers [A Review]. Top. Curr. Chem. 2001; 217: 201–238.</note>
<part><date>2001</date>
<detail type="volume"><caption>vol.</caption>
<number>217</number>
</detail>
<extent unit="pages"><start>201</start>
<end>238</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Top. Curr. Chem.</title>
</titleInfo>
<part><date>2001</date>
<detail type="volume"><caption>vol.</caption>
<number>217</number>
</detail>
<extent unit="pages"><start>201</start>
<end>238</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit47"><titleInfo><title>Automated high‐throughput synthesis of artificial glycopeptides. Small‐molecule probes for chemical glycobiology</title>
</titleInfo>
<name type="personal"><namePart type="given">P</namePart>
<namePart type="family">Arya</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">A</namePart>
<namePart type="family">Barkley</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">KD</namePart>
<namePart type="family">Randell</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Arya P, Barkley A, Randell KD. Automated high‐throughput synthesis of artificial glycopeptides. Small‐molecule probes for chemical glycobiology. J. Comb. Chem. 2002; 4: 193–198.</note>
<part><date>2002</date>
<detail type="volume"><caption>vol.</caption>
<number>4</number>
</detail>
<extent unit="pages"><start>193</start>
<end>198</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>J. Comb. Chem.</title>
</titleInfo>
<part><date>2002</date>
<detail type="volume"><caption>vol.</caption>
<number>4</number>
</detail>
<extent unit="pages"><start>193</start>
<end>198</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit48"><titleInfo><title>Synthesis of glycoproteins</title>
</titleInfo>
<name type="personal"><namePart type="given">BG</namePart>
<namePart type="family">Davis</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Davis BG. Synthesis of glycoproteins [A Review]. Chem. Rev. 2002; 102: 579–601.</note>
<part><date>2002</date>
<detail type="volume"><caption>vol.</caption>
<number>102</number>
</detail>
<extent unit="pages"><start>579</start>
<end>601</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Chem. Rev.</title>
</titleInfo>
<part><date>2002</date>
<detail type="volume"><caption>vol.</caption>
<number>102</number>
</detail>
<extent unit="pages"><start>579</start>
<end>601</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit49"><titleInfo><title>Dendronized polymers: synthesis, characterization, assembly at interfaces, and manipulation</title>
</titleInfo>
<name type="personal"><namePart type="given">AD</namePart>
<namePart type="family">Schluter</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">JP</namePart>
<namePart type="family">Rabe</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Schluter AD, Rabe JP. Dendronized polymers: synthesis, characterization, assembly at interfaces, and manipulation [A Review]. Angew. Chem. Int. Ed. Engl. 2000; 39: 864–883.</note>
<part><date>2000</date>
<detail type="volume"><caption>vol.</caption>
<number>39</number>
</detail>
<extent unit="pages"><start>864</start>
<end>883</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Angew. Chem. Int. Ed. Engl.</title>
</titleInfo>
<part><date>2000</date>
<detail type="volume"><caption>vol.</caption>
<number>39</number>
</detail>
<extent unit="pages"><start>864</start>
<end>883</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit50"><titleInfo><title>Dendrimers: properties and applications</title>
</titleInfo>
<name type="personal"><namePart type="given">B</namePart>
<namePart type="family">Klajnert</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">M</namePart>
<namePart type="family">Bryszewska</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Klajnert B, Bryszewska M. Dendrimers: properties and applications [A Review]. Acta Biochim. Pol. 2001; 48: 199–208.</note>
<part><date>2001</date>
<detail type="volume"><caption>vol.</caption>
<number>48</number>
</detail>
<extent unit="pages"><start>199</start>
<end>208</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Acta Biochim. Pol.</title>
</titleInfo>
<part><date>2001</date>
<detail type="volume"><caption>vol.</caption>
<number>48</number>
</detail>
<extent unit="pages"><start>199</start>
<end>208</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit51"><titleInfo><title>Chemical glycosylation in the synthesis of glycoconjugate antitumour vaccines</title>
</titleInfo>
<name type="personal"><namePart type="given">DP</namePart>
<namePart type="family">Galonic</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">DY</namePart>
<namePart type="family">Gin</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Galonic DP, Gin DY. Chemical glycosylation in the synthesis of glycoconjugate antitumour vaccines [A Review]. Nature 2007; 446: 1000–1007.</note>
<part><date>2007</date>
<detail type="volume"><caption>vol.</caption>
<number>446</number>
</detail>
<extent unit="pages"><start>1000</start>
<end>1007</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Nature</title>
</titleInfo>
<part><date>2007</date>
<detail type="volume"><caption>vol.</caption>
<number>446</number>
</detail>
<extent unit="pages"><start>1000</start>
<end>1007</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit52"><titleInfo><title>Recent progress in the field of glycopeptide synthesis</title>
</titleInfo>
<name type="personal"><namePart type="given">H</namePart>
<namePart type="family">Hojo</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">Y</namePart>
<namePart type="family">Nakahara</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Hojo H, Nakahara Y. Recent progress in the field of glycopeptide synthesis [A Review]. Biopolymers (Pept. Sci.) 2007; 88: 308–324.</note>
<part><date>2007</date>
<detail type="volume"><caption>vol.</caption>
<number>88</number>
</detail>
<extent unit="pages"><start>308</start>
<end>324</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Biopolymers (Pept. Sci.)</title>
</titleInfo>
<part><date>2007</date>
<detail type="volume"><caption>vol.</caption>
<number>88</number>
</detail>
<extent unit="pages"><start>308</start>
<end>324</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit53"><titleInfo><title>The case for polyvalent cancer vaccines that induce antibodies</title>
</titleInfo>
<name type="personal"><namePart type="given">G</namePart>
<namePart type="family">Ragupathi</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">P</namePart>
<namePart type="family">Livingston</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Ragupathi G, Livingston P. The case for polyvalent cancer vaccines that induce antibodies [A Review]. Expert Rev. Vaccines 2002; 1: 89–102.</note>
<part><date>2002</date>
<detail type="volume"><caption>vol.</caption>
<number>1</number>
</detail>
<extent unit="pages"><start>89</start>
<end>102</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Expert Rev. Vaccines</title>
</titleInfo>
<part><date>2002</date>
<detail type="volume"><caption>vol.</caption>
<number>1</number>
</detail>
<extent unit="pages"><start>89</start>
<end>102</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit54"><titleInfo><title>Carbohydrate vaccines as immunotherapy for cancer</title>
</titleInfo>
<name type="personal"><namePart type="given">SF</namePart>
<namePart type="family">Slovin</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">SJ</namePart>
<namePart type="family">Keding</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">G</namePart>
<namePart type="family">Ragupathi</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Slovin SF, Keding SJ, Ragupathi G. Carbohydrate vaccines as immunotherapy for cancer [A Review]. Immunol. Cell Biol. 2005; 83: 418–428.</note>
<part><date>2005</date>
<detail type="volume"><caption>vol.</caption>
<number>83</number>
</detail>
<extent unit="pages"><start>418</start>
<end>428</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Immunol. Cell Biol.</title>
</titleInfo>
<part><date>2005</date>
<detail type="volume"><caption>vol.</caption>
<number>83</number>
</detail>
<extent unit="pages"><start>418</start>
<end>428</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit55"><titleInfo><title>A clinical development paradigm for cancer vaccines and related biologics</title>
</titleInfo>
<name type="personal"><namePart type="given">A</namePart>
<namePart type="family">Hoos</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">G</namePart>
<namePart type="family">Parmiani</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">K</namePart>
<namePart type="family">Hege</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">M</namePart>
<namePart type="family">Sznol</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">H</namePart>
<namePart type="family">Loibner</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">A</namePart>
<namePart type="family">Eggermont</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">W</namePart>
<namePart type="family">Urba</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">B</namePart>
<namePart type="family">Blumenstein</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">N</namePart>
<namePart type="family">Sacks</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">U</namePart>
<namePart type="family">Keilholz</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">G</namePart>
<namePart type="family">Nichol</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Hoos A, Parmiani G, Hege K, Sznol M, Loibner H, Eggermont A, Urba W, Blumenstein B, Sacks N, Keilholz U, Nichol G. A clinical development paradigm for cancer vaccines and related biologics [A Review]. J. Immunother. 2007; 30: 1–15.</note>
<part><date>2007</date>
<detail type="volume"><caption>vol.</caption>
<number>30</number>
</detail>
<extent unit="pages"><start>1</start>
<end>15</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>J. Immunother.</title>
</titleInfo>
<part><date>2007</date>
<detail type="volume"><caption>vol.</caption>
<number>30</number>
</detail>
<extent unit="pages"><start>1</start>
<end>15</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit56"><titleInfo><title>Tumor antigens as surrogate markers and targets for therapy and vaccines</title>
</titleInfo>
<name type="personal"><namePart type="given">A</namePart>
<namePart type="family">Dalgleish</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">H</namePart>
<namePart type="family">Pandha</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Dalgleish A, Pandha H. Tumor antigens as surrogate markers and targets for therapy and vaccines [A Review]. Adv. Cancer Res. 2007; 96: 175–190.</note>
<part><date>2007</date>
<detail type="volume"><caption>vol.</caption>
<number>96</number>
</detail>
<extent unit="pages"><start>175</start>
<end>190</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Adv. Cancer Res.</title>
</titleInfo>
<part><date>2007</date>
<detail type="volume"><caption>vol.</caption>
<number>96</number>
</detail>
<extent unit="pages"><start>175</start>
<end>190</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit57"><titleInfo><title>Macromolecular MRI contrast agents for imaging tumor angiogenesis</title>
</titleInfo>
<name type="personal"><namePart type="given">T</namePart>
<namePart type="family">Barrett</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">H</namePart>
<namePart type="family">Kobayashi</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">M</namePart>
<namePart type="family">Brechbiel</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">PL</namePart>
<namePart type="family">Choyke</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Barrett T, Kobayashi H, Brechbiel M, Choyke PL. Macromolecular MRI contrast agents for imaging tumor angiogenesis [A Review]. Eur. J. Radiol. 2006; 60: 353–366.</note>
<part><date>2006</date>
<detail type="volume"><caption>vol.</caption>
<number>60</number>
</detail>
<extent unit="pages"><start>353</start>
<end>366</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Eur. J. Radiol.</title>
</titleInfo>
<part><date>2006</date>
<detail type="volume"><caption>vol.</caption>
<number>60</number>
</detail>
<extent unit="pages"><start>353</start>
<end>366</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit58"><titleInfo><title>Dendrimers and antivirals: A review</title>
</titleInfo>
<name type="personal"><namePart type="given">A</namePart>
<namePart type="family">Rosa Borges</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">CL</namePart>
<namePart type="family">Schengrund</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Rosa Borges A, Schengrund CL. Dendrimers and antivirals: A review [A Review]. Curr. Drug Targets Infect. Disord. 2005; 5: 247–254.</note>
<part><date>2005</date>
<detail type="volume"><caption>vol.</caption>
<number>5</number>
</detail>
<extent unit="pages"><start>247</start>
<end>254</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Curr. Drug Targets Infect. Disord.</title>
</titleInfo>
<part><date>2005</date>
<detail type="volume"><caption>vol.</caption>
<number>5</number>
</detail>
<extent unit="pages"><start>247</start>
<end>254</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit59"><titleInfo><title>Glycobiology of AIDS</title>
</titleInfo>
<name type="personal"><namePart type="given">T</namePart>
<namePart type="family">Feizi</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>book-chapter</genre>
<relatedItem type="host"><titleInfo><title>Carbohydrates in Chemistry and Biology</title>
</titleInfo>
<originInfo><publisher>WILEY‐VCH</publisher>
<place><placeTerm type="text">Weinheim, New York</placeTerm>
</place>
</originInfo>
<part><date>2000</date>
<extent unit="pages"><start>851</start>
<end>866</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit60"><titleInfo><title>Glycodendritic structures: promising new antiviral drugs</title>
</titleInfo>
<name type="personal"><namePart type="given">J</namePart>
<namePart type="family">Rojo</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">R</namePart>
<namePart type="family">Delgado</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Rojo J, Delgado R. Glycodendritic structures: promising new antiviral drugs [A Review]. J. Antimicrob. Chemother. 2004; 54: 579–581.</note>
<part><date>2004</date>
<detail type="volume"><caption>vol.</caption>
<number>54</number>
</detail>
<extent unit="pages"><start>579</start>
<end>581</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>J. Antimicrob. Chemother.</title>
</titleInfo>
<part><date>2004</date>
<detail type="volume"><caption>vol.</caption>
<number>54</number>
</detail>
<extent unit="pages"><start>579</start>
<end>581</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit61"><titleInfo><title>Synthetic peptides for the immunodiagnosis of human diseases</title>
</titleInfo>
<name type="personal"><namePart type="given">MJ</namePart>
<namePart type="family">Gomara</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">I</namePart>
<namePart type="family">Haro</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Gomara MJ, Haro I. Synthetic peptides for the immunodiagnosis of human diseases [A Review]. Curr. Med. Chem. 2007; 14: 531–546.</note>
<part><date>2007</date>
<detail type="volume"><caption>vol.</caption>
<number>14</number>
</detail>
<extent unit="pages"><start>531</start>
<end>546</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Curr. Med. Chem.</title>
</titleInfo>
<part><date>2007</date>
<detail type="volume"><caption>vol.</caption>
<number>14</number>
</detail>
<extent unit="pages"><start>531</start>
<end>546</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit62"><titleInfo><title>Dendrimers in gene delivery</title>
</titleInfo>
<name type="personal"><namePart type="given">Ch</namePart>
<namePart type="family">Dufes</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">IF</namePart>
<namePart type="family">Uchegbu</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">AG</namePart>
<namePart type="family">Schatzlein</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Dufes Ch, Uchegbu IF, Schatzlein AG. Dendrimers in gene delivery [A Review]. Adv. Drug Deliv. Rev. 2005; 57: 2177–2202.</note>
<part><date>2005</date>
<detail type="volume"><caption>vol.</caption>
<number>57</number>
</detail>
<extent unit="pages"><start>2177</start>
<end>2202</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Adv. Drug Deliv. Rev.</title>
</titleInfo>
<part><date>2005</date>
<detail type="volume"><caption>vol.</caption>
<number>57</number>
</detail>
<extent unit="pages"><start>2177</start>
<end>2202</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit63"><titleInfo><title>Bioinspired applications of functional dendrimers</title>
</titleInfo>
<name type="personal"><namePart type="given">WD</namePart>
<namePart type="family">Jang</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">K</namePart>
<namePart type="family">Kataoka</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Jang WD, Kataoka K. Bioinspired applications of functional dendrimers [A Review]. J. Drug Del. Sci. Tech. 2005; 15: 19–30.</note>
<part><date>2005</date>
<detail type="volume"><caption>vol.</caption>
<number>15</number>
</detail>
<extent unit="pages"><start>19</start>
<end>30</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>J. Drug Del. Sci. Tech.</title>
</titleInfo>
<part><date>2005</date>
<detail type="volume"><caption>vol.</caption>
<number>15</number>
</detail>
<extent unit="pages"><start>19</start>
<end>30</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit64"><titleInfo><title>Dendritic supermolecules‐towards controllable nanomaterials</title>
</titleInfo>
<name type="personal"><namePart type="given">DK</namePart>
<namePart type="family">Smith</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Smith DK. Dendritic supermolecules‐towards controllable nanomaterials [A Review]. Chem. Commun. 2006; 34–44.</note>
<part><date>2006</date>
<extent unit="pages"><start>34</start>
<end>44</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Chem. Commun.</title>
</titleInfo>
<part><date>2006</date>
<extent unit="pages"><start>34</start>
<end>44</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit65"><titleInfo><title>Artificial viruses: a nanotechnological approach to gene delivery</title>
</titleInfo>
<name type="personal"><namePart type="given">E</namePart>
<namePart type="family">Mastrobattista</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">MAEM</namePart>
<namePart type="family">van der Aa</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">WE</namePart>
<namePart type="family">Hennink</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">DJA</namePart>
<namePart type="family">Crommelin</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Mastrobattista E, van der Aa MAEM, Hennink WE, Crommelin DJA. Artificial viruses: a nanotechnological approach to gene delivery [A Review]. Nat. Rev. Drug Discov. 2006; 5: 115–121.</note>
<part><date>2006</date>
<detail type="volume"><caption>vol.</caption>
<number>5</number>
</detail>
<extent unit="pages"><start>115</start>
<end>121</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Nat. Rev. Drug Discov.</title>
</titleInfo>
<part><date>2006</date>
<detail type="volume"><caption>vol.</caption>
<number>5</number>
</detail>
<extent unit="pages"><start>115</start>
<end>121</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit66"><titleInfo><title>Design of functional dendritic polymers for application as drug and gene delivery systems</title>
</titleInfo>
<name type="personal"><namePart type="given">Z</namePart>
<namePart type="family">Sideratou</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">LA</namePart>
<namePart type="family">Tziveleka</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">Ch</namePart>
<namePart type="family">Kontoyianni</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">D</namePart>
<namePart type="family">Tsiourvas</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">CM</namePart>
<namePart type="family">Paleos</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Sideratou Z, Tziveleka LA, Kontoyianni Ch, Tsiourvas D, Paleos CM. Design of functional dendritic polymers for application as drug and gene delivery systems [A Review]. Gene Ther. Mol. Biol. 2006; 10: 71–94.</note>
<part><date>2006</date>
<detail type="volume"><caption>vol.</caption>
<number>10</number>
</detail>
<extent unit="pages"><start>71</start>
<end>94</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Gene Ther. Mol. Biol.</title>
</titleInfo>
<part><date>2006</date>
<detail type="volume"><caption>vol.</caption>
<number>10</number>
</detail>
<extent unit="pages"><start>71</start>
<end>94</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit67"><titleInfo><title>Dendritic polymers in glycobiology</title>
</titleInfo>
<name type="personal"><namePart type="given">DE</namePart>
<namePart type="family">Tsvetkov</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">NE</namePart>
<namePart type="family">Nifantiev</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Tsvetkov DE, Nifantiev NE. Dendritic polymers in glycobiology [A Review]. Russ. Chem. Bull. Int. Ed. 2005; 54: 1065–1083.</note>
<part><date>2005</date>
<detail type="volume"><caption>vol.</caption>
<number>54</number>
</detail>
<extent unit="pages"><start>1065</start>
<end>1083</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Russ. Chem. Bull. Int. Ed.</title>
</titleInfo>
<part><date>2005</date>
<detail type="volume"><caption>vol.</caption>
<number>54</number>
</detail>
<extent unit="pages"><start>1065</start>
<end>1083</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit68"><titleInfo><title>Thermodynamic models of the multivalency effect</title>
</titleInfo>
<name type="personal"><namePart type="given">PI</namePart>
<namePart type="family">Kitov</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">DR</namePart>
<namePart type="family">Bundle</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>book-chapter</genre>
<relatedItem type="host"><titleInfo><title>Carbohydrate‐Based Drug Discovery</title>
</titleInfo>
<originInfo><publisher>Wiley‐VCH GmbH & Co. KGaA</publisher>
<place><placeTerm type="text">Weinheim</placeTerm>
</place>
</originInfo>
<part><date>2003</date>
<detail type="volume"><caption>vol.</caption>
<number>2</number>
</detail>
<extent unit="pages"><start>541</start>
<end>574</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit69"><titleInfo><title>Chemoenzymatic synthesis of HIV‐1 gp41 glycopeptides: effects of glycosylation on the anti‐HIV activity and α‐helix bundle‐forming ability of peptide C34</title>
</titleInfo>
<name type="personal"><namePart type="given">LX</namePart>
<namePart type="family">Wang</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">H</namePart>
<namePart type="family">Song</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">S</namePart>
<namePart type="family">Liu</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">H</namePart>
<namePart type="family">Lu</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">S</namePart>
<namePart type="family">Jiang</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">J</namePart>
<namePart type="family">Ni</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">H</namePart>
<namePart type="family">Li</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Wang LX, Song H, Liu S, Lu H, Jiang S, Ni J, Li H. Chemoenzymatic synthesis of HIV‐1 gp41 glycopeptides: effects of glycosylation on the anti‐HIV activity and α‐helix bundle‐forming ability of peptide C34. Chembiochem 2005; 6: 1068–1074.</note>
<part><date>2005</date>
<detail type="volume"><caption>vol.</caption>
<number>6</number>
</detail>
<extent unit="pages"><start>1068</start>
<end>1074</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Chembiochem</title>
</titleInfo>
<part><date>2005</date>
<detail type="volume"><caption>vol.</caption>
<number>6</number>
</detail>
<extent unit="pages"><start>1068</start>
<end>1074</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit70"><titleInfo><title>Role of glycosylation in development</title>
</titleInfo>
<name type="personal"><namePart type="given">RS</namePart>
<namePart type="family">Haltiwanger</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">JB</namePart>
<namePart type="family">Lowe</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Haltiwanger RS, Lowe JB. Role of glycosylation in development [A Review]. Annu. Rev. Biochem. 2004; 73: 491–537.</note>
<part><date>2004</date>
<detail type="volume"><caption>vol.</caption>
<number>73</number>
</detail>
<extent unit="pages"><start>491</start>
<end>537</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Annu. Rev. Biochem.</title>
</titleInfo>
<part><date>2004</date>
<detail type="volume"><caption>vol.</caption>
<number>73</number>
</detail>
<extent unit="pages"><start>491</start>
<end>537</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit71"><titleInfo><title>The role of glycosylation in protein antigenic properties</title>
</titleInfo>
<name type="personal"><namePart type="given">E</namePart>
<namePart type="family">Lisowska</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Lisowska E. The role of glycosylation in protein antigenic properties [A Review]. Cell. Mol. Life Sci. 2002; 59: 445–455.</note>
<part><date>2002</date>
<detail type="volume"><caption>vol.</caption>
<number>59</number>
</detail>
<extent unit="pages"><start>445</start>
<end>455</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Cell. Mol. Life Sci.</title>
</titleInfo>
<part><date>2002</date>
<detail type="volume"><caption>vol.</caption>
<number>59</number>
</detail>
<extent unit="pages"><start>445</start>
<end>455</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit72"><titleInfo><title>Effects of glycosylation on peptide conformation: a synergistic experimental and computational study</title>
</titleInfo>
<name type="personal"><namePart type="given">CJ</namePart>
<namePart type="family">Bosques</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">SM</namePart>
<namePart type="family">Tschampel</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">RJ</namePart>
<namePart type="family">Woods</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">B</namePart>
<namePart type="family">Imperiali</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Bosques CJ, Tschampel SM, Woods RJ, Imperiali B. Effects of glycosylation on peptide conformation: a synergistic experimental and computational study. J. Am. Chem. Soc. 2004; 126: 8421–8425.</note>
<part><date>2004</date>
<detail type="volume"><caption>vol.</caption>
<number>126</number>
</detail>
<extent unit="pages"><start>8421</start>
<end>8425</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>J. Am. Chem. Soc.</title>
</titleInfo>
<part><date>2004</date>
<detail type="volume"><caption>vol.</caption>
<number>126</number>
</detail>
<extent unit="pages"><start>8421</start>
<end>8425</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit73"><titleInfo><title>Binding patterns of DTR‐specific antibodies reveal a glycosylation‐conditioned tumor‐specific epitope of the epithelial mucin (MUC1)</title>
</titleInfo>
<name type="personal"><namePart type="given">U</namePart>
<namePart type="family">Karsten</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">N</namePart>
<namePart type="family">Serttas</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">H</namePart>
<namePart type="family">Paulsen</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">A</namePart>
<namePart type="family">Danielczyk</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">S</namePart>
<namePart type="family">Goletz</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Karsten U, Serttas N, Paulsen H, Danielczyk A, Goletz S. Binding patterns of DTR‐specific antibodies reveal a glycosylation‐conditioned tumor‐specific epitope of the epithelial mucin (MUC1). Glycobiology 2004; 14: 681–692.</note>
<part><date>2004</date>
<detail type="volume"><caption>vol.</caption>
<number>14</number>
</detail>
<extent unit="pages"><start>681</start>
<end>692</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Glycobiology</title>
</titleInfo>
<part><date>2004</date>
<detail type="volume"><caption>vol.</caption>
<number>14</number>
</detail>
<extent unit="pages"><start>681</start>
<end>692</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit74"><titleInfo><title>Protein glycosylation and cancer</title>
</titleInfo>
<name type="personal"><namePart type="given">JW</namePart>
<namePart type="family">Dennis</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">M</namePart>
<namePart type="family">Granovski</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>book-chapter</genre>
<relatedItem type="host"><titleInfo><title>Carbohydrates in Chemistry and Biology</title>
</titleInfo>
<originInfo><publisher>WILEY‐VCH</publisher>
<place><placeTerm type="text">Weinheim, New York</placeTerm>
</place>
</originInfo>
<part><date>2000</date>
<extent unit="pages"><start>923</start>
<end>944</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit75"><titleInfo><title>The chemistry and biology of mucin‐type O‐linked glycosylation</title>
</titleInfo>
<name type="personal"><namePart type="given">HC</namePart>
<namePart type="family">Hang</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">CR</namePart>
<namePart type="family">Bertozzi</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Hang HC, Bertozzi CR. The chemistry and biology of mucin‐type O‐linked glycosylation [A Review]. Bioorg. Med. Chem. 2005; 13: 5021–5034.</note>
<part><date>2005</date>
<detail type="volume"><caption>vol.</caption>
<number>13</number>
</detail>
<extent unit="pages"><start>5021</start>
<end>5034</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Bioorg. Med. Chem.</title>
</titleInfo>
<part><date>2005</date>
<detail type="volume"><caption>vol.</caption>
<number>13</number>
</detail>
<extent unit="pages"><start>5021</start>
<end>5034</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit76"><titleInfo><title>Immunological characterization of peptide mimetics of carbohydrate antigens in vaccine design strategies</title>
</titleInfo>
<name type="personal"><namePart type="given">B</namePart>
<namePart type="family">Monzavi‐Karbassi</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">G</namePart>
<namePart type="family">Cunto‐Amesty</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">P</namePart>
<namePart type="family">Luo</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">A</namePart>
<namePart type="family">Lees</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">T</namePart>
<namePart type="family">Kieber‐Emmons</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Monzavi‐Karbassi B, Cunto‐Amesty G, Luo P, Lees A, Kieber‐Emmons T. Immunological characterization of peptide mimetics of carbohydrate antigens in vaccine design strategies. Biologicals 2001; 29: 249–257.</note>
<part><date>2001</date>
<detail type="volume"><caption>vol.</caption>
<number>29</number>
</detail>
<extent unit="pages"><start>249</start>
<end>257</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Biologicals</title>
</titleInfo>
<part><date>2001</date>
<detail type="volume"><caption>vol.</caption>
<number>29</number>
</detail>
<extent unit="pages"><start>249</start>
<end>257</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit77"><titleInfo><title>A glycopeptide in complex with MHC class I uses the GalNAc residue as an anchor</title>
</titleInfo>
<name type="personal"><namePart type="given">V</namePart>
<namePart type="family">Apostolopoulos</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">E</namePart>
<namePart type="family">Yuriev</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">PA</namePart>
<namePart type="family">Ramsland</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">J</namePart>
<namePart type="family">Halton</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">C</namePart>
<namePart type="family">Osinski</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">W</namePart>
<namePart type="family">Li</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">M</namePart>
<namePart type="family">Plebanski</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">H</namePart>
<namePart type="family">Paulsen</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">IF</namePart>
<namePart type="family">McKenzie</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Apostolopoulos V, Yuriev E, Ramsland PA, Halton J, Osinski C, Li W, Plebanski M, Paulsen H, McKenzie IF. A glycopeptide in complex with MHC class I uses the GalNAc residue as an anchor. Proc. Natl. Acad. Sci. U.S.A. 2003; 100: 15029–15034.</note>
<part><date>2003</date>
<detail type="volume"><caption>vol.</caption>
<number>100</number>
</detail>
<extent unit="pages"><start>15029</start>
<end>15034</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Proc. Natl. Acad. Sci. U.S.A.</title>
</titleInfo>
<part><date>2003</date>
<detail type="volume"><caption>vol.</caption>
<number>100</number>
</detail>
<extent unit="pages"><start>15029</start>
<end>15034</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit78"><titleInfo><title>Synthetic glycopeptides for the development of cancer vaccines</title>
</titleInfo>
<name type="personal"><namePart type="given">A</namePart>
<namePart type="family">Liakatos</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">H</namePart>
<namePart type="family">Kunz</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Liakatos A, Kunz H. Synthetic glycopeptides for the development of cancer vaccines [A Review]. Curr. Opin. Mol. Ther. 2007; 9: 35–44.</note>
<part><date>2007</date>
<detail type="volume"><caption>vol.</caption>
<number>9</number>
</detail>
<extent unit="pages"><start>35</start>
<end>44</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Curr. Opin. Mol. Ther.</title>
</titleInfo>
<part><date>2007</date>
<detail type="volume"><caption>vol.</caption>
<number>9</number>
</detail>
<extent unit="pages"><start>35</start>
<end>44</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit79"><titleInfo><title>Carbohydrate vaccines in cancer: Immunogenicity of a fully synthetic globo H hexasaccharide conjugate in man</title>
</titleInfo>
<name type="personal"><namePart type="given">SF</namePart>
<namePart type="family">Slovin</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">G</namePart>
<namePart type="family">Ragupathi</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">S</namePart>
<namePart type="family">Adluri</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">G</namePart>
<namePart type="family">Ungers</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">K</namePart>
<namePart type="family">Terry</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">S</namePart>
<namePart type="family">Kim</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">M</namePart>
<namePart type="family">Spassova</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">WG</namePart>
<namePart type="family">Bornmann</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">M</namePart>
<namePart type="family">Fazzari</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">L</namePart>
<namePart type="family">Dantis</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">K</namePart>
<namePart type="family">Olkiewicz</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">KO</namePart>
<namePart type="family">Lloyd</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">PO</namePart>
<namePart type="family">Livingston</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">SJ</namePart>
<namePart type="family">Danishefsky</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">HI</namePart>
<namePart type="family">Scher</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Slovin SF, Ragupathi G, Adluri S, Ungers G, Terry K, Kim S, Spassova M, Bornmann WG, Fazzari M, Dantis L, Olkiewicz K, Lloyd KO, Livingston PO, Danishefsky SJ, Scher HI. Carbohydrate vaccines in cancer: Immunogenicity of a fully synthetic globo H hexasaccharide conjugate in man. Proc. Natl. Acad. Sci. U.S.A. 1999; 96: 5710–5715.</note>
<part><date>1999</date>
<detail type="volume"><caption>vol.</caption>
<number>96</number>
</detail>
<extent unit="pages"><start>5710</start>
<end>5715</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Proc. Natl. Acad. Sci. U.S.A.</title>
</titleInfo>
<part><date>1999</date>
<detail type="volume"><caption>vol.</caption>
<number>96</number>
</detail>
<extent unit="pages"><start>5710</start>
<end>5715</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit80"><titleInfo><title>Pursuit of carbohydrate‐based anticancer vaccines: preparation of a multiantigennic unimolar glycopeptide containing the TN, MBr1 and Lewisy antigens</title>
</titleInfo>
<name type="personal"><namePart type="given">JR</namePart>
<namePart type="family">Allen</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">ChR</namePart>
<namePart type="family">Harris</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">SJ</namePart>
<namePart type="family">Danishefsky</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Allen JR, Harris ChR, Danishefsky SJ. Pursuit of carbohydrate‐based anticancer vaccines: preparation of a multiantigennic unimolar glycopeptide containing the TN, MBr1 and Lewisy antigens. J. Am. Chem. Soc. 2001; 123: 1890–1897.</note>
<part><date>2001</date>
<detail type="volume"><caption>vol.</caption>
<number>123</number>
</detail>
<extent unit="pages"><start>1890</start>
<end>1897</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>J. Am. Chem. Soc.</title>
</titleInfo>
<part><date>2001</date>
<detail type="volume"><caption>vol.</caption>
<number>123</number>
</detail>
<extent unit="pages"><start>1890</start>
<end>1897</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit81"><titleInfo><title>Vaccination of patients with small‐cell lung cancer with synthetic fucosyl GM‐1 conjugated to keyhole limpet hemocyanin</title>
</titleInfo>
<name type="personal"><namePart type="given">LM</namePart>
<namePart type="family">Krug</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">G</namePart>
<namePart type="family">Ragupathi</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">Ch</namePart>
<namePart type="family">Hood</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">MG</namePart>
<namePart type="family">Kris</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">VA</namePart>
<namePart type="family">Miller</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">JR</namePart>
<namePart type="family">Allen</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">SJ</namePart>
<namePart type="family">Keding</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">SJ</namePart>
<namePart type="family">Danishefsky</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">J</namePart>
<namePart type="family">Goméz</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">L</namePart>
<namePart type="family">Tison</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">B</namePart>
<namePart type="family">Pizzo</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">V</namePart>
<namePart type="family">Baez</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">PO</namePart>
<namePart type="family">Livingston</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Krug LM, Ragupathi G, Hood Ch, Kris MG, Miller VA, Allen JR, Keding SJ, Danishefsky SJ, Goméz J, Tison L, Pizzo B, Baez V, Livingston PO. Vaccination of patients with small‐cell lung cancer with synthetic fucosyl GM‐1 conjugated to keyhole limpet hemocyanin. Clin. Cancer Res. 2004; 10: 6094–6100.</note>
<part><date>2004</date>
<detail type="volume"><caption>vol.</caption>
<number>10</number>
</detail>
<extent unit="pages"><start>6094</start>
<end>6100</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Clin. Cancer Res.</title>
</titleInfo>
<part><date>2004</date>
<detail type="volume"><caption>vol.</caption>
<number>10</number>
</detail>
<extent unit="pages"><start>6094</start>
<end>6100</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit82"><titleInfo><title>Induction of carbohydrate‐specific antibodies in HLA‐DR transgenic mice by a synthetic glycopeptide: a potential anti cancer vaccine for human use</title>
</titleInfo>
<name type="personal"><namePart type="given">S</namePart>
<namePart type="family">Vichier‐Guerre</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">S</namePart>
<namePart type="family">Lo‐Man</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">L</namePart>
<namePart type="family">BenMohamed</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">E</namePart>
<namePart type="family">Dériaud</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">S</namePart>
<namePart type="family">Kovats</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">C</namePart>
<namePart type="family">Leclerc</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">S</namePart>
<namePart type="family">Bay</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Vichier‐Guerre S, Lo‐Man S, BenMohamed L, Dériaud E, Kovats S, Leclerc C, Bay S. Induction of carbohydrate‐specific antibodies in HLA‐DR transgenic mice by a synthetic glycopeptide: a potential anti cancer vaccine for human use. J. Pept. Res. 2003; 62: 117–124.</note>
<part><date>2003</date>
<detail type="volume"><caption>vol.</caption>
<number>62</number>
</detail>
<extent unit="pages"><start>117</start>
<end>124</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>J. Pept. Res.</title>
</titleInfo>
<part><date>2003</date>
<detail type="volume"><caption>vol.</caption>
<number>62</number>
</detail>
<extent unit="pages"><start>117</start>
<end>124</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit83"><titleInfo><title>Synthesis of complex carbohydrates and glycoconjugates: enzyme‐based and programable one‐pot strategies</title>
</titleInfo>
<name type="personal"><namePart type="given">KM</namePart>
<namePart type="family">Koeller</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">ChH</namePart>
<namePart type="family">Wong</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Koeller KM, Wong ChH. Synthesis of complex carbohydrates and glycoconjugates: enzyme‐based and programable one‐pot strategies [A Review]. Chem. Rev. 2000; 100: 4465–4493.</note>
<part><date>2000</date>
<detail type="volume"><caption>vol.</caption>
<number>100</number>
</detail>
<extent unit="pages"><start>4465</start>
<end>4493</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Chem. Rev.</title>
</titleInfo>
<part><date>2000</date>
<detail type="volume"><caption>vol.</caption>
<number>100</number>
</detail>
<extent unit="pages"><start>4465</start>
<end>4493</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit84"><titleInfo><title>Tumor‐associated carbohydrate antigens defining tumor malignancy: basis for development of anti‐cancer vaccines</title>
</titleInfo>
<name type="personal"><namePart type="given">S</namePart>
<namePart type="family">Hakomori</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Hakomori S. Tumor‐associated carbohydrate antigens defining tumor malignancy: basis for development of anti‐cancer vaccines [A Review]. Adv. Exp. Med. Biol. 2001; 491: 369–402.</note>
<part><date>2001</date>
<detail type="volume"><caption>vol.</caption>
<number>491</number>
</detail>
<extent unit="pages"><start>369</start>
<end>402</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Adv. Exp. Med. Biol.</title>
</titleInfo>
<part><date>2001</date>
<detail type="volume"><caption>vol.</caption>
<number>491</number>
</detail>
<extent unit="pages"><start>369</start>
<end>402</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit85"><titleInfo><title>Lipid and carbohydrate based adjuvant/carriers in immunology</title>
</titleInfo>
<name type="personal"><namePart type="given">RP</namePart>
<namePart type="family">McGeary</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">C</namePart>
<namePart type="family">Olive</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">I</namePart>
<namePart type="family">Toth</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">McGeary RP, Olive C, Toth I. Lipid and carbohydrate based adjuvant/carriers in immunology [A Review]. J. Pept. Sci. 2003; 9: 405–418.</note>
<part><date>2003</date>
<detail type="volume"><caption>vol.</caption>
<number>9</number>
</detail>
<extent unit="pages"><start>405</start>
<end>418</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>J. Pept. Sci.</title>
</titleInfo>
<part><date>2003</date>
<detail type="volume"><caption>vol.</caption>
<number>9</number>
</detail>
<extent unit="pages"><start>405</start>
<end>418</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit86"><titleInfo><title>Tumor antigen‐based immunotherapy and immunoprevention of cancer</title>
</titleInfo>
<name type="personal"><namePart type="given">SO</namePart>
<namePart type="family">Ryan</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">KR</namePart>
<namePart type="family">Gantt</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">OJ</namePart>
<namePart type="family">Finn</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Ryan SO, Gantt KR, Finn OJ. Tumor antigen‐based immunotherapy and immunoprevention of cancer [A Review]. Int. Arch. Allergy Immunol. 2007; 142: 179–189.</note>
<part><date>2007</date>
<detail type="volume"><caption>vol.</caption>
<number>142</number>
</detail>
<extent unit="pages"><start>179</start>
<end>189</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Int. Arch. Allergy Immunol.</title>
</titleInfo>
<part><date>2007</date>
<detail type="volume"><caption>vol.</caption>
<number>142</number>
</detail>
<extent unit="pages"><start>179</start>
<end>189</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit87"><titleInfo><title>Designer glycopeptides for cytotoxic T cell‐based elimination of carcinomas</title>
</titleInfo>
<name type="personal"><namePart type="given">Y</namePart>
<namePart type="family">Xu</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">SJ</namePart>
<namePart type="family">Gendler</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">A</namePart>
<namePart type="family">Franco</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Xu Y, Gendler SJ, Franco A. Designer glycopeptides for cytotoxic T cell‐based elimination of carcinomas. J. Exp. Med. 2004; 199: 707–716.</note>
<part><date>2004</date>
<detail type="volume"><caption>vol.</caption>
<number>199</number>
</detail>
<extent unit="pages"><start>707</start>
<end>716</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>J. Exp. Med.</title>
</titleInfo>
<part><date>2004</date>
<detail type="volume"><caption>vol.</caption>
<number>199</number>
</detail>
<extent unit="pages"><start>707</start>
<end>716</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit88"><titleInfo><title>CTL‐based cancer preventive/therapeutic vaccines for carcinomas: role of tumour‐associated carbohydrate antigens</title>
</titleInfo>
<name type="personal"><namePart type="given">A</namePart>
<namePart type="family">Franco</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Franco A. CTL‐based cancer preventive/therapeutic vaccines for carcinomas: role of tumour‐associated carbohydrate antigens [A Review]. Scand. J. Immunol. 2005; 61: 391–397.</note>
<part><date>2005</date>
<detail type="volume"><caption>vol.</caption>
<number>61</number>
</detail>
<extent unit="pages"><start>391</start>
<end>397</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Scand. J. Immunol.</title>
</titleInfo>
<part><date>2005</date>
<detail type="volume"><caption>vol.</caption>
<number>61</number>
</detail>
<extent unit="pages"><start>391</start>
<end>397</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit89"><titleInfo><title>Peptide mimotopes as surrogate antigens of carbohydrates in vaccine discovery</title>
</titleInfo>
<name type="personal"><namePart type="given">B</namePart>
<namePart type="family">Monzavi‐Karbassi</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">G</namePart>
<namePart type="family">Cunto‐Amesty</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">P</namePart>
<namePart type="family">Luo</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">T</namePart>
<namePart type="family">Kieber‐Emmons</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Monzavi‐Karbassi B, Cunto‐Amesty G, Luo P, Kieber‐Emmons T. Peptide mimotopes as surrogate antigens of carbohydrates in vaccine discovery [A Review]. Trends Biotechnol. 2002; 20: 207–214.</note>
<part><date>2002</date>
<detail type="volume"><caption>vol.</caption>
<number>20</number>
</detail>
<extent unit="pages"><start>207</start>
<end>214</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Trends Biotechnol.</title>
</titleInfo>
<part><date>2002</date>
<detail type="volume"><caption>vol.</caption>
<number>20</number>
</detail>
<extent unit="pages"><start>207</start>
<end>214</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit90"><titleInfo><title>Structure and function of mucins</title>
</titleInfo>
<name type="personal"><namePart type="given">J</namePart>
<namePart type="family">Taylor‐Papadimitriou</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">JM</namePart>
<namePart type="family">Burchell</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>book-chapter</genre>
<relatedItem type="host"><titleInfo><title>Carbohydrates in Chemistry and Biology</title>
</titleInfo>
<originInfo><publisher>WILEY‐VCH</publisher>
<place><placeTerm type="text">Weinheim, New York</placeTerm>
</place>
</originInfo>
<part><date>2000</date>
<extent unit="pages"><start>669</start>
<end>684</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit91"><titleInfo><title>Glycobiology of the immune system</title>
</titleInfo>
<name type="personal"><namePart type="given">EF</namePart>
<namePart type="family">Hounsell</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>book-chapter</genre>
<relatedItem type="host"><titleInfo><title>Carbohydrates in Chemistry and Biology</title>
</titleInfo>
<originInfo><publisher>WILEY‐VCH</publisher>
<place><placeTerm type="text">Weinheim, New York</placeTerm>
</place>
</originInfo>
<part><date>2000</date>
<extent unit="pages"><start>1029</start>
<end>1042</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit92"><titleInfo><title>Principles of mucin architecture: structural studies on synthetic glycopeptides bearing clustered mono‐, di‐, tri‐, and hexasaccharide glycodomains</title>
</titleInfo>
<name type="personal"><namePart type="given">DM</namePart>
<namePart type="family">Coltart</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">AK</namePart>
<namePart type="family">Royyuru</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">LJ</namePart>
<namePart type="family">Williams</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">PW</namePart>
<namePart type="family">Glunz</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">D</namePart>
<namePart type="family">Sames</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">SD</namePart>
<namePart type="family">Kuduk</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">JB</namePart>
<namePart type="family">Schwarz</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">XT</namePart>
<namePart type="family">Chen</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">SJ</namePart>
<namePart type="family">Danishefsky</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">DH</namePart>
<namePart type="family">Live</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Coltart DM, Royyuru AK, Williams LJ, Glunz PW, Sames D, Kuduk SD, Schwarz JB, Chen XT, Danishefsky SJ, Live DH. Principles of mucin architecture: structural studies on synthetic glycopeptides bearing clustered mono‐, di‐, tri‐, and hexasaccharide glycodomains. J. Am. Chem. Soc. 2002; 124: 9833–9844.</note>
<part><date>2002</date>
<detail type="volume"><caption>vol.</caption>
<number>124</number>
</detail>
<extent unit="pages"><start>9833</start>
<end>9844</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>J. Am. Chem. Soc.</title>
</titleInfo>
<part><date>2002</date>
<detail type="volume"><caption>vol.</caption>
<number>124</number>
</detail>
<extent unit="pages"><start>9833</start>
<end>9844</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit93"><titleInfo><title>Probing cell surface “glyco‐architecture” through total synthesis. Immunological consequences of a human blood group determinant in a clustered mucin‐like context</title>
</titleInfo>
<name type="personal"><namePart type="given">PW</namePart>
<namePart type="family">Glunz</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">S</namePart>
<namePart type="family">Hintermann</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">JB</namePart>
<namePart type="family">Schwarz</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">SD</namePart>
<namePart type="family">Kuduk</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">XT</namePart>
<namePart type="family">Chen</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">LJ</namePart>
<namePart type="family">Williams</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">D</namePart>
<namePart type="family">Sames</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">SJ</namePart>
<namePart type="family">Danishefsky</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">V</namePart>
<namePart type="family">Kudryashov</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">KO</namePart>
<namePart type="family">Lloyd</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Glunz PW, Hintermann S, Schwarz JB, Kuduk SD, Chen XT, Williams LJ, Sames D, Danishefsky SJ, Kudryashov V, Lloyd KO. Probing cell surface “glyco‐architecture” through total synthesis. Immunological consequences of a human blood group determinant in a clustered mucin‐like context. J. Am. Chem. Soc. 1999; 121: 10636–10637.</note>
<part><date>1999</date>
<detail type="volume"><caption>vol.</caption>
<number>121</number>
</detail>
<extent unit="pages"><start>10636</start>
<end>10637</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>J. Am. Chem. Soc.</title>
</titleInfo>
<part><date>1999</date>
<detail type="volume"><caption>vol.</caption>
<number>121</number>
</detail>
<extent unit="pages"><start>10636</start>
<end>10637</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit94"><titleInfo><title>On the power of chemical synthesis: immunological evaluation of models for multiantigenic carbohydrate‐based cancer vaccines</title>
</titleInfo>
<name type="personal"><namePart type="given">G</namePart>
<namePart type="family">Ragupathi</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">DM</namePart>
<namePart type="family">Coltart</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">LJ</namePart>
<namePart type="family">Williams</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">F</namePart>
<namePart type="family">Koide</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">E</namePart>
<namePart type="family">Kagan</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">J</namePart>
<namePart type="family">Allen</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">Ch</namePart>
<namePart type="family">Harris</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">PW</namePart>
<namePart type="family">Glunz</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">PO</namePart>
<namePart type="family">Livingston</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">SJ</namePart>
<namePart type="family">Danishefsky</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Ragupathi G, Coltart DM, Williams LJ, Koide F, Kagan E, Allen J, Harris Ch, Glunz PW, Livingston PO, Danishefsky SJ. On the power of chemical synthesis: immunological evaluation of models for multiantigenic carbohydrate‐based cancer vaccines. Proc. Natl. Acad. Sci. U.S.A. 2002; 99: 13699–13704.</note>
<part><date>2002</date>
<detail type="volume"><caption>vol.</caption>
<number>99</number>
</detail>
<extent unit="pages"><start>13699</start>
<end>13704</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Proc. Natl. Acad. Sci. U.S.A.</title>
</titleInfo>
<part><date>2002</date>
<detail type="volume"><caption>vol.</caption>
<number>99</number>
</detail>
<extent unit="pages"><start>13699</start>
<end>13704</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit95"><titleInfo><title>Prospects for total synthesis: A vision for a totally synthetic vaccine targeting epithelial tumors</title>
</titleInfo>
<name type="personal"><namePart type="given">SJ</namePart>
<namePart type="family">Keding</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">SJ</namePart>
<namePart type="family">Danishefsky</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Keding SJ, Danishefsky SJ. Prospects for total synthesis: A vision for a totally synthetic vaccine targeting epithelial tumors. Proc. Natl. Acad. Sci. U.S.A. 2004; 101: 11937–11492.</note>
<part><date>2004</date>
<detail type="volume"><caption>vol.</caption>
<number>101</number>
</detail>
<extent unit="pages"><start>11937</start>
<end>11492</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Proc. Natl. Acad. Sci. U.S.A.</title>
</titleInfo>
<part><date>2004</date>
<detail type="volume"><caption>vol.</caption>
<number>101</number>
</detail>
<extent unit="pages"><start>11937</start>
<end>11492</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit96"><titleInfo><title>Olefin cross‐metathesis: a powerful tool for constructing vaccines composed of multimeric antigens</title>
</titleInfo>
<name type="personal"><namePart type="given">Q</namePart>
<namePart type="family">Wan</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">YS</namePart>
<namePart type="family">Cho</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">TH</namePart>
<namePart type="family">Lambert</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">SJ</namePart>
<namePart type="family">Danishefsky</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Wan Q, Cho YS, Lambert TH, Danishefsky SJ. Olefin cross‐metathesis: a powerful tool for constructing vaccines composed of multimeric antigens. J. Carbohydr. Chem. 2005; 24: 425–440.</note>
<part><date>2005</date>
<detail type="volume"><caption>vol.</caption>
<number>24</number>
</detail>
<extent unit="pages"><start>425</start>
<end>440</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>J. Carbohydr. Chem.</title>
</titleInfo>
<part><date>2005</date>
<detail type="volume"><caption>vol.</caption>
<number>24</number>
</detail>
<extent unit="pages"><start>425</start>
<end>440</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit97"><titleInfo><title>Preparation and evaluation of unimolecular pentavalent and hexavalent antigenic constructs targeting prostate and breast cancer: a synthetic route to anticancer vaccine candidates</title>
</titleInfo>
<name type="personal"><namePart type="given">G</namePart>
<namePart type="family">Ragupathi</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">F</namePart>
<namePart type="family">Koide</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">PO</namePart>
<namePart type="family">Livingston</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">YS</namePart>
<namePart type="family">Cho</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">A</namePart>
<namePart type="family">Endo</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">Q</namePart>
<namePart type="family">Wan</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">MK</namePart>
<namePart type="family">Spassova</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">SJ</namePart>
<namePart type="family">Keding</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">J</namePart>
<namePart type="family">Allen</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">O</namePart>
<namePart type="family">Ouerfelli</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">RM</namePart>
<namePart type="family">Wilson</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">SJ</namePart>
<namePart type="family">Danishefsky</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Ragupathi G, Koide F, Livingston PO, Cho YS, Endo A, Wan Q, Spassova MK, Keding SJ, Allen J, Ouerfelli O, Wilson RM, Danishefsky SJ. Preparation and evaluation of unimolecular pentavalent and hexavalent antigenic constructs targeting prostate and breast cancer: a synthetic route to anticancer vaccine candidates. J. Am. Chem. Soc. 2006; 128: 2715–2725.</note>
<part><date>2006</date>
<detail type="volume"><caption>vol.</caption>
<number>128</number>
</detail>
<extent unit="pages"><start>2715</start>
<end>2725</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>J. Am. Chem. Soc.</title>
</titleInfo>
<part><date>2006</date>
<detail type="volume"><caption>vol.</caption>
<number>128</number>
</detail>
<extent unit="pages"><start>2715</start>
<end>2725</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit98"><titleInfo><title>Organic synthesis in pursuit of immunology: large scale synthesis of peracetylated GM2 glycosylamino acid for preparation of a multiantigenic prostate cancer vaccine</title>
</titleInfo>
<name type="personal"><namePart type="given">YS</namePart>
<namePart type="family">Cho</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">Q</namePart>
<namePart type="family">Wan</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">SJ</namePart>
<namePart type="family">Danishefsky</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Cho YS, Wan Q, Danishefsky SJ. Organic synthesis in pursuit of immunology: large scale synthesis of peracetylated GM2 glycosylamino acid for preparation of a multiantigenic prostate cancer vaccine. Bioorg. Med. Chem. 2005; 13: 5259–5266.</note>
<part><date>2005</date>
<detail type="volume"><caption>vol.</caption>
<number>13</number>
</detail>
<extent unit="pages"><start>5259</start>
<end>5266</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Bioorg. Med. Chem.</title>
</titleInfo>
<part><date>2005</date>
<detail type="volume"><caption>vol.</caption>
<number>13</number>
</detail>
<extent unit="pages"><start>5259</start>
<end>5266</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit99"><titleInfo><title>Synthesis of selected Ley and KH‐1 analogues: a medicinal chemistry approach to vaccine optimization</title>
</titleInfo>
<name type="personal"><namePart type="given">MK</namePart>
<namePart type="family">Spassova</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">WG</namePart>
<namePart type="family">Bornmann</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">G</namePart>
<namePart type="family">Ragupathi</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">G</namePart>
<namePart type="family">Sukenick</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">PO</namePart>
<namePart type="family">Livingston</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">SJ</namePart>
<namePart type="family">Danishefsky</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Spassova MK, Bornmann WG, Ragupathi G, Sukenick G, Livingston PO, Danishefsky SJ. Synthesis of selected Ley and KH‐1 analogues: a medicinal chemistry approach to vaccine optimization. J. Org. Chem. 2005; 70: 3383–3395.</note>
<part><date>2005</date>
<detail type="volume"><caption>vol.</caption>
<number>70</number>
</detail>
<extent unit="pages"><start>3383</start>
<end>3395</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>J. Org. Chem.</title>
</titleInfo>
<part><date>2005</date>
<detail type="volume"><caption>vol.</caption>
<number>70</number>
</detail>
<extent unit="pages"><start>3383</start>
<end>3395</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit100"><titleInfo><title>Novel adjuvant systems</title>
</titleInfo>
<name type="personal"><namePart type="given">MJ</namePart>
<namePart type="family">McCluskie</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">RD</namePart>
<namePart type="family">Weeratna</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">McCluskie MJ, Weeratna RD. Novel adjuvant systems [A Review]. Curr. Drug Targets‐Infect. Disord. 2001; 1: 263–271.</note>
<part><date>2001</date>
<detail type="volume"><caption>vol.</caption>
<number>1</number>
</detail>
<extent unit="pages"><start>263</start>
<end>271</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Curr. Drug Targets‐Infect. Disord.</title>
</titleInfo>
<part><date>2001</date>
<detail type="volume"><caption>vol.</caption>
<number>1</number>
</detail>
<extent unit="pages"><start>263</start>
<end>271</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit101"><titleInfo><title>Glycodendrimers: novel glycotope isosteres unmasking sugar coding. Case study with T‐antigen markers from breast cancer MUC1 glycoprotein</title>
</titleInfo>
<name type="personal"><namePart type="given">R</namePart>
<namePart type="family">Roy</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">MG</namePart>
<namePart type="family">Baek</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Roy R, Baek MG. Glycodendrimers: novel glycotope isosteres unmasking sugar coding. Case study with T‐antigen markers from breast cancer MUC1 glycoprotein [A Review]. Rev. Mol. Biotechnol. 2002; 90: 291–309.</note>
<part><date>2002</date>
<detail type="volume"><caption>vol.</caption>
<number>90</number>
</detail>
<extent unit="pages"><start>291</start>
<end>309</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Rev. Mol. Biotechnol.</title>
</titleInfo>
<part><date>2002</date>
<detail type="volume"><caption>vol.</caption>
<number>90</number>
</detail>
<extent unit="pages"><start>291</start>
<end>309</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit102"><titleInfo><title>Carbohydrates as the next frontier in pharmaceutical research</title>
</titleInfo>
<name type="personal"><namePart type="given">DB</namePart>
<namePart type="family">Werz</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">PH</namePart>
<namePart type="family">Seeberger</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Werz DB, Seeberger PH. Carbohydrates as the next frontier in pharmaceutical research [A Review]. Chem. Eur. J. 2005; 11: 3194–3206.</note>
<part><date>2005</date>
<detail type="volume"><caption>vol.</caption>
<number>11</number>
</detail>
<extent unit="pages"><start>3194</start>
<end>3206</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Chem. Eur. J.</title>
</titleInfo>
<part><date>2005</date>
<detail type="volume"><caption>vol.</caption>
<number>11</number>
</detail>
<extent unit="pages"><start>3194</start>
<end>3206</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit103"><titleInfo><title>Epitopic structure of Tn glycophorin A for an anti‐Tn antibody (MLS 128)</title>
</titleInfo>
<name type="personal"><namePart type="given">H</namePart>
<namePart type="family">Nakada</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">M</namePart>
<namePart type="family">Inoue</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">Y</namePart>
<namePart type="family">Numata</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">N</namePart>
<namePart type="family">Tanaka</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">I</namePart>
<namePart type="family">Funakoshi</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">S</namePart>
<namePart type="family">Fukui</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">A</namePart>
<namePart type="family">Mellors</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">I</namePart>
<namePart type="family">Yamashina</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Nakada H, Inoue M, Numata Y, Tanaka N, Funakoshi I, Fukui S, Mellors A, Yamashina I. Epitopic structure of Tn glycophorin A for an anti‐Tn antibody (MLS 128). Proc. Natl. Acad. Sci. U.S.A. 1993; 90: 2495–2499.</note>
<part><date>1993</date>
<detail type="volume"><caption>vol.</caption>
<number>90</number>
</detail>
<extent unit="pages"><start>2495</start>
<end>2499</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Proc. Natl. Acad. Sci. U.S.A.</title>
</titleInfo>
<part><date>1993</date>
<detail type="volume"><caption>vol.</caption>
<number>90</number>
</detail>
<extent unit="pages"><start>2495</start>
<end>2499</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit104"><titleInfo><title>Vaccines prepared with sialyl‐Tn and sialyl‐Tn trimers using the 4‐(4‐maleimidomethyl)cyclohexane‐1‐carboxyl hydrazide linker group result in optimal antibody titers against ovine submaxillary mucin and sialyl‐Tn‐positive tumor cells</title>
</titleInfo>
<name type="personal"><namePart type="given">G</namePart>
<namePart type="family">Ragupathi</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">L</namePart>
<namePart type="family">Howard</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">S</namePart>
<namePart type="family">Cappello</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">RR</namePart>
<namePart type="family">Koganty</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">D</namePart>
<namePart type="family">Qiu</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">BM</namePart>
<namePart type="family">Longeneckar</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">MA</namePart>
<namePart type="family">Reddish</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">KO</namePart>
<namePart type="family">Lloyd</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">PO</namePart>
<namePart type="family">Livingston</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Ragupathi G, Howard L, Cappello S, Koganty RR, Qiu D, Longeneckar BM, Reddish MA, Lloyd KO, Livingston PO. Vaccines prepared with sialyl‐Tn and sialyl‐Tn trimers using the 4‐(4‐maleimidomethyl)cyclohexane‐1‐carboxyl hydrazide linker group result in optimal antibody titers against ovine submaxillary mucin and sialyl‐Tn‐positive tumor cells. Cancer Immunol. Immunother. 1999; 48: 1–8.</note>
<part><date>1999</date>
<detail type="volume"><caption>vol.</caption>
<number>48</number>
</detail>
<extent unit="pages"><start>1</start>
<end>8</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Cancer Immunol. Immunother.</title>
</titleInfo>
<part><date>1999</date>
<detail type="volume"><caption>vol.</caption>
<number>48</number>
</detail>
<extent unit="pages"><start>1</start>
<end>8</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit105"><titleInfo><title>Vaccination of breast cancer patients (pts) with no evidence of disease (NED) with sialyl TN cluster (sTN(c))‐keyhole limpet hemocyanin (KLH) conjugate plus adjuvant QS‐21: Preliminary results</title>
</titleInfo>
<name type="personal"><namePart type="given">M</namePart>
<namePart type="family">Dicker</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">T</namePart>
<namePart type="family">Gilewski</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">G</namePart>
<namePart type="family">Ragupathi</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">R</namePart>
<namePart type="family">Adluri</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">RR</namePart>
<namePart type="family">Koganty</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">M</namePart>
<namePart type="family">Longenecker</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">AN</namePart>
<namePart type="family">Houghton</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">L</namePart>
<namePart type="family">Norton</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">PO</namePart>
<namePart type="family">Livingston</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Dicker M, Gilewski T, Ragupathi G, Adluri R, Koganty RR, Longenecker M, Houghton AN, Norton L, Livingston PO. Vaccination of breast cancer patients (pts) with no evidence of disease (NED) with sialyl TN cluster (sTN(c))‐keyhole limpet hemocyanin (KLH) conjugate plus adjuvant QS‐21: Preliminary results. Proc. Annu. Meet. Am. Soc. Clin. Oncol. 1997; 16: A1572.</note>
<part><date>1997</date>
<detail type="volume"><caption>vol.</caption>
<number>16</number>
</detail>
<extent unit="pages"><start>A1572</start>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Proc. Annu. Meet. Am. Soc. Clin. Oncol.</title>
</titleInfo>
<part><date>1997</date>
<detail type="volume"><caption>vol.</caption>
<number>16</number>
</detail>
<extent unit="pages"><start>A1572</start>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit106"><titleInfo><title>Dendrimer drugs</title>
</titleInfo>
<name type="personal"><namePart type="given">U</namePart>
<namePart type="family">Boas</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">JB</namePart>
<namePart type="family">Christensen</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">PMH</namePart>
<namePart type="family">Heegaard</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>book-chapter</genre>
<relatedItem type="host"><titleInfo><title>Dendrimers in Medicine and Biotechnology; New Molecular Tools</title>
</titleInfo>
<originInfo><publisher>RSC Publishing</publisher>
<place><placeTerm type="text">Cambridge, UK</placeTerm>
</place>
</originInfo>
<part><date>2006</date>
<extent unit="pages"><start>90</start>
<end>129</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit107"><titleInfo><title>Solid phase synthesis of glycopeptide dendrimers with Tn antigenic structure and their biological activities. Part I</title>
</titleInfo>
<name type="personal"><namePart type="given">J</namePart>
<namePart type="family">Ježek</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">J</namePart>
<namePart type="family">Velek</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">P</namePart>
<namePart type="family">Vepřek</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">V</namePart>
<namePart type="family">Velková</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">T</namePart>
<namePart type="family">Trnka</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">J</namePart>
<namePart type="family">Pecka</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">M</namePart>
<namePart type="family">Ledvina</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">J</namePart>
<namePart type="family">Vondrášek</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">M</namePart>
<namePart type="family">Písacka</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Ježek J, Velek J, Vepřek P, Velková V, Trnka T, Pecka J, Ledvina M, Vondrášek J, Písacka M. Solid phase synthesis of glycopeptide dendrimers with Tn antigenic structure and their biological activities. Part I. J. Pept. Sci. 1999; 5: 46–55.</note>
<part><date>1999</date>
<detail type="volume"><caption>vol.</caption>
<number>5</number>
</detail>
<extent unit="pages"><start>46</start>
<end>55</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>J. Pept. Sci.</title>
</titleInfo>
<part><date>1999</date>
<detail type="volume"><caption>vol.</caption>
<number>5</number>
</detail>
<extent unit="pages"><start>46</start>
<end>55</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit108"><titleInfo><title>A fully synthetic immunogen carrying a carcinoma‐associated carbohydrate for active specific immunotherapy</title>
</titleInfo>
<name type="personal"><namePart type="given">R</namePart>
<namePart type="family">Lo‐Man</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">S</namePart>
<namePart type="family">Bay</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">S</namePart>
<namePart type="family">Vichier‐Guerre</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">E</namePart>
<namePart type="family">Dériaud</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">D</namePart>
<namePart type="family">Cantacuzene</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">C</namePart>
<namePart type="family">Leclerc</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Lo‐Man R, Bay S, Vichier‐Guerre S, Dériaud E, Cantacuzene D, Leclerc C. A fully synthetic immunogen carrying a carcinoma‐associated carbohydrate for active specific immunotherapy. Cancer Res. 1999; 59: 1520–1524.</note>
<part><date>1999</date>
<detail type="volume"><caption>vol.</caption>
<number>59</number>
</detail>
<extent unit="pages"><start>1520</start>
<end>1524</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Cancer Res.</title>
</titleInfo>
<part><date>1999</date>
<detail type="volume"><caption>vol.</caption>
<number>59</number>
</detail>
<extent unit="pages"><start>1520</start>
<end>1524</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit109"><titleInfo><title>Preparation of a multiple antigen glycopeptide (MAG) carrying the Tn antigen. A possible approach to a synthetic carbohydrate vaccine</title>
</titleInfo>
<name type="personal"><namePart type="given">S</namePart>
<namePart type="family">Bay</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">R</namePart>
<namePart type="family">Lo‐Man</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">E</namePart>
<namePart type="family">Osinaga</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">H</namePart>
<namePart type="family">Nakada</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">C</namePart>
<namePart type="family">Leclerc</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">D</namePart>
<namePart type="family">Cantacuzene</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Bay S, Lo‐Man R, Osinaga E, Nakada H, Leclerc C, Cantacuzene D. Preparation of a multiple antigen glycopeptide (MAG) carrying the Tn antigen. A possible approach to a synthetic carbohydrate vaccine. J. Pept. Res. 1997; 49: 620–625.</note>
<part><date>1997</date>
<detail type="volume"><caption>vol.</caption>
<number>49</number>
</detail>
<extent unit="pages"><start>620</start>
<end>625</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>J. Pept. Res.</title>
</titleInfo>
<part><date>1997</date>
<detail type="volume"><caption>vol.</caption>
<number>49</number>
</detail>
<extent unit="pages"><start>620</start>
<end>625</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit110"><titleInfo><title>Short synthetic glycopeptides successfully induce antibody responses to carcinoma‐associated Tn antigen</title>
</titleInfo>
<name type="personal"><namePart type="given">S</namePart>
<namePart type="family">Vichier‐Guerre</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">R</namePart>
<namePart type="family">Lo‐Man</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">S</namePart>
<namePart type="family">Bay</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">E</namePart>
<namePart type="family">Deriaud</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">H</namePart>
<namePart type="family">Nakada</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">C</namePart>
<namePart type="family">Leclerc</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">D</namePart>
<namePart type="family">Cantacuzene</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Vichier‐Guerre S, Lo‐Man R, Bay S, Deriaud E, Nakada H, Leclerc C, Cantacuzene D. Short synthetic glycopeptides successfully induce antibody responses to carcinoma‐associated Tn antigen. J. Pept. Res. 2000; 55: 173–180.</note>
<part><date>2000</date>
<detail type="volume"><caption>vol.</caption>
<number>55</number>
</detail>
<extent unit="pages"><start>173</start>
<end>180</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>J. Pept. Res.</title>
</titleInfo>
<part><date>2000</date>
<detail type="volume"><caption>vol.</caption>
<number>55</number>
</detail>
<extent unit="pages"><start>173</start>
<end>180</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit111"><titleInfo><title>Anti‐tumor immunity provided by a synthetic multiple antigenic glycopeptide displaying a tri‐Tn glycotope</title>
</titleInfo>
<name type="personal"><namePart type="given">R</namePart>
<namePart type="family">Lo‐Man</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">S</namePart>
<namePart type="family">Vichier‐Guerre</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">S</namePart>
<namePart type="family">Bay</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">E</namePart>
<namePart type="family">Dériaud</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">D</namePart>
<namePart type="family">Cantacuzene</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">C</namePart>
<namePart type="family">Leclerc</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Lo‐Man R, Vichier‐Guerre S, Bay S, Dériaud E, Cantacuzene D, Leclerc C. Anti‐tumor immunity provided by a synthetic multiple antigenic glycopeptide displaying a tri‐Tn glycotope. J. Immunol. 2001; 166: 2849–2854.</note>
<part><date>2001</date>
<detail type="volume"><caption>vol.</caption>
<number>166</number>
</detail>
<extent unit="pages"><start>2849</start>
<end>2854</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>J. Immunol.</title>
</titleInfo>
<part><date>2001</date>
<detail type="volume"><caption>vol.</caption>
<number>166</number>
</detail>
<extent unit="pages"><start>2849</start>
<end>2854</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit112"><titleInfo><title>A fully synthetic therapeutic vaccine candidate targeting carcinoma‐associated Tn carbohydrate antigen induces tumor‐specific antibodies in nonhuman primates</title>
</titleInfo>
<name type="personal"><namePart type="given">R</namePart>
<namePart type="family">Lo‐Man</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">S</namePart>
<namePart type="family">Vichier‐Guerre</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">R</namePart>
<namePart type="family">Perraut</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">E</namePart>
<namePart type="family">Dériaud</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">V</namePart>
<namePart type="family">Huteau</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">L</namePart>
<namePart type="family">BenMohamed</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">OM</namePart>
<namePart type="family">Diop</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">PO</namePart>
<namePart type="family">Livingston</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">S</namePart>
<namePart type="family">Bay</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">C</namePart>
<namePart type="family">Leclerc</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Lo‐Man R, Vichier‐Guerre S, Perraut R, Dériaud E, Huteau V, BenMohamed L, Diop OM, Livingston PO, Bay S, Leclerc C. A fully synthetic therapeutic vaccine candidate targeting carcinoma‐associated Tn carbohydrate antigen induces tumor‐specific antibodies in nonhuman primates. Cancer Res. 2004; 64: 4987–4994.</note>
<part><date>2004</date>
<detail type="volume"><caption>vol.</caption>
<number>64</number>
</detail>
<extent unit="pages"><start>4987</start>
<end>4994</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Cancer Res.</title>
</titleInfo>
<part><date>2004</date>
<detail type="volume"><caption>vol.</caption>
<number>64</number>
</detail>
<extent unit="pages"><start>4987</start>
<end>4994</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit113"><titleInfo><title>Synthesis and immunological evaluation of an antitumor neoglycopeptide vaccine bearing a novel homoserine Tn antigen</title>
</titleInfo>
<name type="personal"><namePart type="given">S</namePart>
<namePart type="family">Vichier‐Guerre</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">R</namePart>
<namePart type="family">Lo‐Man</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">V</namePart>
<namePart type="family">Huteau</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">E</namePart>
<namePart type="family">Dériaud</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">C</namePart>
<namePart type="family">Leclerc</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">S</namePart>
<namePart type="family">Bay</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Vichier‐Guerre S, Lo‐Man R, Huteau V, Dériaud E, Leclerc C, Bay S. Synthesis and immunological evaluation of an antitumor neoglycopeptide vaccine bearing a novel homoserine Tn antigen. Bioorg. Med. Chem. Lett. 2004; 14: 3567–3570.</note>
<part><date>2004</date>
<detail type="volume"><caption>vol.</caption>
<number>14</number>
</detail>
<extent unit="pages"><start>3567</start>
<end>3570</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Bioorg. Med. Chem. Lett.</title>
</titleInfo>
<part><date>2004</date>
<detail type="volume"><caption>vol.</caption>
<number>14</number>
</detail>
<extent unit="pages"><start>3567</start>
<end>3570</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit114"><titleInfo><title>Chemoselective assembly and immunological evaluation of multiepitopic glycoconjugates bearing clustered Tn antigen as synthetic anticancer vaccines</title>
</titleInfo>
<name type="personal"><namePart type="given">S</namePart>
<namePart type="family">Grigalevicius</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">S</namePart>
<namePart type="family">Chierici</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">O</namePart>
<namePart type="family">Renaudet</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">R</namePart>
<namePart type="family">Lo‐Man</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">E</namePart>
<namePart type="family">Dériaud</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">C</namePart>
<namePart type="family">Leclerc</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">P</namePart>
<namePart type="family">Dumy</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Grigalevicius S, Chierici S, Renaudet O, Lo‐Man R, Dériaud E, Leclerc C, Dumy P. Chemoselective assembly and immunological evaluation of multiepitopic glycoconjugates bearing clustered Tn antigen as synthetic anticancer vaccines. Bioconjug. Chem. 2005; 16: 1149–1159.</note>
<part><date>2005</date>
<detail type="volume"><caption>vol.</caption>
<number>16</number>
</detail>
<extent unit="pages"><start>1149</start>
<end>1159</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Bioconjug. Chem.</title>
</titleInfo>
<part><date>2005</date>
<detail type="volume"><caption>vol.</caption>
<number>16</number>
</detail>
<extent unit="pages"><start>1149</start>
<end>1159</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit115"><titleInfo><title>Enzymatic large‐scale synthesis of MUC6‐Tn glycoconjugates for antitumor vaccination</title>
</titleInfo>
<name type="personal"><namePart type="given">T</namePart>
<namePart type="family">Freire</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">R</namePart>
<namePart type="family">Lo‐Man</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">F</namePart>
<namePart type="family">Piller</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">V</namePart>
<namePart type="family">Piller</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">C</namePart>
<namePart type="family">Leclerc</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">S</namePart>
<namePart type="family">Bay</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Freire T, Lo‐Man R, Piller F, Piller V, Leclerc C, Bay S. Enzymatic large‐scale synthesis of MUC6‐Tn glycoconjugates for antitumor vaccination. Glycobiology 2006; 16: 390–401.</note>
<part><date>2006</date>
<detail type="volume"><caption>vol.</caption>
<number>16</number>
</detail>
<extent unit="pages"><start>390</start>
<end>401</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Glycobiology</title>
</titleInfo>
<part><date>2006</date>
<detail type="volume"><caption>vol.</caption>
<number>16</number>
</detail>
<extent unit="pages"><start>390</start>
<end>401</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit116"><titleInfo><title>Design and synthesis of water‐soluble glycopolymers bearing breast tumor marker and enhanced lipophilicity for solid‐phase assays</title>
</titleInfo>
<name type="personal"><namePart type="given">MG</namePart>
<namePart type="family">Baek</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">R</namePart>
<namePart type="family">Roy</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Baek MG, Roy R. Design and synthesis of water‐soluble glycopolymers bearing breast tumor marker and enhanced lipophilicity for solid‐phase assays. Biomacromolecules 2000; 1: 768–770.</note>
<part><date>2000</date>
<detail type="volume"><caption>vol.</caption>
<number>1</number>
</detail>
<extent unit="pages"><start>768</start>
<end>770</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Biomacromolecules</title>
</titleInfo>
<part><date>2000</date>
<detail type="volume"><caption>vol.</caption>
<number>1</number>
</detail>
<extent unit="pages"><start>768</start>
<end>770</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit117"><titleInfo><title>Design and synthesis of Ley‐bearing glycopeptides that mimic cell surface Ley mucin glycoprotein architecture</title>
</titleInfo>
<name type="personal"><namePart type="given">PW</namePart>
<namePart type="family">Glunz</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">S</namePart>
<namePart type="family">Hintermann</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">LJ</namePart>
<namePart type="family">Williams</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">JB</namePart>
<namePart type="family">Schwarz</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">SD</namePart>
<namePart type="family">Kuduk</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">V</namePart>
<namePart type="family">Kudryashov</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">KO</namePart>
<namePart type="family">Lloyd</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">SJ</namePart>
<namePart type="family">Danishefsky</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Glunz PW, Hintermann S, Williams LJ, Schwarz JB, Kuduk SD, Kudryashov V, Lloyd KO, Danishefsky SJ. Design and synthesis of Ley‐bearing glycopeptides that mimic cell surface Ley mucin glycoprotein architecture. J. Am. Chem. Soc. 2000; 122: 7273–7279.</note>
<part><date>2000</date>
<detail type="volume"><caption>vol.</caption>
<number>122</number>
</detail>
<extent unit="pages"><start>7273</start>
<end>7279</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>J. Am. Chem. Soc.</title>
</titleInfo>
<part><date>2000</date>
<detail type="volume"><caption>vol.</caption>
<number>122</number>
</detail>
<extent unit="pages"><start>7273</start>
<end>7279</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit118"><titleInfo><title>Toward optimized carbohydrate‐based anticancer vaccines: Epitope clustering, carrier structure, and adjuvant all influence antibody response to Lewisy conjugates in mice</title>
</titleInfo>
<name type="personal"><namePart type="given">V</namePart>
<namePart type="family">Kudryashov</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">PW</namePart>
<namePart type="family">Glunz</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">LJ</namePart>
<namePart type="family">Williams</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">S</namePart>
<namePart type="family">Hintermann</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">SJ</namePart>
<namePart type="family">Danishefsky</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">KO</namePart>
<namePart type="family">Lloyd</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Kudryashov V, Glunz PW, Williams LJ, Hintermann S, Danishefsky SJ, Lloyd KO. Toward optimized carbohydrate‐based anticancer vaccines: Epitope clustering, carrier structure, and adjuvant all influence antibody response to Lewisy conjugates in mice. Proc. Natl. Acad. Sci. U.S.A. 2001; 98: 3264–3269.</note>
<part><date>2001</date>
<detail type="volume"><caption>vol.</caption>
<number>98</number>
</detail>
<extent unit="pages"><start>3264</start>
<end>3269</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Proc. Natl. Acad. Sci. U.S.A.</title>
</titleInfo>
<part><date>2001</date>
<detail type="volume"><caption>vol.</caption>
<number>98</number>
</detail>
<extent unit="pages"><start>3264</start>
<end>3269</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit119"><titleInfo><title>Immunization of metastatic breast cancer patients with a fully synthetic globo H conjugate: A phase I trial</title>
</titleInfo>
<name type="personal"><namePart type="given">T</namePart>
<namePart type="family">Gilewski</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">G</namePart>
<namePart type="family">Ragupathi</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">S</namePart>
<namePart type="family">Bhuta</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">LJ</namePart>
<namePart type="family">Williams</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">C</namePart>
<namePart type="family">Musselli</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">XF</namePart>
<namePart type="family">Zhang</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">KP</namePart>
<namePart type="family">Bencsath</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">KS</namePart>
<namePart type="family">Panageas</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">J</namePart>
<namePart type="family">Chin</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">CA</namePart>
<namePart type="family">Hudis</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">L</namePart>
<namePart type="family">Norton</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">AN</namePart>
<namePart type="family">Houghton</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">PO</namePart>
<namePart type="family">Livingston</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">SJ</namePart>
<namePart type="family">Danishefsky</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Gilewski T, Ragupathi G, Bhuta S, Williams LJ, Musselli C, Zhang XF, Bencsath KP, Panageas KS, Chin J, Hudis CA, Norton L, Houghton AN, Livingston PO, Danishefsky SJ. Immunization of metastatic breast cancer patients with a fully synthetic globo H conjugate: A phase I trial. Proc. Natl. Acad. Sci. U.S.A. 2001; 98: 3270–3275.</note>
<part><date>2001</date>
<detail type="volume"><caption>vol.</caption>
<number>98</number>
</detail>
<extent unit="pages"><start>3270</start>
<end>3275</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Proc. Natl. Acad. Sci. U.S.A.</title>
</titleInfo>
<part><date>2001</date>
<detail type="volume"><caption>vol.</caption>
<number>98</number>
</detail>
<extent unit="pages"><start>3270</start>
<end>3275</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit120"><titleInfo><title>A polyvalent vaccine for high‐risk prostate patients: are more antigens better?</title>
</titleInfo>
<name type="personal"><namePart type="given">SF</namePart>
<namePart type="family">Slovin</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">G</namePart>
<namePart type="family">Ragupathi</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">C</namePart>
<namePart type="family">Fernandez</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">M</namePart>
<namePart type="family">Diani</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">MP</namePart>
<namePart type="family">Jefferson</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">A</namePart>
<namePart type="family">Wilton</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">WK</namePart>
<namePart type="family">Kelly</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">M</namePart>
<namePart type="family">Morris</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">D</namePart>
<namePart type="family">Solit</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">H</namePart>
<namePart type="family">Clausen</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">P</namePart>
<namePart type="family">Livingston</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">HI</namePart>
<namePart type="family">Scher</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Slovin SF, Ragupathi G, Fernandez C, Diani M, Jefferson MP, Wilton A, Kelly WK, Morris M, Solit D, Clausen H, Livingston P, Scher HI. A polyvalent vaccine for high‐risk prostate patients: are more antigens better? Cancer Immunol. Immunother. 2007; 56: 1921–1930.</note>
<part><date>2007</date>
<detail type="volume"><caption>vol.</caption>
<number>56</number>
</detail>
<extent unit="pages"><start>1921</start>
<end>1930</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Cancer Immunol. Immunother.</title>
</titleInfo>
<part><date>2007</date>
<detail type="volume"><caption>vol.</caption>
<number>56</number>
</detail>
<extent unit="pages"><start>1921</start>
<end>1930</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit121"><titleInfo><title>Dendrimers as drugs: discovery and preclinical and clinical development of dendrimer‐based microbicides for HIV and STI prevention</title>
</titleInfo>
<name type="personal"><namePart type="given">TD</namePart>
<namePart type="family">McCarthy</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">P</namePart>
<namePart type="family">Karellas</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">SA</namePart>
<namePart type="family">Henderson</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">M</namePart>
<namePart type="family">Giannis</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">DF</namePart>
<namePart type="family">O'Keefe</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">G</namePart>
<namePart type="family">Heery</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">JRA</namePart>
<namePart type="family">Paull</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">BR</namePart>
<namePart type="family">Matthews</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">G</namePart>
<namePart type="family">Holan</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">McCarthy TD, Karellas P, Henderson SA, Giannis M, O'Keefe DF, Heery G, Paull JRA, Matthews BR, Holan G. Dendrimers as drugs: discovery and preclinical and clinical development of dendrimer‐based microbicides for HIV and STI prevention [A Review]. Mol. Pharm. 2005; 2: 312–318.</note>
<part><date>2005</date>
<detail type="volume"><caption>vol.</caption>
<number>2</number>
</detail>
<extent unit="pages"><start>312</start>
<end>318</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Mol. Pharm.</title>
</titleInfo>
<part><date>2005</date>
<detail type="volume"><caption>vol.</caption>
<number>2</number>
</detail>
<extent unit="pages"><start>312</start>
<end>318</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit122"><titleInfo><title>Toward oligosaccharide‐ and glycopeptide‐based HIV vaccines</title>
</titleInfo>
<name type="personal"><namePart type="given">LX</namePart>
<namePart type="family">Wang</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Wang LX. Toward oligosaccharide‐ and glycopeptide‐based HIV vaccines [A Review]. Curr. Opin. Drug Discov. Devel. 2006; 9: 194–206.</note>
<part><date>2006</date>
<detail type="volume"><caption>vol.</caption>
<number>9</number>
</detail>
<extent unit="pages"><start>194</start>
<end>206</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Curr. Opin. Drug Discov. Devel.</title>
</titleInfo>
<part><date>2006</date>
<detail type="volume"><caption>vol.</caption>
<number>9</number>
</detail>
<extent unit="pages"><start>194</start>
<end>206</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit123"><titleInfo><title>Synthesis of novel, multivalent glycodendrimers as ligands for HIV‐1 gp120</title>
</titleInfo>
<name type="personal"><namePart type="given">RD</namePart>
<namePart type="family">Kensinger</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">BC</namePart>
<namePart type="family">Yowler</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">AJ</namePart>
<namePart type="family">Benesi</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">CL</namePart>
<namePart type="family">Schengrund</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Kensinger RD, Yowler BC, Benesi AJ, Schengrund CL. Synthesis of novel, multivalent glycodendrimers as ligands for HIV‐1 gp120. Bioconjug. Chem. 2004; 15: 349–358.</note>
<part><date>2004</date>
<detail type="volume"><caption>vol.</caption>
<number>15</number>
</detail>
<extent unit="pages"><start>349</start>
<end>358</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Bioconjug. Chem.</title>
</titleInfo>
<part><date>2004</date>
<detail type="volume"><caption>vol.</caption>
<number>15</number>
</detail>
<extent unit="pages"><start>349</start>
<end>358</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit124"><titleInfo><title>Novel polysulfated galactose‐derivatized dendrimers as binding antagonists of human immunodeficiency virus type 1 infection</title>
</titleInfo>
<name type="personal"><namePart type="given">RD</namePart>
<namePart type="family">Kensinger</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">BJ</namePart>
<namePart type="family">Catalone</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">FC</namePart>
<namePart type="family">Krebs</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">B</namePart>
<namePart type="family">Wigdahl</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">CL</namePart>
<namePart type="family">Schengrund</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Kensinger RD, Catalone BJ, Krebs FC, Wigdahl B, Schengrund CL. Novel polysulfated galactose‐derivatized dendrimers as binding antagonists of human immunodeficiency virus type 1 infection. Antimicrob. Agents Chemother. 2004; 48: 1614–1623.</note>
<part><date>2004</date>
<detail type="volume"><caption>vol.</caption>
<number>48</number>
</detail>
<extent unit="pages"><start>1614</start>
<end>1623</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Antimicrob. Agents Chemother.</title>
</titleInfo>
<part><date>2004</date>
<detail type="volume"><caption>vol.</caption>
<number>48</number>
</detail>
<extent unit="pages"><start>1614</start>
<end>1623</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit125"><titleInfo><title>Toward fully synthetic carbohydrate‐based HIV antigen design: on the critical role of bivalency</title>
</titleInfo>
<name type="personal"><namePart type="given">VY</namePart>
<namePart type="family">Dudkin</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">M</namePart>
<namePart type="family">Orlova</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">X</namePart>
<namePart type="family">Geng</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">M</namePart>
<namePart type="family">Mandal</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">WC</namePart>
<namePart type="family">Olson</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">SJ</namePart>
<namePart type="family">Danishefsky</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Dudkin VY, Orlova M, Geng X, Mandal M, Olson WC, Danishefsky SJ. Toward fully synthetic carbohydrate‐based HIV antigen design: on the critical role of bivalency. J. Am. Chem. Soc. 2004; 126: 9560–9562.</note>
<part><date>2004</date>
<detail type="volume"><caption>vol.</caption>
<number>126</number>
</detail>
<extent unit="pages"><start>9560</start>
<end>9562</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>J. Am. Chem. Soc.</title>
</titleInfo>
<part><date>2004</date>
<detail type="volume"><caption>vol.</caption>
<number>126</number>
</detail>
<extent unit="pages"><start>9560</start>
<end>9562</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit126"><titleInfo><title>Fully synthetic carbohydrate HIV antigens designed on the logic of the 2G12 antibody</title>
</titleInfo>
<name type="personal"><namePart type="given">IJ</namePart>
<namePart type="family">Krauss</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">JG</namePart>
<namePart type="family">Joyce</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">AC</namePart>
<namePart type="family">Finnefrock</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">HC</namePart>
<namePart type="family">Song</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">VY</namePart>
<namePart type="family">Dudkin</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">X</namePart>
<namePart type="family">Geng</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">JD</namePart>
<namePart type="family">Warren</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">M</namePart>
<namePart type="family">Chastain</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">JW</namePart>
<namePart type="family">Shiver</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">SJ</namePart>
<namePart type="family">Danishefsky</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Krauss IJ, Joyce JG, Finnefrock AC, Song HC, Dudkin VY, Geng X, Warren JD, Chastain M, Shiver JW, Danishefsky SJ. Fully synthetic carbohydrate HIV antigens designed on the logic of the 2G12 antibody. J. Am. Chem. Soc. 2007; 129: 11042–11044.</note>
<part><date>2007</date>
<detail type="volume"><caption>vol.</caption>
<number>129</number>
</detail>
<extent unit="pages"><start>11042</start>
<end>11044</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>J. Am. Chem. Soc.</title>
</titleInfo>
<part><date>2007</date>
<detail type="volume"><caption>vol.</caption>
<number>129</number>
</detail>
<extent unit="pages"><start>11042</start>
<end>11044</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit127"><titleInfo><title>Design and synthesis of a template‐assembled oligomannose cluster as an epitope mimic for human HIV‐neutralizing antibody 2G12</title>
</titleInfo>
<name type="personal"><namePart type="given">H</namePart>
<namePart type="family">Li</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">LX</namePart>
<namePart type="family">Wang</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Li H, Wang LX. Design and synthesis of a template‐assembled oligomannose cluster as an epitope mimic for human HIV‐neutralizing antibody 2G12. Org. Biomol. Chem. 2004; 2: 483–488.</note>
<part><date>2004</date>
<detail type="volume"><caption>vol.</caption>
<number>2</number>
</detail>
<extent unit="pages"><start>483</start>
<end>488</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Org. Biomol. Chem.</title>
</titleInfo>
<part><date>2004</date>
<detail type="volume"><caption>vol.</caption>
<number>2</number>
</detail>
<extent unit="pages"><start>483</start>
<end>488</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit128"><titleInfo><title>Direct Fmoc/tert‐Bu solid phase synthesis of octamannosyl polylysine dendrimer‐peptide conjugates</title>
</titleInfo>
<name type="personal"><namePart type="given">EA</namePart>
<namePart type="family">Kantchev</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">CC</namePart>
<namePart type="family">Chang</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">DK</namePart>
<namePart type="family">Chang</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Kantchev EA, Chang CC, Chang DK. Direct Fmoc/tert‐Bu solid phase synthesis of octamannosyl polylysine dendrimer‐peptide conjugates. Biopolymers 2006; 84: 232–240.</note>
<part><date>2006</date>
<detail type="volume"><caption>vol.</caption>
<number>84</number>
</detail>
<extent unit="pages"><start>232</start>
<end>240</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Biopolymers</title>
</titleInfo>
<part><date>2006</date>
<detail type="volume"><caption>vol.</caption>
<number>84</number>
</detail>
<extent unit="pages"><start>232</start>
<end>240</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit129"><titleInfo><title>Targeting potential and anti‐HIV activity of lamivudine loaded mannosylated poly (propyleneimine) dendrimer</title>
</titleInfo>
<name type="personal"><namePart type="given">T</namePart>
<namePart type="family">Dutta</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">NK</namePart>
<namePart type="family">Jain</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Dutta T, Jain NK. Targeting potential and anti‐HIV activity of lamivudine loaded mannosylated poly (propyleneimine) dendrimer. Biochim. Biophys. Acta 2007; 1770: 681–686.</note>
<part><date>2007</date>
<detail type="volume"><caption>vol.</caption>
<number>1770</number>
</detail>
<extent unit="pages"><start>681</start>
<end>686</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Biochim. Biophys. Acta</title>
</titleInfo>
<part><date>2007</date>
<detail type="volume"><caption>vol.</caption>
<number>1770</number>
</detail>
<extent unit="pages"><start>681</start>
<end>686</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit130"><titleInfo><title>Influence of generation 2–5 of PAMAM dendrimer on the inhibition of Tat peptide/TAR RNA binding in HIV‐1 transcription</title>
</titleInfo>
<name type="personal"><namePart type="given">W</namePart>
<namePart type="family">Wang</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">Z</namePart>
<namePart type="family">Guo</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">Y</namePart>
<namePart type="family">Chen</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">T</namePart>
<namePart type="family">Liu</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">L</namePart>
<namePart type="family">Jiang</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Wang W, Guo Z, Chen Y, Liu T, Jiang L. Influence of generation 2–5 of PAMAM dendrimer on the inhibition of Tat peptide/TAR RNA binding in HIV‐1 transcription. Chem. Biol. Drug Des. 2006; 68: 314–318.</note>
<part><date>2006</date>
<detail type="volume"><caption>vol.</caption>
<number>68</number>
</detail>
<extent unit="pages"><start>314</start>
<end>318</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Chem. Biol. Drug Des.</title>
</titleInfo>
<part><date>2006</date>
<detail type="volume"><caption>vol.</caption>
<number>68</number>
</detail>
<extent unit="pages"><start>314</start>
<end>318</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit131"><titleInfo><title>Polyamidoamine dendrimers inhibit binding of Tat peptide to TAR RNA</title>
</titleInfo>
<name type="personal"><namePart type="given">H</namePart>
<namePart type="family">Zhao</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">J</namePart>
<namePart type="family">Li</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">F</namePart>
<namePart type="family">Xi</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">L</namePart>
<namePart type="family">Jiang</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Zhao H, Li J, Xi F, Jiang L. Polyamidoamine dendrimers inhibit binding of Tat peptide to TAR RNA. FEBS Lett. 2004; 563: 241–245.</note>
<part><date>2004</date>
<detail type="volume"><caption>vol.</caption>
<number>563</number>
</detail>
<extent unit="pages"><start>241</start>
<end>245</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>FEBS Lett.</title>
</titleInfo>
<part><date>2004</date>
<detail type="volume"><caption>vol.</caption>
<number>563</number>
</detail>
<extent unit="pages"><start>241</start>
<end>245</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit132"><titleInfo><title>The glycobiology of influenza viruses</title>
</titleInfo>
<name type="personal"><namePart type="given">SJ</namePart>
<namePart type="family">Stray</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">GM</namePart>
<namePart type="family">Air</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>book-chapter</genre>
<relatedItem type="host"><titleInfo><title>Carbohydrates in Chemistry and Biology</title>
</titleInfo>
<originInfo><publisher>WILEY‐VCH</publisher>
<place><placeTerm type="text">Weinheim, New York</placeTerm>
</place>
</originInfo>
<part><date>2000</date>
<extent unit="pages"><start>839</start>
<end>850</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit133"><titleInfo><title>Glycotentacles: synthesis of cyclic glycopeptides, toward a tailored blocker of influenza virus hemagglutinin</title>
</titleInfo>
<name type="personal"><namePart type="given">T</namePart>
<namePart type="family">Ohta</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">N</namePart>
<namePart type="family">Miura</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">N</namePart>
<namePart type="family">Fujitani</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">F</namePart>
<namePart type="family">Nakajima</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">K</namePart>
<namePart type="family">Niikura</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">R</namePart>
<namePart type="family">Sadamoto</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">ChT</namePart>
<namePart type="family">Guo</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">T</namePart>
<namePart type="family">Suzuki</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">Y</namePart>
<namePart type="family">Suzuki</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">K</namePart>
<namePart type="family">Monde</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">SI</namePart>
<namePart type="family">Nishimura</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Ohta T, Miura N, Fujitani N, Nakajima F, Niikura K, Sadamoto R, Guo ChT, Suzuki T, Suzuki Y, Monde K, Nishimura SI. Glycotentacles: synthesis of cyclic glycopeptides, toward a tailored blocker of influenza virus hemagglutinin. Angew. Chem. Int. Ed. Engl. 2003; 42: 5186–5189.</note>
<part><date>2003</date>
<detail type="volume"><caption>vol.</caption>
<number>42</number>
</detail>
<extent unit="pages"><start>5186</start>
<end>5189</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Angew. Chem. Int. Ed. Engl.</title>
</titleInfo>
<part><date>2003</date>
<detail type="volume"><caption>vol.</caption>
<number>42</number>
</detail>
<extent unit="pages"><start>5186</start>
<end>5189</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit134"><titleInfo><title>Inhibition of viral adhesion and infection by sialic‐acid‐conjugated dendritic polymers</title>
</titleInfo>
<name type="personal"><namePart type="given">JD</namePart>
<namePart type="family">Reuter</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">A</namePart>
<namePart type="family">Myc</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">MM</namePart>
<namePart type="family">Hayes</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">Z</namePart>
<namePart type="family">Gan</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">R</namePart>
<namePart type="family">Roy</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">D</namePart>
<namePart type="family">Qin</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">R</namePart>
<namePart type="family">Yin</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">LT</namePart>
<namePart type="family">Piehler</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">R</namePart>
<namePart type="family">Esfand</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">DA</namePart>
<namePart type="family">Tomalia</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">JR</namePart>
<namePart type="family">Baker Jr</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Reuter JD, Myc A, Hayes MM, Gan Z, Roy R, Qin D, Yin R, Piehler LT, Esfand R, Tomalia DA, Baker JR Jr. Inhibition of viral adhesion and infection by sialic‐acid‐conjugated dendritic polymers. Bioconjug. Chem. 1999; 10: 271–278.</note>
<part><date>1999</date>
<detail type="volume"><caption>vol.</caption>
<number>10</number>
</detail>
<extent unit="pages"><start>271</start>
<end>278</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Bioconjug. Chem.</title>
</titleInfo>
<part><date>1999</date>
<detail type="volume"><caption>vol.</caption>
<number>10</number>
</detail>
<extent unit="pages"><start>271</start>
<end>278</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit135"><titleInfo><title>Chitosan chemistry and pharmaceutical perspectives</title>
</titleInfo>
<name type="personal"><namePart type="given">MNV</namePart>
<namePart type="family">Ravi Kumar</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">RAA</namePart>
<namePart type="family">Muzzarelli</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">C</namePart>
<namePart type="family">Muzzarelli</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">H</namePart>
<namePart type="family">Sashiwa</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">AJ</namePart>
<namePart type="family">Domb</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Ravi Kumar MNV, Muzzarelli RAA, Muzzarelli C, Sashiwa H, Domb AJ. Chitosan chemistry and pharmaceutical perspectives [A Review]. Chem. Rev. 2004; 104: 6017–6084.</note>
<part><date>2004</date>
<detail type="volume"><caption>vol.</caption>
<number>104</number>
</detail>
<extent unit="pages"><start>6017</start>
<end>6084</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Chem. Rev.</title>
</titleInfo>
<part><date>2004</date>
<detail type="volume"><caption>vol.</caption>
<number>104</number>
</detail>
<extent unit="pages"><start>6017</start>
<end>6084</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit136"><titleInfo><title>Chemically modified chitin and chitosan as biomaterials</title>
</titleInfo>
<name type="personal"><namePart type="given">H</namePart>
<namePart type="family">Sashiwa</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">S</namePart>
<namePart type="family">Aiba</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Sashiwa H, Aiba S. Chemically modified chitin and chitosan as biomaterials [A Review]. Prog. Polym. Sci. 2004; 29: 887–908.</note>
<part><date>2004</date>
<detail type="volume"><caption>vol.</caption>
<number>29</number>
</detail>
<extent unit="pages"><start>887</start>
<end>908</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Prog. Polym. Sci.</title>
</titleInfo>
<part><date>2004</date>
<detail type="volume"><caption>vol.</caption>
<number>29</number>
</detail>
<extent unit="pages"><start>887</start>
<end>908</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit137"><titleInfo><title>Chemical modification of chitosan.3. Hyperbranched chitosan‐sialic acid dendrimer hybrid with tetraethylene glycol spacer</title>
</titleInfo>
<name type="personal"><namePart type="given">H</namePart>
<namePart type="family">Sashiwa</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">Y</namePart>
<namePart type="family">Shigemasa</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">R</namePart>
<namePart type="family">Roy</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Sashiwa H, Shigemasa Y, Roy R. Chemical modification of chitosan.3. Hyperbranched chitosan‐sialic acid dendrimer hybrid with tetraethylene glycol spacer. Macromolecules 2000; 33: 6913–6915.</note>
<part><date>2000</date>
<detail type="volume"><caption>vol.</caption>
<number>33</number>
</detail>
<extent unit="pages"><start>6913</start>
<end>6915</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Macromolecules</title>
</titleInfo>
<part><date>2000</date>
<detail type="volume"><caption>vol.</caption>
<number>33</number>
</detail>
<extent unit="pages"><start>6913</start>
<end>6915</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit138"><titleInfo><title>Chemical modification of chitosan.10. Synthesis of dendronized chitosan‐sialic acid hybrid using convergent grafting of preassembled dendrons built on gallic acid and tri(ethylene glycol) backbone</title>
</titleInfo>
<name type="personal"><namePart type="given">H</namePart>
<namePart type="family">Sashiwa</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">Y</namePart>
<namePart type="family">Shigemasa</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">R</namePart>
<namePart type="family">Roy</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Sashiwa H, Shigemasa Y, Roy R. Chemical modification of chitosan.10. Synthesis of dendronized chitosan‐sialic acid hybrid using convergent grafting of preassembled dendrons built on gallic acid and tri(ethylene glycol) backbone. Macromolecules 2001; 34: 3905–3909.</note>
<part><date>2001</date>
<detail type="volume"><caption>vol.</caption>
<number>34</number>
</detail>
<extent unit="pages"><start>3905</start>
<end>3909</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Macromolecules</title>
</titleInfo>
<part><date>2001</date>
<detail type="volume"><caption>vol.</caption>
<number>34</number>
</detail>
<extent unit="pages"><start>3905</start>
<end>3909</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit139"><titleInfo><title>Highly convergent synthesis of dendrimerized chitosan‐sialic acid hybrid</title>
</titleInfo>
<name type="personal"><namePart type="given">H</namePart>
<namePart type="family">Sashiwa</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">Y</namePart>
<namePart type="family">Shigemasa</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">R</namePart>
<namePart type="family">Roy</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Sashiwa H, Shigemasa Y, Roy R. Highly convergent synthesis of dendrimerized chitosan‐sialic acid hybrid. Macromolecules 2001; 34: 3211–3214.</note>
<part><date>2001</date>
<detail type="volume"><caption>vol.</caption>
<number>34</number>
</detail>
<extent unit="pages"><start>3211</start>
<end>3214</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Macromolecules</title>
</titleInfo>
<part><date>2001</date>
<detail type="volume"><caption>vol.</caption>
<number>34</number>
</detail>
<extent unit="pages"><start>3211</start>
<end>3214</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit140"><titleInfo><title>Prevention of influenza pneumonitis by sialic acid‐conjugated dendritic polymers</title>
</titleInfo>
<name type="personal"><namePart type="given">JJ</namePart>
<namePart type="family">Landers</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">Z</namePart>
<namePart type="family">Cao</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">I</namePart>
<namePart type="family">Lee</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">LT</namePart>
<namePart type="family">Piehler</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">PP</namePart>
<namePart type="family">Myc</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">A</namePart>
<namePart type="family">Myc</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">T</namePart>
<namePart type="family">Hamouda</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">AT</namePart>
<namePart type="family">Galecki</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">JR</namePart>
<namePart type="family">Baker Jr</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Landers JJ, Cao Z, Lee I, Piehler LT, Myc PP, Myc A, Hamouda T, Galecki AT, Baker JR Jr. Prevention of influenza pneumonitis by sialic acid‐conjugated dendritic polymers. J. Infect. Dis. 2002; 186: 1222–1230.</note>
<part><date>2002</date>
<detail type="volume"><caption>vol.</caption>
<number>186</number>
</detail>
<extent unit="pages"><start>1222</start>
<end>1230</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>J. Infect. Dis.</title>
</titleInfo>
<part><date>2002</date>
<detail type="volume"><caption>vol.</caption>
<number>186</number>
</detail>
<extent unit="pages"><start>1222</start>
<end>1230</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit141"><titleInfo><title>Neoglycoconjugates based on dendrimer poly(aminoamides)</title>
</titleInfo>
<name type="personal"><namePart type="given">DE</namePart>
<namePart type="family">Tsvetkov</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">PE</namePart>
<namePart type="family">Cheshev</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">AB</namePart>
<namePart type="family">Tuzikov</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">AA</namePart>
<namePart type="family">Chinarev</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">GV</namePart>
<namePart type="family">Pazynina</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">MA</namePart>
<namePart type="family">Sablina</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">AS</namePart>
<namePart type="family">Gambaryan</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">NV</namePart>
<namePart type="family">Bovin</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">R</namePart>
<namePart type="family">Rieben</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">AS</namePart>
<namePart type="family">Shashkov</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">NE</namePart>
<namePart type="family">Nifantiev</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Tsvetkov DE, Cheshev PE, Tuzikov AB, Chinarev AA, Pazynina GV, Sablina MA, Gambaryan AS, Bovin NV, Rieben R, Shashkov AS, Nifantiev NE. Neoglycoconjugates based on dendrimer poly(aminoamides). Russ. J. Bioorganic Chem. 2002; 28: 470–486.</note>
<part><date>2002</date>
<detail type="volume"><caption>vol.</caption>
<number>28</number>
</detail>
<extent unit="pages"><start>470</start>
<end>486</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Russ. J. Bioorganic Chem.</title>
</titleInfo>
<part><date>2002</date>
<detail type="volume"><caption>vol.</caption>
<number>28</number>
</detail>
<extent unit="pages"><start>470</start>
<end>486</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit142"><titleInfo><title>Thiosialoside clusters using carbosilane dendrimer core scaffolds as a new class of influenza neuraminidase inhibitors</title>
</titleInfo>
<name type="personal"><namePart type="given">JI</namePart>
<namePart type="family">Sakamoto</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">T</namePart>
<namePart type="family">Koyama</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">D</namePart>
<namePart type="family">Miyamoto</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">S</namePart>
<namePart type="family">Yingsakmongkon</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">KIPJ</namePart>
<namePart type="family">Hidari</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">W</namePart>
<namePart type="family">Jampangern</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">T</namePart>
<namePart type="family">Suzuki</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">Y</namePart>
<namePart type="family">Suzuki</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">Y</namePart>
<namePart type="family">Esumi</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">K</namePart>
<namePart type="family">Hatano</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">D</namePart>
<namePart type="family">Terunuma</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">K</namePart>
<namePart type="family">Matsuoka</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Sakamoto JI, Koyama T, Miyamoto D, Yingsakmongkon S, Hidari KIPJ, Jampangern W, Suzuki T, Suzuki Y, Esumi Y, Hatano K, Terunuma D, Matsuoka K. Thiosialoside clusters using carbosilane dendrimer core scaffolds as a new class of influenza neuraminidase inhibitors. Bioorg. Med. Chem. Lett. 2007; 17: 717–721.</note>
<part><date>2007</date>
<detail type="volume"><caption>vol.</caption>
<number>17</number>
</detail>
<extent unit="pages"><start>717</start>
<end>721</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Bioorg. Med. Chem. Lett.</title>
</titleInfo>
<part><date>2007</date>
<detail type="volume"><caption>vol.</caption>
<number>17</number>
</detail>
<extent unit="pages"><start>717</start>
<end>721</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit143"><titleInfo><title>Dendrimeric micelles for controlled drug release and targeted delivery</title>
</titleInfo>
<name type="personal"><namePart type="given">AV</namePart>
<namePart type="family">Ambade</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">EN</namePart>
<namePart type="family">Savariar</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">S</namePart>
<namePart type="family">Thayumanavan</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Ambade AV, Savariar EN, Thayumanavan S. Dendrimeric micelles for controlled drug release and targeted delivery [A Review]. Mol. Pharm. 2005; 2: 264–272.</note>
<part><date>2005</date>
<detail type="volume"><caption>vol.</caption>
<number>2</number>
</detail>
<extent unit="pages"><start>264</start>
<end>272</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Mol. Pharm.</title>
</titleInfo>
<part><date>2005</date>
<detail type="volume"><caption>vol.</caption>
<number>2</number>
</detail>
<extent unit="pages"><start>264</start>
<end>272</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit144"><titleInfo><title>PAMAM dendrimer‐based multifunctional conjugate for cancer therapy: synthesis, characterization, and functionality</title>
</titleInfo>
<name type="personal"><namePart type="given">IJ</namePart>
<namePart type="family">Majoros</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">A</namePart>
<namePart type="family">Myc</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">T</namePart>
<namePart type="family">Thomas</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">ChB</namePart>
<namePart type="family">Mehta</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">JR</namePart>
<namePart type="family">Baker Jr</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Majoros IJ, Myc A, Thomas T, Mehta ChB, Baker JR Jr. PAMAM dendrimer‐based multifunctional conjugate for cancer therapy: synthesis, characterization, and functionality. Biomacromolecules 2006; 7: 572–579.</note>
<part><date>2006</date>
<detail type="volume"><caption>vol.</caption>
<number>7</number>
</detail>
<extent unit="pages"><start>572</start>
<end>579</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Biomacromolecules</title>
</titleInfo>
<part><date>2006</date>
<detail type="volume"><caption>vol.</caption>
<number>7</number>
</detail>
<extent unit="pages"><start>572</start>
<end>579</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit145"><titleInfo><title>Dendrimers and dendritic polymers in drug delivery</title>
</titleInfo>
<name type="personal"><namePart type="given">ER</namePart>
<namePart type="family">Gillies</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">JMJ</namePart>
<namePart type="family">Fréchet</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Gillies ER, Fréchet JMJ. Dendrimers and dendritic polymers in drug delivery [A Review]. Drug Discov. Today 2005; 10: 35–43.</note>
<part><date>2005</date>
<detail type="volume"><caption>vol.</caption>
<number>10</number>
</detail>
<extent unit="pages"><start>35</start>
<end>43</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Drug Discov. Today</title>
</titleInfo>
<part><date>2005</date>
<detail type="volume"><caption>vol.</caption>
<number>10</number>
</detail>
<extent unit="pages"><start>35</start>
<end>43</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit146"><titleInfo><title>Transcytosis of nanoparticle and dendrimer delivery systems: evolving vistas</title>
</titleInfo>
<name type="personal"><namePart type="given">AT</namePart>
<namePart type="family">Florence</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">N</namePart>
<namePart type="family">Hussain</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Florence AT, Hussain N. Transcytosis of nanoparticle and dendrimer delivery systems: evolving vistas [A Review]. Adv. Drug Deliv. Rev. 2001; 50(Suppl. 1): 69–89.</note>
<part><date>2001</date>
<detail type="volume"><caption>vol.</caption>
<number>50</number>
</detail>
<detail type="issue"><caption>no.</caption>
<number>Suppl. 1</number>
</detail>
<extent unit="pages"><start>69</start>
<end>89</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Adv. Drug Deliv. Rev.</title>
</titleInfo>
<part><date>2001</date>
<detail type="volume"><caption>vol.</caption>
<number>50</number>
</detail>
<detail type="issue"><caption>no.</caption>
<number>Suppl. 1</number>
</detail>
<extent unit="pages"><start>69</start>
<end>89</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit147"><titleInfo><title>Targeting cancer cells with dendrimers</title>
</titleInfo>
<name type="personal"><namePart type="given">SG</namePart>
<namePart type="family">Sampathkumar</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">KJ</namePart>
<namePart type="family">Yarema</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Sampathkumar SG, Yarema KJ. Targeting cancer cells with dendrimers [A Preview]. Chem. Biol. 2005; 12: 5–6.</note>
<part><date>2005</date>
<detail type="volume"><caption>vol.</caption>
<number>12</number>
</detail>
<extent unit="pages"><start>5</start>
<end>6</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Chem. Biol.</title>
</titleInfo>
<part><date>2005</date>
<detail type="volume"><caption>vol.</caption>
<number>12</number>
</detail>
<extent unit="pages"><start>5</start>
<end>6</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit148"><titleInfo><title>Nano‐oncology: drug delivery, imaging, and sensing</title>
</titleInfo>
<name type="personal"><namePart type="given">NG</namePart>
<namePart type="family">Portney</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">M</namePart>
<namePart type="family">Ozkan</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Portney NG, Ozkan M. Nano‐oncology: drug delivery, imaging, and sensing [A Review]. Anal. Bioanal. Chem. 2006; 384: 620–630.</note>
<part><date>2006</date>
<detail type="volume"><caption>vol.</caption>
<number>384</number>
</detail>
<extent unit="pages"><start>620</start>
<end>630</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Anal. Bioanal. Chem.</title>
</titleInfo>
<part><date>2006</date>
<detail type="volume"><caption>vol.</caption>
<number>384</number>
</detail>
<extent unit="pages"><start>620</start>
<end>630</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit149"><titleInfo><title>Polymer therapeutics for cancer: current status and future challenges</title>
</titleInfo>
<name type="personal"><namePart type="given">R</namePart>
<namePart type="family">Satchi‐Fainaro</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">R</namePart>
<namePart type="family">Duncan</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">CM</namePart>
<namePart type="family">Barnes</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Satchi‐Fainaro R, Duncan R, Barnes CM. Polymer therapeutics for cancer: current status and future challenges [A Review]. Adv. Polym. Sci. 2006; 193: 1–65.</note>
<part><date>2006</date>
<detail type="volume"><caption>vol.</caption>
<number>193</number>
</detail>
<extent unit="pages"><start>1</start>
<end>65</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Adv. Polym. Sci.</title>
</titleInfo>
<part><date>2006</date>
<detail type="volume"><caption>vol.</caption>
<number>193</number>
</detail>
<extent unit="pages"><start>1</start>
<end>65</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit150"><titleInfo><title>Gateways to clinical trials</title>
</titleInfo>
<name type="personal"><namePart type="given">M</namePart>
<namePart type="family">Bayes</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">X</namePart>
<namePart type="family">Rabasseda</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">JR</namePart>
<namePart type="family">Prous</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Bayes M, Rabasseda X, Prous JR. Gateways to clinical trials [A Review]. Methods Find. Exp. Clin. Pharmacol. 2005; 27: 411–461.</note>
<part><date>2005</date>
<detail type="volume"><caption>vol.</caption>
<number>27</number>
</detail>
<extent unit="pages"><start>411</start>
<end>461</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Methods Find. Exp. Clin. Pharmacol.</title>
</titleInfo>
<part><date>2005</date>
<detail type="volume"><caption>vol.</caption>
<number>27</number>
</detail>
<extent unit="pages"><start>411</start>
<end>461</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit151"><titleInfo><title>Design and selection of vaccine adjuvants: principles and practice</title>
</titleInfo>
<name type="personal"><namePart type="given">CR</namePart>
<namePart type="family">Alving</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">GR</namePart>
<namePart type="family">Matyas</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>book-chapter</genre>
<relatedItem type="host"><titleInfo><title>The Grand Challenge for the Future. Vaccines for Poverty‐Related Diseases from Bench to Field</title>
</titleInfo>
<originInfo><publisher>Birkhauser</publisher>
<place><placeTerm type="text">Basel</placeTerm>
</place>
</originInfo>
<part><date>2005</date>
<extent unit="pages"><start>99</start>
<end>118</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit152"><titleInfo><title>Immunomodulators and delivery systems for vaccination by mucosal routes</title>
</titleInfo>
<name type="personal"><namePart type="given">EJ</namePart>
<namePart type="family">Ryan</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">LM</namePart>
<namePart type="family">Daly</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">KHG</namePart>
<namePart type="family">Mills</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Ryan EJ, Daly LM, Mills KHG. Immunomodulators and delivery systems for vaccination by mucosal routes [A Review]. Trends Biotechnol. 2001; 19: 293–304.</note>
<part><date>2001</date>
<detail type="volume"><caption>vol.</caption>
<number>19</number>
</detail>
<extent unit="pages"><start>293</start>
<end>304</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Trends Biotechnol.</title>
</titleInfo>
<part><date>2001</date>
<detail type="volume"><caption>vol.</caption>
<number>19</number>
</detail>
<extent unit="pages"><start>293</start>
<end>304</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit153"><titleInfo><title>Molecular adjuvants and immunomodulators: new approaches to immunization</title>
</titleInfo>
<name type="personal"><namePart type="given">AG</namePart>
<namePart type="family">Johnson</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Johnson AG. Molecular adjuvants and immunomodulators: new approaches to immunization [A Review]. Clin. Microbiol. Rev. 1994; 7: 277–289.</note>
<part><date>1994</date>
<detail type="volume"><caption>vol.</caption>
<number>7</number>
</detail>
<extent unit="pages"><start>277</start>
<end>289</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Clin. Microbiol. Rev.</title>
</titleInfo>
<part><date>1994</date>
<detail type="volume"><caption>vol.</caption>
<number>7</number>
</detail>
<extent unit="pages"><start>277</start>
<end>289</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit154"><titleInfo><title>New generation of mucosal adjuvants for the induction of protective immunity</title>
</titleInfo>
<name type="personal"><namePart type="given">Y</namePart>
<namePart type="family">Yuki</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">H</namePart>
<namePart type="family">Kiyono</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Yuki Y, Kiyono H. New generation of mucosal adjuvants for the induction of protective immunity [A Review]. Rev. Med. Virol. 2003; 13: 293–310.</note>
<part><date>2003</date>
<detail type="volume"><caption>vol.</caption>
<number>13</number>
</detail>
<extent unit="pages"><start>293</start>
<end>310</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Rev. Med. Virol.</title>
</titleInfo>
<part><date>2003</date>
<detail type="volume"><caption>vol.</caption>
<number>13</number>
</detail>
<extent unit="pages"><start>293</start>
<end>310</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit155"><titleInfo><title>Recent developments in adjuvants for vaccines against infectious diseases</title>
</titleInfo>
<name type="personal"><namePart type="given">DT</namePart>
<namePart type="family">O'Hagan</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">ML</namePart>
<namePart type="family">MacKichan</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">M</namePart>
<namePart type="family">Sing</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">O'Hagan DT, MacKichan ML, Sing M. Recent developments in adjuvants for vaccines against infectious diseases [A Review]. Biomol. Eng. 2001; 18: 69–85.</note>
<part><date>2001</date>
<detail type="volume"><caption>vol.</caption>
<number>18</number>
</detail>
<extent unit="pages"><start>69</start>
<end>85</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Biomol. Eng.</title>
</titleInfo>
<part><date>2001</date>
<detail type="volume"><caption>vol.</caption>
<number>18</number>
</detail>
<extent unit="pages"><start>69</start>
<end>85</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit156"><titleInfo><title>Delivery systems and adjuvants for oral vaccines</title>
</titleInfo>
<name type="personal"><namePart type="given">EC</namePart>
<namePart type="family">Lavelle</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">DT</namePart>
<namePart type="family">O'Hagan</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Lavelle EC, O'Hagan DT. Delivery systems and adjuvants for oral vaccines [A Review]. Expert Opin. Drug Deliv. 2006; 3: 747–762.</note>
<part><date>2006</date>
<detail type="volume"><caption>vol.</caption>
<number>3</number>
</detail>
<extent unit="pages"><start>747</start>
<end>762</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Expert Opin. Drug Deliv.</title>
</titleInfo>
<part><date>2006</date>
<detail type="volume"><caption>vol.</caption>
<number>3</number>
</detail>
<extent unit="pages"><start>747</start>
<end>762</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit157"><titleInfo><title>Fully synthetic carbohydrate‐based vaccines in biochemically relapsed prostate cancer: clinical trial results with α‐N‐acetylgalactosamine‐O‐serine/threonine conjugate vaccine</title>
</titleInfo>
<name type="personal"><namePart type="given">SF</namePart>
<namePart type="family">Slovin</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">G</namePart>
<namePart type="family">Ragupathi</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">C</namePart>
<namePart type="family">Musselli</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">K</namePart>
<namePart type="family">Olkiewicz</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">D</namePart>
<namePart type="family">Verbel</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">SD</namePart>
<namePart type="family">Kuduk</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">JB</namePart>
<namePart type="family">Schwarz</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">D</namePart>
<namePart type="family">Sames</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">S</namePart>
<namePart type="family">Danishefsky</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">PO</namePart>
<namePart type="family">Livingston</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">HI</namePart>
<namePart type="family">Scher</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Slovin SF, Ragupathi G, Musselli C, Olkiewicz K, Verbel D, Kuduk SD, Schwarz JB, Sames D, Danishefsky S, Livingston PO, Scher HI. Fully synthetic carbohydrate‐based vaccines in biochemically relapsed prostate cancer: clinical trial results with α‐N‐acetylgalactosamine‐O‐serine/threonine conjugate vaccine. J. Clin. Oncol. 2003; 21: 4292–4298.</note>
<part><date>2003</date>
<detail type="volume"><caption>vol.</caption>
<number>21</number>
</detail>
<extent unit="pages"><start>4292</start>
<end>4298</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>J. Clin. Oncol.</title>
</titleInfo>
<part><date>2003</date>
<detail type="volume"><caption>vol.</caption>
<number>21</number>
</detail>
<extent unit="pages"><start>4292</start>
<end>4298</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit158"><titleInfo><title>Total synthesis of a human breast tumor associated antigen</title>
</titleInfo>
<name type="personal"><namePart type="given">MT</namePart>
<namePart type="family">Bilodeau</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">TK</namePart>
<namePart type="family">Park</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">S</namePart>
<namePart type="family">Hu</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">JT</namePart>
<namePart type="family">Randolph</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">SJ</namePart>
<namePart type="family">Danishefsky</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">PO</namePart>
<namePart type="family">Livingston</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">S</namePart>
<namePart type="family">Zhang</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Bilodeau MT, Park TK, Hu S, Randolph JT, Danishefsky SJ, Livingston PO, Zhang S. Total synthesis of a human breast tumor associated antigen. J. Am. Chem. Soc. 1995; 117: 7840–7841.</note>
<part><date>1995</date>
<detail type="volume"><caption>vol.</caption>
<number>117</number>
</detail>
<extent unit="pages"><start>7840</start>
<end>7841</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>J. Am. Chem. Soc.</title>
</titleInfo>
<part><date>1995</date>
<detail type="volume"><caption>vol.</caption>
<number>117</number>
</detail>
<extent unit="pages"><start>7840</start>
<end>7841</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit159"><titleInfo><title>A second generation synthesis of the MBr1 (globo‐H) breast tumor antigen: new application of the n‐pentenyl glycoside method for achieving complex carbohydrate protein linkages</title>
</titleInfo>
<name type="personal"><namePart type="given">JR</namePart>
<namePart type="family">Allen</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">JG</namePart>
<namePart type="family">Allen</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">XF</namePart>
<namePart type="family">Zhang</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">LJ</namePart>
<namePart type="family">Williams</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">A</namePart>
<namePart type="family">Zatorski</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">G</namePart>
<namePart type="family">Ragupathi</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">PO</namePart>
<namePart type="family">Livingston</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">SJ</namePart>
<namePart type="family">Danishefsky</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Allen JR, Allen JG, Zhang XF, Williams LJ, Zatorski A, Ragupathi G, Livingston PO, Danishefsky SJ. A second generation synthesis of the MBr1 (globo‐H) breast tumor antigen: new application of the n‐pentenyl glycoside method for achieving complex carbohydrate protein linkages. Chem. Eur. J. 2000; 6: 1366–1375.</note>
<part><date>2000</date>
<detail type="volume"><caption>vol.</caption>
<number>6</number>
</detail>
<extent unit="pages"><start>1366</start>
<end>1375</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Chem. Eur. J.</title>
</titleInfo>
<part><date>2000</date>
<detail type="volume"><caption>vol.</caption>
<number>6</number>
</detail>
<extent unit="pages"><start>1366</start>
<end>1375</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit160"><titleInfo><title>A preclinical study comparing approaches for augmenting the immunogenicity of a heptavalent KLH‐conjugate vaccine against epithelial cancers</title>
</titleInfo>
<name type="personal"><namePart type="given">G</namePart>
<namePart type="family">Ragupathi</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">F</namePart>
<namePart type="family">Koide</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">N</namePart>
<namePart type="family">Sathyan</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">E</namePart>
<namePart type="family">Kagan</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">M</namePart>
<namePart type="family">Spassova</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">W</namePart>
<namePart type="family">Bornmann</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">P</namePart>
<namePart type="family">Gregor</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">CA</namePart>
<namePart type="family">Reis</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">H</namePart>
<namePart type="family">Clausen</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">SJ</namePart>
<namePart type="family">Danishefsky</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">PO</namePart>
<namePart type="family">Livingston</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Ragupathi G, Koide F, Sathyan N, Kagan E, Spassova M, Bornmann W, Gregor P, Reis CA, Clausen H, Danishefsky SJ, Livingston PO. A preclinical study comparing approaches for augmenting the immunogenicity of a heptavalent KLH‐conjugate vaccine against epithelial cancers. Cancer Immunol. Immunother. 2003; 52: 608–616.</note>
<part><date>2003</date>
<detail type="volume"><caption>vol.</caption>
<number>52</number>
</detail>
<extent unit="pages"><start>608</start>
<end>616</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Cancer Immunol. Immunother.</title>
</titleInfo>
<part><date>2003</date>
<detail type="volume"><caption>vol.</caption>
<number>52</number>
</detail>
<extent unit="pages"><start>608</start>
<end>616</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit161"><titleInfo><title>Immunization of high‐risk breast cancer patients with clustered sTn‐KLH conjugate plus the immunologic adjuvant QS‐21</title>
</titleInfo>
<name type="personal"><namePart type="given">TA</namePart>
<namePart type="family">Gilewski</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">G</namePart>
<namePart type="family">Ragupathi</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">M</namePart>
<namePart type="family">Dickler</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">S</namePart>
<namePart type="family">Powell</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">S</namePart>
<namePart type="family">Bhuta</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">K</namePart>
<namePart type="family">Panageas</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">RR</namePart>
<namePart type="family">Koganty</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">J</namePart>
<namePart type="family">Chin‐Eng</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">C</namePart>
<namePart type="family">Hudis</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">L</namePart>
<namePart type="family">Norton</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">AN</namePart>
<namePart type="family">Houghton</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">PO</namePart>
<namePart type="family">Livingston</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Gilewski TA, Ragupathi G, Dickler M, Powell S, Bhuta S, Panageas K, Koganty RR, Chin‐Eng J, Hudis C, Norton L, Houghton AN, Livingston PO. Immunization of high‐risk breast cancer patients with clustered sTn‐KLH conjugate plus the immunologic adjuvant QS‐21. Clin. Cancer Res. 2007; 13: 2977–2985.</note>
<part><date>2007</date>
<detail type="volume"><caption>vol.</caption>
<number>13</number>
</detail>
<extent unit="pages"><start>2977</start>
<end>2985</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Clin. Cancer Res.</title>
</titleInfo>
<part><date>2007</date>
<detail type="volume"><caption>vol.</caption>
<number>13</number>
</detail>
<extent unit="pages"><start>2977</start>
<end>2985</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit162"><titleInfo><title>Application of Quillaja saponaria extracts as oral adjuvants for plant‐made vaccines</title>
</titleInfo>
<name type="personal"><namePart type="given">DD</namePart>
<namePart type="family">Kirk</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">R</namePart>
<namePart type="family">Rempel</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">J</namePart>
<namePart type="family">Pinkhasov</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">AM</namePart>
<namePart type="family">Walmsley</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Kirk DD, Rempel R, Pinkhasov J, Walmsley AM. Application of Quillaja saponaria extracts as oral adjuvants for plant‐made vaccines [A Review]. Expert. Opin. Biol. Ther. 2004; 4: 947–958.</note>
<part><date>2004</date>
<detail type="volume"><caption>vol.</caption>
<number>4</number>
</detail>
<extent unit="pages"><start>947</start>
<end>958</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Expert. Opin. Biol. Ther.</title>
</titleInfo>
<part><date>2004</date>
<detail type="volume"><caption>vol.</caption>
<number>4</number>
</detail>
<extent unit="pages"><start>947</start>
<end>958</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit163"><titleInfo><title>ISCOMATRIX™ adjuvant: an adjuvant suitable for use in anticancer vaccines</title>
</titleInfo>
<name type="personal"><namePart type="given">TJ</namePart>
<namePart type="family">Stewart</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">D</namePart>
<namePart type="family">Drane</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">J</namePart>
<namePart type="family">Malliaros</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">H</namePart>
<namePart type="family">Elmer</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">KM</namePart>
<namePart type="family">Malcolm</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">JC</namePart>
<namePart type="family">Cox</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">SJ</namePart>
<namePart type="family">Edwards</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">IH</namePart>
<namePart type="family">Frazer</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">JP</namePart>
<namePart type="family">Fernando</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Stewart TJ, Drane D, Malliaros J, Elmer H, Malcolm KM, Cox JC, Edwards SJ, Frazer IH, Fernando JP. ISCOMATRIX™ adjuvant: an adjuvant suitable for use in anticancer vaccines. Vaccine 2004; 22: 3738–3743.</note>
<part><date>2004</date>
<detail type="volume"><caption>vol.</caption>
<number>22</number>
</detail>
<extent unit="pages"><start>3738</start>
<end>3743</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Vaccine</title>
</titleInfo>
<part><date>2004</date>
<detail type="volume"><caption>vol.</caption>
<number>22</number>
</detail>
<extent unit="pages"><start>3738</start>
<end>3743</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit164"><titleInfo><title>Lipopeptides of the N‐terminus of Escherichia coli lipoprotein: synthesis, mitogenicity and properties in monolayer experiments</title>
</titleInfo>
<name type="personal"><namePart type="given">W</namePart>
<namePart type="family">Prass</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">H</namePart>
<namePart type="family">Ringsdorf</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">W</namePart>
<namePart type="family">Bessler</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">KH</namePart>
<namePart type="family">Wiesmuller</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">G</namePart>
<namePart type="family">Jung</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Prass W, Ringsdorf H, Bessler W, Wiesmuller KH, Jung G. Lipopeptides of the N‐terminus of Escherichia coli lipoprotein: synthesis, mitogenicity and properties in monolayer experiments. Biochim. Biophys. Acta 1987; 900: 116–128.</note>
<part><date>1987</date>
<detail type="volume"><caption>vol.</caption>
<number>900</number>
</detail>
<extent unit="pages"><start>116</start>
<end>128</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Biochim. Biophys. Acta</title>
</titleInfo>
<part><date>1987</date>
<detail type="volume"><caption>vol.</caption>
<number>900</number>
</detail>
<extent unit="pages"><start>116</start>
<end>128</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit165"><titleInfo><title>Synthesis of novel immunologically active tripalmitoyl‐S‐glycerylcysteinyl lipopeptides as useful intermediates for immunogen preparations</title>
</titleInfo>
<name type="personal"><namePart type="given">J</namePart>
<namePart type="family">Metzger</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">KH</namePart>
<namePart type="family">Wiesmuller</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">R</namePart>
<namePart type="family">Schaude</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">WG</namePart>
<namePart type="family">Bessler</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">G</namePart>
<namePart type="family">Jung</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Metzger J, Wiesmuller KH, Schaude R, Bessler WG, Jung G. Synthesis of novel immunologically active tripalmitoyl‐S‐glycerylcysteinyl lipopeptides as useful intermediates for immunogen preparations. Int. J. Pept. Protein Res. 1991; 37: 46–57.</note>
<part><date>1991</date>
<detail type="volume"><caption>vol.</caption>
<number>37</number>
</detail>
<extent unit="pages"><start>46</start>
<end>57</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Int. J. Pept. Protein Res.</title>
</titleInfo>
<part><date>1991</date>
<detail type="volume"><caption>vol.</caption>
<number>37</number>
</detail>
<extent unit="pages"><start>46</start>
<end>57</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit166"><titleInfo><title>Synthetic vaccines: synthesis of a dimeric Tn antigen‐lipopeptide conjugate that elicits immune responses against Tn‐expressing glycoproteins</title>
</titleInfo>
<name type="personal"><namePart type="given">T</namePart>
<namePart type="family">Toyokuni</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">B</namePart>
<namePart type="family">Dean</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">S</namePart>
<namePart type="family">Cai</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">D</namePart>
<namePart type="family">Boivin</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">S</namePart>
<namePart type="family">Hakomori</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">AK</namePart>
<namePart type="family">Singhal</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Toyokuni T, Dean B, Cai S, Boivin D, Hakomori S, Singhal AK. Synthetic vaccines: synthesis of a dimeric Tn antigen‐lipopeptide conjugate that elicits immune responses against Tn‐expressing glycoproteins. J. Am. Chem. Soc. 1994; 116: 395–396.</note>
<part><date>1994</date>
<detail type="volume"><caption>vol.</caption>
<number>116</number>
</detail>
<extent unit="pages"><start>395</start>
<end>396</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>J. Am. Chem. Soc.</title>
</titleInfo>
<part><date>1994</date>
<detail type="volume"><caption>vol.</caption>
<number>116</number>
</detail>
<extent unit="pages"><start>395</start>
<end>396</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit167"><titleInfo><title>Synthetic carbohydrate vaccines: synthesis and immunogenicity of Tn antigen conjugates</title>
</titleInfo>
<name type="personal"><namePart type="given">T</namePart>
<namePart type="family">Toyokuni</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">S</namePart>
<namePart type="family">Hakomori</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">AK</namePart>
<namePart type="family">Singhal</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Toyokuni T, Hakomori S, Singhal AK. Synthetic carbohydrate vaccines: synthesis and immunogenicity of Tn antigen conjugates. Bioorg. Med. Chem. 1994; 2: 1119–1132.</note>
<part><date>1994</date>
<detail type="volume"><caption>vol.</caption>
<number>2</number>
</detail>
<extent unit="pages"><start>1119</start>
<end>1132</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Bioorg. Med. Chem.</title>
</titleInfo>
<part><date>1994</date>
<detail type="volume"><caption>vol.</caption>
<number>2</number>
</detail>
<extent unit="pages"><start>1119</start>
<end>1132</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit168"><titleInfo><title>MDP and other muropeptides–direct and synergistic effects on the immune system</title>
</titleInfo>
<name type="personal"><namePart type="given">S</namePart>
<namePart type="family">Traub</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">S</namePart>
<namePart type="family">von Aulock</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">T</namePart>
<namePart type="family">Hartung</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">C</namePart>
<namePart type="family">Hermann</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Traub S, von Aulock S, Hartung T, Hermann C. MDP and other muropeptides–direct and synergistic effects on the immune system [A Review]. J. Endotoxin Res. 2006; 12: 69–85.</note>
<part><date>2006</date>
<detail type="volume"><caption>vol.</caption>
<number>12</number>
</detail>
<extent unit="pages"><start>69</start>
<end>85</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>J. Endotoxin Res.</title>
</titleInfo>
<part><date>2006</date>
<detail type="volume"><caption>vol.</caption>
<number>12</number>
</detail>
<extent unit="pages"><start>69</start>
<end>85</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit169"><titleInfo><title>Liposomal muramyl tripeptide phosphatidyl ethanolamine: ifosfamide‐containing chemotherapy in osteosarcoma</title>
</titleInfo>
<name type="personal"><namePart type="given">P</namePart>
<namePart type="family">Anderson</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Anderson P. Liposomal muramyl tripeptide phosphatidyl ethanolamine: ifosfamide‐containing chemotherapy in osteosarcoma [A Review]. Future Oncol. 2006; 2: 333–343.</note>
<part><date>2006</date>
<detail type="volume"><caption>vol.</caption>
<number>2</number>
</detail>
<extent unit="pages"><start>333</start>
<end>343</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Future Oncol.</title>
</titleInfo>
<part><date>2006</date>
<detail type="volume"><caption>vol.</caption>
<number>2</number>
</detail>
<extent unit="pages"><start>333</start>
<end>343</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit170"><titleInfo><title>Comparison of antigen constructs and carrier molecules for augmenting the immunogenicity of the monosaccharide epithelial cancer antigen Tn</title>
</titleInfo>
<name type="personal"><namePart type="given">E</namePart>
<namePart type="family">Kagan</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">G</namePart>
<namePart type="family">Ragupathi</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">SS</namePart>
<namePart type="family">Yi</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">CA</namePart>
<namePart type="family">Reis</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">J</namePart>
<namePart type="family">Gildersleeve</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">D</namePart>
<namePart type="family">Kahne</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">H</namePart>
<namePart type="family">Clausen</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">SJ</namePart>
<namePart type="family">Danishefsky</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">PO</namePart>
<namePart type="family">Livingston</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Kagan E, Ragupathi G, Yi SS, Reis CA, Gildersleeve J, Kahne D, Clausen H, Danishefsky SJ, Livingston PO. Comparison of antigen constructs and carrier molecules for augmenting the immunogenicity of the monosaccharide epithelial cancer antigen Tn. Cancer Immunol. Immunother. 2005; 54: 424–430.</note>
<part><date>2005</date>
<detail type="volume"><caption>vol.</caption>
<number>54</number>
</detail>
<extent unit="pages"><start>424</start>
<end>430</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Cancer Immunol. Immunother.</title>
</titleInfo>
<part><date>2005</date>
<detail type="volume"><caption>vol.</caption>
<number>54</number>
</detail>
<extent unit="pages"><start>424</start>
<end>430</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit171"><titleInfo><title>“Wave‐type” structure of a synthetic hexaglycosylated decapeptide: a part of the extracellular domain of human glycophorin A</title>
</titleInfo>
<name type="personal"><namePart type="given">O</namePart>
<namePart type="family">Schuster</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">G</namePart>
<namePart type="family">Klich</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">V</namePart>
<namePart type="family">Sinnwell</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">H</namePart>
<namePart type="family">Kranz</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">H</namePart>
<namePart type="family">Paulsen</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">B</namePart>
<namePart type="family">Meyer</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Schuster O, Klich G, Sinnwell V, Kranz H, Paulsen H, Meyer B. “Wave‐type” structure of a synthetic hexaglycosylated decapeptide: a part of the extracellular domain of human glycophorin A. J. Biomol. NMR 1999; 14: 33–45.</note>
<part><date>1999</date>
<detail type="volume"><caption>vol.</caption>
<number>14</number>
</detail>
<extent unit="pages"><start>33</start>
<end>45</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>J. Biomol. NMR</title>
</titleInfo>
<part><date>1999</date>
<detail type="volume"><caption>vol.</caption>
<number>14</number>
</detail>
<extent unit="pages"><start>33</start>
<end>45</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit172"><titleInfo><title>Synthesis of oxime‐linked mucin mimics containing the tumor‐related TN and sialyl TN antigens</title>
</titleInfo>
<name type="personal"><namePart type="given">LA</namePart>
<namePart type="family">Marcaurelle</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">Y</namePart>
<namePart type="family">Shin</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">S</namePart>
<namePart type="family">Goon</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">CR</namePart>
<namePart type="family">Bertozzi</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Marcaurelle LA, Shin Y, Goon S, Bertozzi CR. Synthesis of oxime‐linked mucin mimics containing the tumor‐related TN and sialyl TN antigens. Org. Lett. 2001; 3: 3691–3694.</note>
<part><date>2001</date>
<detail type="volume"><caption>vol.</caption>
<number>3</number>
</detail>
<extent unit="pages"><start>3691</start>
<end>3694</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Org. Lett.</title>
</titleInfo>
<part><date>2001</date>
<detail type="volume"><caption>vol.</caption>
<number>3</number>
</detail>
<extent unit="pages"><start>3691</start>
<end>3694</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit173"><titleInfo><title>Synthesis and biological evaluation of an anticancer vaccine containing the C‐glycoside analogue of the Tn epitope</title>
</titleInfo>
<name type="personal"><namePart type="given">F</namePart>
<namePart type="family">Peri</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">L</namePart>
<namePart type="family">Cipolla</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">M</namePart>
<namePart type="family">Rescigno</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">B</namePart>
<namePart type="family">La Ferla</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">F</namePart>
<namePart type="family">Nicotra</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Peri F, Cipolla L, Rescigno M, La Ferla B, Nicotra F. Synthesis and biological evaluation of an anticancer vaccine containing the C‐glycoside analogue of the Tn epitope. Bioconjug. Chem. 2001; 12: 325–328.</note>
<part><date>2001</date>
<detail type="volume"><caption>vol.</caption>
<number>12</number>
</detail>
<extent unit="pages"><start>325</start>
<end>328</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Bioconjug. Chem.</title>
</titleInfo>
<part><date>2001</date>
<detail type="volume"><caption>vol.</caption>
<number>12</number>
</detail>
<extent unit="pages"><start>325</start>
<end>328</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit174"><titleInfo><title>Oligomeric glycopeptidomimetics bearing the cancer related TN‐antigen</title>
</titleInfo>
<name type="personal"><namePart type="given">JM</namePart>
<namePart type="family">Kim</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">R</namePart>
<namePart type="family">Roy</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Kim JM, Roy R. Oligomeric glycopeptidomimetics bearing the cancer related TN‐antigen. Tetrahedron Lett. 1997; 38: 3487–3490.</note>
<part><date>1997</date>
<detail type="volume"><caption>vol.</caption>
<number>38</number>
</detail>
<extent unit="pages"><start>3487</start>
<end>3490</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Tetrahedron Lett.</title>
</titleInfo>
<part><date>1997</date>
<detail type="volume"><caption>vol.</caption>
<number>38</number>
</detail>
<extent unit="pages"><start>3487</start>
<end>3490</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit175"><titleInfo><title>Peptoids: A modular approach to drug discovery</title>
</titleInfo>
<name type="personal"><namePart type="given">RJ</namePart>
<namePart type="family">Simon</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">RS</namePart>
<namePart type="family">Kania</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">RN</namePart>
<namePart type="family">Zuckermann</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">VD</namePart>
<namePart type="family">Huebner</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">DA</namePart>
<namePart type="family">Jewell</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">S</namePart>
<namePart type="family">Banville</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">S</namePart>
<namePart type="family">Ng</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">L</namePart>
<namePart type="family">Wang</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">S</namePart>
<namePart type="family">Rosenberg</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">ChK</namePart>
<namePart type="family">Marlowe</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">DC</namePart>
<namePart type="family">Spellmeyer</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">R</namePart>
<namePart type="family">Tan</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">AD</namePart>
<namePart type="family">Frankel</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">DV</namePart>
<namePart type="family">Santi</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">FE</namePart>
<namePart type="family">Cohen</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">PA</namePart>
<namePart type="family">Barlett</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Simon RJ, Kania RS, Zuckermann RN, Huebner VD, Jewell DA, Banville S, Ng S, Wang L, Rosenberg S, Marlowe ChK, Spellmeyer DC, Tan R, Frankel AD, Santi DV, Cohen FE, Barlett PA. Peptoids: A modular approach to drug discovery. Proc. Natl. Acad. Sci. U.S.A. 1992; 89: 9367–9371.</note>
<part><date>1992</date>
<detail type="volume"><caption>vol.</caption>
<number>89</number>
</detail>
<extent unit="pages"><start>9367</start>
<end>9371</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Proc. Natl. Acad. Sci. U.S.A.</title>
</titleInfo>
<part><date>1992</date>
<detail type="volume"><caption>vol.</caption>
<number>89</number>
</detail>
<extent unit="pages"><start>9367</start>
<end>9371</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit176"><titleInfo><title>New directions in the synthesis of glycopeptide mimetics</title>
</titleInfo>
<name type="personal"><namePart type="given">LA</namePart>
<namePart type="family">Marcaurelle</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">CR</namePart>
<namePart type="family">Bertozzi</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Marcaurelle LA, Bertozzi CR. New directions in the synthesis of glycopeptide mimetics [A Review]. Chem. Eur. J. 1999; 5: 1384–1390.</note>
<part><date>1999</date>
<detail type="volume"><caption>vol.</caption>
<number>5</number>
</detail>
<extent unit="pages"><start>1384</start>
<end>1390</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Chem. Eur. J.</title>
</titleInfo>
<part><date>1999</date>
<detail type="volume"><caption>vol.</caption>
<number>5</number>
</detail>
<extent unit="pages"><start>1384</start>
<end>1390</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit177"><titleInfo><title>Novel lysine‐peptoid hybrids with antibacterial properties</title>
</titleInfo>
<name type="personal"><namePart type="given">TS</namePart>
<namePart type="family">Ryge</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">PR</namePart>
<namePart type="family">Hansen</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Ryge TS, Hansen PR. Novel lysine‐peptoid hybrids with antibacterial properties. J. Pept. Sci. 2005; 11: 727–734.</note>
<part><date>2005</date>
<detail type="volume"><caption>vol.</caption>
<number>11</number>
</detail>
<extent unit="pages"><start>727</start>
<end>734</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>J. Pept. Sci.</title>
</titleInfo>
<part><date>2005</date>
<detail type="volume"><caption>vol.</caption>
<number>11</number>
</detail>
<extent unit="pages"><start>727</start>
<end>734</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit178"><titleInfo><title>A potentially valuable advance in the synthesis of carbohydrate‐based anticancer vaccines through extended cycloaddition chemistry</title>
</titleInfo>
<name type="personal"><namePart type="given">Q</namePart>
<namePart type="family">Wan</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">J</namePart>
<namePart type="family">Chen</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">G</namePart>
<namePart type="family">Chen</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">SJ</namePart>
<namePart type="family">Danishefsky</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Wan Q, Chen J, Chen G, Danishefsky SJ. A potentially valuable advance in the synthesis of carbohydrate‐based anticancer vaccines through extended cycloaddition chemistry. J. Org. Chem. 2006; 71: 8244–8249.</note>
<part><date>2006</date>
<detail type="volume"><caption>vol.</caption>
<number>71</number>
</detail>
<extent unit="pages"><start>8244</start>
<end>8249</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>J. Org. Chem.</title>
</titleInfo>
<part><date>2006</date>
<detail type="volume"><caption>vol.</caption>
<number>71</number>
</detail>
<extent unit="pages"><start>8244</start>
<end>8249</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit179"><titleInfo><title>Molecular dynamics study of the effect of the gamma‐Abu insert on the conformational behavior of the glycopeptide dendrimers based on the oligolysine scaffold in N,N′‐dimethylformamide</title>
</titleInfo>
<name type="personal"><namePart type="given">P</namePart>
<namePart type="family">Vepřek</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">J</namePart>
<namePart type="family">Ježek</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">T</namePart>
<namePart type="family">Trnka</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">J</namePart>
<namePart type="family">Vondrášek</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Vepřek P, Ježek J, Trnka T, Vondrášek J. Molecular dynamics study of the effect of the gamma‐Abu insert on the conformational behavior of the glycopeptide dendrimers based on the oligolysine scaffold in N,N′‐dimethylformamide. J. Biomol. Struct. Dyn. 2004; 22: 79–90.</note>
<part><date>2004</date>
<detail type="volume"><caption>vol.</caption>
<number>22</number>
</detail>
<extent unit="pages"><start>79</start>
<end>90</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>J. Biomol. Struct. Dyn.</title>
</titleInfo>
<part><date>2004</date>
<detail type="volume"><caption>vol.</caption>
<number>22</number>
</detail>
<extent unit="pages"><start>79</start>
<end>90</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit180"><titleInfo><title>Synthesis and protein‐binding properties of T‐antigen containing glycoPAMAM dendrimers</title>
</titleInfo>
<name type="personal"><namePart type="given">MG</namePart>
<namePart type="family">Baek</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">R</namePart>
<namePart type="family">Roy</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Baek MG, Roy R. Synthesis and protein‐binding properties of T‐antigen containing glycoPAMAM dendrimers. Bioorg. Med. Chem. 2002; 10: 11–17.</note>
<part><date>2002</date>
<detail type="volume"><caption>vol.</caption>
<number>10</number>
</detail>
<extent unit="pages"><start>11</start>
<end>17</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Bioorg. Med. Chem.</title>
</titleInfo>
<part><date>2002</date>
<detail type="volume"><caption>vol.</caption>
<number>10</number>
</detail>
<extent unit="pages"><start>11</start>
<end>17</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit181"><titleInfo><title>Multivalent breast cancer T‐antigen markers scaffolded onto PAMAM dendrimers</title>
</titleInfo>
<name type="personal"><namePart type="given">R</namePart>
<namePart type="family">Roy</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">MG</namePart>
<namePart type="family">Baek</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Roy R, Baek MG. Multivalent breast cancer T‐antigen markers scaffolded onto PAMAM dendrimers [A Review]. Meth. Enzymol. 2003; 362: 240–249.</note>
<part><date>2003</date>
<detail type="volume"><caption>vol.</caption>
<number>362</number>
</detail>
<extent unit="pages"><start>240</start>
<end>249</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Meth. Enzymol.</title>
</titleInfo>
<part><date>2003</date>
<detail type="volume"><caption>vol.</caption>
<number>362</number>
</detail>
<extent unit="pages"><start>240</start>
<end>249</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit182"><titleInfo><title>Simultaneous binding of mouse monoclonal antibody and streptavidin to heterobifunctional dendritic L‐lysine core bearing T‐antigen tumor marker and biotin</title>
</titleInfo>
<name type="personal"><namePart type="given">MG</namePart>
<namePart type="family">Baek</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">R</namePart>
<namePart type="family">Roy</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Baek MG, Roy R. Simultaneous binding of mouse monoclonal antibody and streptavidin to heterobifunctional dendritic L‐lysine core bearing T‐antigen tumor marker and biotin. Bioorg. Med. Chem. 2001; 9: 3005–3011.</note>
<part><date>2001</date>
<detail type="volume"><caption>vol.</caption>
<number>9</number>
</detail>
<extent unit="pages"><start>3005</start>
<end>3011</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Bioorg. Med. Chem.</title>
</titleInfo>
<part><date>2001</date>
<detail type="volume"><caption>vol.</caption>
<number>9</number>
</detail>
<extent unit="pages"><start>3005</start>
<end>3011</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit183"><titleInfo><title>Vaccination with Theratope® (STn‐KLH) as treatment for breast cancer</title>
</titleInfo>
<name type="personal"><namePart type="given">LA</namePart>
<namePart type="family">Holmberg</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">BM</namePart>
<namePart type="family">Sandmaier</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Holmberg LA, Sandmaier BM. Vaccination with Theratope® (STn‐KLH) as treatment for breast cancer [A Review]. Expert Rev. Vaccines 2004; 3: 655–663.</note>
<part><date>2004</date>
<detail type="volume"><caption>vol.</caption>
<number>3</number>
</detail>
<extent unit="pages"><start>655</start>
<end>663</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Expert Rev. Vaccines</title>
</titleInfo>
<part><date>2004</date>
<detail type="volume"><caption>vol.</caption>
<number>3</number>
</detail>
<extent unit="pages"><start>655</start>
<end>663</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit184"><titleInfo><title>Theratope® vaccine (STn‐KLH)</title>
</titleInfo>
<name type="personal"><namePart type="given">LA</namePart>
<namePart type="family">Holmberg</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">BM</namePart>
<namePart type="family">Sandmaier</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Holmberg LA, Sandmaier BM. Theratope® vaccine (STn‐KLH). [A Review]. Expert Opin. Biol. Ther. 2001; 1: 881–891.</note>
<part><date>2001</date>
<detail type="volume"><caption>vol.</caption>
<number>1</number>
</detail>
<extent unit="pages"><start>881</start>
<end>891</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Expert Opin. Biol. Ther.</title>
</titleInfo>
<part><date>2001</date>
<detail type="volume"><caption>vol.</caption>
<number>1</number>
</detail>
<extent unit="pages"><start>881</start>
<end>891</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit185"><titleInfo><title>Solid‐phase synthesis of the glycopeptide of human glycophorin AM bearing the consecutive sialyl‐T antigen</title>
</titleInfo>
<name type="personal"><namePart type="given">S</namePart>
<namePart type="family">Ando</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">Y</namePart>
<namePart type="family">Nakahara</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">Y</namePart>
<namePart type="family">Ito</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">T</namePart>
<namePart type="family">Ogawa</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">Y</namePart>
<namePart type="family">Nakahara</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Ando S, Nakahara Y, Ito Y, Ogawa T, Nakahara Y. Solid‐phase synthesis of the glycopeptide of human glycophorin AM bearing the consecutive sialyl‐T antigen. Carbohydr. Res. 2000; 329: 773–780.</note>
<part><date>2000</date>
<detail type="volume"><caption>vol.</caption>
<number>329</number>
</detail>
<extent unit="pages"><start>773</start>
<end>780</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Carbohydr. Res.</title>
</titleInfo>
<part><date>2000</date>
<detail type="volume"><caption>vol.</caption>
<number>329</number>
</detail>
<extent unit="pages"><start>773</start>
<end>780</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit186"><titleInfo><title>Characterization of glycosphingolipid antigen defined by the monoclonal antibody MBr1 expressed in normal and neoplastic epithelial cells of human mammary gland</title>
</titleInfo>
<name type="personal"><namePart type="given">EG</namePart>
<namePart type="family">Bremer</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">SB</namePart>
<namePart type="family">Levery</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">S</namePart>
<namePart type="family">Sonnino</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">R</namePart>
<namePart type="family">Ghidoni</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">S</namePart>
<namePart type="family">Canevari</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">R</namePart>
<namePart type="family">Kannagi</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">S</namePart>
<namePart type="family">Hakomori</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Bremer EG, Levery SB, Sonnino S, Ghidoni R, Canevari S, Kannagi R, Hakomori S. Characterization of glycosphingolipid antigen defined by the monoclonal antibody MBr1 expressed in normal and neoplastic epithelial cells of human mammary gland. J. Biol. Chem. 1984; 259: 14773–14777.</note>
<part><date>1984</date>
<detail type="volume"><caption>vol.</caption>
<number>259</number>
</detail>
<extent unit="pages"><start>14773</start>
<end>14777</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>J. Biol. Chem.</title>
</titleInfo>
<part><date>1984</date>
<detail type="volume"><caption>vol.</caption>
<number>259</number>
</detail>
<extent unit="pages"><start>14773</start>
<end>14777</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit187"><titleInfo><title>Improved survival in stage III melanoma patients with GM2 antibodies: a randomized trial of adjuvant vaccination with GM2 ganglioside</title>
</titleInfo>
<name type="personal"><namePart type="given">PO</namePart>
<namePart type="family">Livingston</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">GY</namePart>
<namePart type="family">Wong</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">S</namePart>
<namePart type="family">Adluri</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">Y</namePart>
<namePart type="family">Tao</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">M</namePart>
<namePart type="family">Padavan</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">R</namePart>
<namePart type="family">Parente</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">C</namePart>
<namePart type="family">Hanlon</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">MJ</namePart>
<namePart type="family">Calves</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">F</namePart>
<namePart type="family">Helling</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">G</namePart>
<namePart type="family">Ritter</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">HF</namePart>
<namePart type="family">Oettgen</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">KO</namePart>
<namePart type="family">Lloyd</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Livingston PO, Wong GY, Adluri S, Tao Y, Padavan M, Parente R, Hanlon C, Calves MJ, Helling F, Ritter G, Oettgen HF, Lloyd KO. Improved survival in stage III melanoma patients with GM2 antibodies: a randomized trial of adjuvant vaccination with GM2 ganglioside. J. Clin. Oncol. 1994; 12: 1036–1044.</note>
<part><date>1994</date>
<detail type="volume"><caption>vol.</caption>
<number>12</number>
</detail>
<extent unit="pages"><start>1036</start>
<end>1044</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>J. Clin. Oncol.</title>
</titleInfo>
<part><date>1994</date>
<detail type="volume"><caption>vol.</caption>
<number>12</number>
</detail>
<extent unit="pages"><start>1036</start>
<end>1044</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit188"><titleInfo><title>Preparation of multifunctional glyconanoparticles as a platform for potential carbohydrate‐based anticancer vaccines</title>
</titleInfo>
<name type="personal"><namePart type="given">R</namePart>
<namePart type="family">Ojeda</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">JL</namePart>
<namePart type="family">de Paz</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">AG</namePart>
<namePart type="family">Barrientos</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">M</namePart>
<namePart type="family">Martin‐Lomas</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">S</namePart>
<namePart type="family">Penadés</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Ojeda R, de Paz JL, Barrientos AG, Martin‐Lomas M, Penadés S. Preparation of multifunctional glyconanoparticles as a platform for potential carbohydrate‐based anticancer vaccines. Carbohydr. Res. 2007; 342: 448–459.</note>
<part><date>2007</date>
<detail type="volume"><caption>vol.</caption>
<number>342</number>
</detail>
<extent unit="pages"><start>448</start>
<end>459</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Carbohydr. Res.</title>
</titleInfo>
<part><date>2007</date>
<detail type="volume"><caption>vol.</caption>
<number>342</number>
</detail>
<extent unit="pages"><start>448</start>
<end>459</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit189"><titleInfo><title>Reiterative cysteine‐based coupling leading to complex, homogeneous glycopeptides</title>
</titleInfo>
<name type="personal"><namePart type="given">B</namePart>
<namePart type="family">Wu</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">JD</namePart>
<namePart type="family">Warren</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">J</namePart>
<namePart type="family">Chen</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">G</namePart>
<namePart type="family">Chen</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">Z</namePart>
<namePart type="family">Hua</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">SJ</namePart>
<namePart type="family">Danishefsky</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Wu B, Warren JD, Chen J, Chen G, Hua Z, Danishefsky SJ. Reiterative cysteine‐based coupling leading to complex, homogeneous glycopeptides. Tetrahedron Lett. 2006; 47: 5219–5223.</note>
<part><date>2006</date>
<detail type="volume"><caption>vol.</caption>
<number>47</number>
</detail>
<extent unit="pages"><start>5219</start>
<end>5223</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Tetrahedron Lett.</title>
</titleInfo>
<part><date>2006</date>
<detail type="volume"><caption>vol.</caption>
<number>47</number>
</detail>
<extent unit="pages"><start>5219</start>
<end>5223</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit190"><titleInfo><title>Building complex glycopeptides: development of a cysteine‐free native chemical ligation protocol</title>
</titleInfo>
<name type="personal"><namePart type="given">B</namePart>
<namePart type="family">Wu</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">J</namePart>
<namePart type="family">Chen</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">JD</namePart>
<namePart type="family">Warren</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">G</namePart>
<namePart type="family">Chen</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">Z</namePart>
<namePart type="family">Hua</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">SJ</namePart>
<namePart type="family">Danishefsky</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Wu B, Chen J, Warren JD, Chen G, Hua Z, Danishefsky SJ. Building complex glycopeptides: development of a cysteine‐free native chemical ligation protocol. Angew. Chem. Int. Ed. Engl. 2006; 45: 4116–4125.</note>
<part><date>2006</date>
<detail type="volume"><caption>vol.</caption>
<number>45</number>
</detail>
<extent unit="pages"><start>4116</start>
<end>4125</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Angew. Chem. Int. Ed. Engl.</title>
</titleInfo>
<part><date>2006</date>
<detail type="volume"><caption>vol.</caption>
<number>45</number>
</detail>
<extent unit="pages"><start>4116</start>
<end>4125</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit191"><titleInfo><title>The role of dynamically correlated equilibria in the folding of macromolecular structures. A model for the design of folded dendrimers</title>
</titleInfo>
<name type="personal"><namePart type="given">JW</namePart>
<namePart type="family">Lockman</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">NM</namePart>
<namePart type="family">Paul</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">JR</namePart>
<namePart type="family">Parquette</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Lockman JW, Paul NM, Parquette JR. The role of dynamically correlated equilibria in the folding of macromolecular structures. A model for the design of folded dendrimers [A Review]. Prog. Polym. Sci. 2005; 30: 423–452.</note>
<part><date>2005</date>
<detail type="volume"><caption>vol.</caption>
<number>30</number>
</detail>
<extent unit="pages"><start>423</start>
<end>452</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Prog. Polym. Sci.</title>
</titleInfo>
<part><date>2005</date>
<detail type="volume"><caption>vol.</caption>
<number>30</number>
</detail>
<extent unit="pages"><start>423</start>
<end>452</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit192"><titleInfo><title>Large oligosaccharide‐based glycodendrimers</title>
</titleInfo>
<name type="personal"><namePart type="given">WB</namePart>
<namePart type="family">Turnbull</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">SA</namePart>
<namePart type="family">Kalovidouris</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">JF</namePart>
<namePart type="family">Stoddart</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Turnbull WB, Kalovidouris SA, Stoddart JF. Large oligosaccharide‐based glycodendrimers. Chem. Eur. J. 2002; 8: 2988–3000.</note>
<part><date>2002</date>
<detail type="volume"><caption>vol.</caption>
<number>8</number>
</detail>
<extent unit="pages"><start>2988</start>
<end>3000</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Chem. Eur. J.</title>
</titleInfo>
<part><date>2002</date>
<detail type="volume"><caption>vol.</caption>
<number>8</number>
</detail>
<extent unit="pages"><start>2988</start>
<end>3000</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit193"><titleInfo><title>Synthesis of cyclodextrin‐based carbohydrate clusters by photoaddition reactions</title>
</titleInfo>
<name type="personal"><namePart type="given">DA</namePart>
<namePart type="family">Fulton</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">JF</namePart>
<namePart type="family">Stoddart</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Fulton DA, Stoddart JF. Synthesis of cyclodextrin‐based carbohydrate clusters by photoaddition reactions. J. Org. Chem. 2001; 66: 8309–8319.</note>
<part><date>2001</date>
<detail type="volume"><caption>vol.</caption>
<number>66</number>
</detail>
<extent unit="pages"><start>8309</start>
<end>8319</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>J. Org. Chem.</title>
</titleInfo>
<part><date>2001</date>
<detail type="volume"><caption>vol.</caption>
<number>66</number>
</detail>
<extent unit="pages"><start>8309</start>
<end>8319</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit194"><titleInfo><title>Molecular dynamics simulations of glycoclusters and glycodendrimers</title>
</titleInfo>
<name type="personal"><namePart type="given">CW</namePart>
<namePart type="family">von der Lieth</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">M</namePart>
<namePart type="family">Frank</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">TK</namePart>
<namePart type="family">Lindhorst</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">von der Lieth CW, Frank M, Lindhorst TK. Molecular dynamics simulations of glycoclusters and glycodendrimers [A Review]. Rev. Mol. Biotechnol. 2002; 90: 311–337.</note>
<part><date>2002</date>
<detail type="volume"><caption>vol.</caption>
<number>90</number>
</detail>
<extent unit="pages"><start>311</start>
<end>337</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Rev. Mol. Biotechnol.</title>
</titleInfo>
<part><date>2002</date>
<detail type="volume"><caption>vol.</caption>
<number>90</number>
</detail>
<extent unit="pages"><start>311</start>
<end>337</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit195"><titleInfo><title>Synthesis of maleimide‐activated carbohydrates as chemoselective tags for site‐specific glycosylation of peptides and proteins</title>
</titleInfo>
<name type="personal"><namePart type="given">J</namePart>
<namePart type="family">Ni</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">S</namePart>
<namePart type="family">Singh</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">LX</namePart>
<namePart type="family">Wang</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Ni J, Singh S, Wang LX. Synthesis of maleimide‐activated carbohydrates as chemoselective tags for site‐specific glycosylation of peptides and proteins. Bioconjug. Chem. 2003; 14: 232–238.</note>
<part><date>2003</date>
<detail type="volume"><caption>vol.</caption>
<number>14</number>
</detail>
<extent unit="pages"><start>232</start>
<end>238</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Bioconjug. Chem.</title>
</titleInfo>
<part><date>2003</date>
<detail type="volume"><caption>vol.</caption>
<number>14</number>
</detail>
<extent unit="pages"><start>232</start>
<end>238</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit196"><titleInfo><title>Carbohydrate‐centered maleimide cluster as a new type of templates for multivalent peptide assembling: synthesis of multivalent HIV‐1 gp41 peptides</title>
</titleInfo>
<name type="personal"><namePart type="given">LX</namePart>
<namePart type="family">Wang</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">J</namePart>
<namePart type="family">Ni</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">S</namePart>
<namePart type="family">Singh</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Wang LX, Ni J, Singh S. Carbohydrate‐centered maleimide cluster as a new type of templates for multivalent peptide assembling: synthesis of multivalent HIV‐1 gp41 peptides. Bioorg. Med. Chem. 2003; 11: 159–166.</note>
<part><date>2003</date>
<detail type="volume"><caption>vol.</caption>
<number>11</number>
</detail>
<extent unit="pages"><start>159</start>
<end>166</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Bioorg. Med. Chem.</title>
</titleInfo>
<part><date>2003</date>
<detail type="volume"><caption>vol.</caption>
<number>11</number>
</detail>
<extent unit="pages"><start>159</start>
<end>166</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit197"><titleInfo><title>In pursuit of carbohydrate‐based HIV vaccines, part 1: The total synthesis of hybrid‐type gp120 fragments</title>
</titleInfo>
<name type="personal"><namePart type="given">M</namePart>
<namePart type="family">Mandal</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">VY</namePart>
<namePart type="family">Dudkin</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">X</namePart>
<namePart type="family">Geng</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">SJ</namePart>
<namePart type="family">Danishefsky</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Mandal M, Dudkin VY, Geng X, Danishefsky SJ. In pursuit of carbohydrate‐based HIV vaccines, part 1: The total synthesis of hybrid‐type gp120 fragments. Angew. Chem. Int. Ed. Engl. 2004; 43: 2557–2561.</note>
<part><date>2004</date>
<detail type="volume"><caption>vol.</caption>
<number>43</number>
</detail>
<extent unit="pages"><start>2557</start>
<end>2561</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Angew. Chem. Int. Ed. Engl.</title>
</titleInfo>
<part><date>2004</date>
<detail type="volume"><caption>vol.</caption>
<number>43</number>
</detail>
<extent unit="pages"><start>2557</start>
<end>2561</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit198"><titleInfo><title>In pursuit of carbohydrate‐based HIV vaccines, Part 2: The total synthesis of high‐mannose‐type gp120 fragments‐evaluation of strategies directed to maximal convergence</title>
</titleInfo>
<name type="personal"><namePart type="given">X</namePart>
<namePart type="family">Geng</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">VY</namePart>
<namePart type="family">Dudkin</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">M</namePart>
<namePart type="family">Mandal</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">SJ</namePart>
<namePart type="family">Danishefsky</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Geng X, Dudkin VY, Mandal M, Danishefsky SJ. In pursuit of carbohydrate‐based HIV vaccines, Part 2: The total synthesis of high‐mannose‐type gp120 fragments‐evaluation of strategies directed to maximal convergence. Angew. Chem. Int. Ed. Engl. 2004; 43: 2562–2565.</note>
<part><date>2004</date>
<detail type="volume"><caption>vol.</caption>
<number>43</number>
</detail>
<extent unit="pages"><start>2562</start>
<end>2565</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Angew. Chem. Int. Ed. Engl.</title>
</titleInfo>
<part><date>2004</date>
<detail type="volume"><caption>vol.</caption>
<number>43</number>
</detail>
<extent unit="pages"><start>2562</start>
<end>2565</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit199"><titleInfo><title>Convergent dendrons and dendrimers: from synthesis to applications</title>
</titleInfo>
<name type="personal"><namePart type="given">SM</namePart>
<namePart type="family">Grayson</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">JMJ</namePart>
<namePart type="family">Fréchet</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Grayson SM, Fréchet JMJ. Convergent dendrons and dendrimers: from synthesis to applications [A Review]. Chem. Rev. 2001; 101: 3819–3867.</note>
<part><date>2001</date>
<detail type="volume"><caption>vol.</caption>
<number>101</number>
</detail>
<extent unit="pages"><start>3819</start>
<end>3867</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Chem. Rev.</title>
</titleInfo>
<part><date>2001</date>
<detail type="volume"><caption>vol.</caption>
<number>101</number>
</detail>
<extent unit="pages"><start>3819</start>
<end>3867</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit200"><titleInfo><title>Calixarenes enhanced as dendrimers. A mini review</title>
</titleInfo>
<name type="personal"><namePart type="given">L</namePart>
<namePart type="family">Baklouti</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">N</namePart>
<namePart type="family">Cheriaa</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">M</namePart>
<namePart type="family">Mahouachi</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">AB</namePart>
<namePart type="family">Othman</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">R</namePart>
<namePart type="family">Abidi</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">JS</namePart>
<namePart type="family">Kim</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">Y</namePart>
<namePart type="family">Kim</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">J</namePart>
<namePart type="family">Vicens</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Baklouti L, Cheriaa N, Mahouachi M, Othman AB, Abidi R, Kim JS, Kim Y, Vicens J. Calixarenes enhanced as dendrimers. A mini review [A Review]. Mini‐Rev. Org. Chem. 2006; 3: 219–228.</note>
<part><date>2006</date>
<detail type="volume"><caption>vol.</caption>
<number>3</number>
</detail>
<extent unit="pages"><start>219</start>
<end>228</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Mini‐Rev. Org. Chem.</title>
</titleInfo>
<part><date>2006</date>
<detail type="volume"><caption>vol.</caption>
<number>3</number>
</detail>
<extent unit="pages"><start>219</start>
<end>228</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit201"><titleInfo><title>Calixarene‐based dendrimers. A timely review</title>
</titleInfo>
<name type="personal"><namePart type="given">L</namePart>
<namePart type="family">Baklouti</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">N</namePart>
<namePart type="family">Cheriaa</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">M</namePart>
<namePart type="family">Mahouachi</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">R</namePart>
<namePart type="family">Abidi</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">JS</namePart>
<namePart type="family">Kim</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">Y</namePart>
<namePart type="family">Kim</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">J</namePart>
<namePart type="family">Vicens</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Baklouti L, Cheriaa N, Mahouachi M, Abidi R, Kim JS, Kim Y, Vicens J. Calixarene‐based dendrimers. A timely review [A Review]. J. Incl. Phenom. Macrocycl. Chem. 2006; 54: 1–7.</note>
<part><date>2006</date>
<detail type="volume"><caption>vol.</caption>
<number>54</number>
</detail>
<extent unit="pages"><start>1</start>
<end>7</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>J. Incl. Phenom. Macrocycl. Chem.</title>
</titleInfo>
<part><date>2006</date>
<detail type="volume"><caption>vol.</caption>
<number>54</number>
</detail>
<extent unit="pages"><start>1</start>
<end>7</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit202"><titleInfo><title>Dynamic combinatorial chemistry</title>
</titleInfo>
<name type="personal"><namePart type="given">I</namePart>
<namePart type="family">Huc</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">R</namePart>
<namePart type="family">Nguyen</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Huc I, Nguyen R. Dynamic combinatorial chemistry [A Review]. Comb. Chem. High Throughput Screen. 2001; 4: 53–74.</note>
<part><date>2001</date>
<detail type="volume"><caption>vol.</caption>
<number>4</number>
</detail>
<extent unit="pages"><start>53</start>
<end>74</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Comb. Chem. High Throughput Screen.</title>
</titleInfo>
<part><date>2001</date>
<detail type="volume"><caption>vol.</caption>
<number>4</number>
</detail>
<extent unit="pages"><start>53</start>
<end>74</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit203"><titleInfo><title>Nanotechnological applications in medicine</title>
</titleInfo>
<name type="personal"><namePart type="given">SD</namePart>
<namePart type="family">Caruthers</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">SA</namePart>
<namePart type="family">Wickline</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">GM</namePart>
<namePart type="family">Lanza</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Caruthers SD, Wickline SA, Lanza GM. Nanotechnological applications in medicine [A Review]. Curr. Opin. Biotechnol. 2007; 18: 26–30.</note>
<part><date>2007</date>
<detail type="volume"><caption>vol.</caption>
<number>18</number>
</detail>
<extent unit="pages"><start>26</start>
<end>30</end>
</extent>
</part>
<relatedItem type="host"><titleInfo><title>Curr. Opin. Biotechnol.</title>
</titleInfo>
<part><date>2007</date>
<detail type="volume"><caption>vol.</caption>
<number>18</number>
</detail>
<extent unit="pages"><start>26</start>
<end>30</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<identifier type="istex">0E9802423ACEDED654B076627B0AF400FBC38155</identifier>
<identifier type="ark">ark:/67375/WNG-G8S292DG-9</identifier>
<identifier type="DOI">10.1002/psc.1011</identifier>
<identifier type="ArticleID">PSC1011</identifier>
<accessCondition type="use and reproduction" contentType="copyright">Copyright © 2008 European Peptide Society and John Wiley & Sons, Ltd.</accessCondition>
<recordInfo><recordContentSource authority="ISTEX" authorityURI="https://loaded-corpus.data.istex.fr" valueURI="https://loaded-corpus.data.istex.fr/ark:/67375/XBH-L0C46X92-X">wiley</recordContentSource>
<recordOrigin>Converted from  (version ) to MODS version 3.6.</recordOrigin>
<recordCreationDate encoding="w3cdtf">2019-11-16</recordCreationDate>
</recordInfo>
</mods>
<json:item><extension>json</extension>
<original>false</original>
<mimetype>application/json</mimetype>
<uri>https://api.istex.fr/ark:/67375/WNG-G8S292DG-9/record.json</uri>
</json:item>
</metadata>
<serie></serie>
</istex>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/H2N2V1/Data/Istex/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000F50 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 000F50 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    H2N2V1
   |flux=    Istex
   |étape=   Corpus
   |type=    RBID
   |clé=     ISTEX:0E9802423ACEDED654B076627B0AF400FBC38155
   |texte=   Glycopeptide dendrimers, Part III—a review: Use of glycopeptide dendrimers in immunotherapy and diagnosis of cancer and viral diseases
}}

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 14 19:59:40 2020. Site generation: Thu Mar 25 15:38:26 2021

	Serveur d'exploration H2N2
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration H2N2

Glycopeptide dendrimers, Part III—a review: Use of glycopeptide dendrimers in immunotherapy and diagnosis of cancer and viral diseases

Glycopeptide dendrimers, Part III—a review: Use of glycopeptide dendrimers in immunotherapy and diagnosis of cancer and viral diseases

Source :

English descriptors

Abstract

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri